Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation
under an Off-Balance Sheet Arrangement of a Registrant.
The information set forth above under “Loan
and Security Agreement” in Item 1.01 is hereby incorporated by reference into this Item 2.03.
Item 5.03. Certificate of Amendment
to Certificate of Designations.
Effective May 17, 2023,
the Board approved and adopted the Certificate of Amendment to the Certificate of Designations of Series B Convertible Preferred Stock
of the Company (the “Certificate of Amendment to the Certificate of Designations”), which was consented to by a majority
of the holders of outstanding shares of Company Series B Convertible Preferred Stock. The Certificate of Amendment to the Certificate
of Designations was filed with the Secretary of State of the State of Delaware on May 17, 2023. The Certificate of Amendment to the Certificate
of Designations provides that holders of Company Series B Convertible Preferred Stock issued and outstanding immediately prior
to the Effective Time (other than any Dissenting Shares) will be entitled to the right to receive cash, without interest, in an amount
equal to (x) the total number of shares of Company Common Stock issuable upon conversion of the Company Series B Convertible Preferred
Stock that are owned immediately prior to the Effective Time, multiplied by (y) the Per Share Merger Price, in each case other than such
shares held by Parent or the Company, which shall be canceled without payment thereon, and that after the Effective Time, no shares of
Series B Convertible Preferred Stock shall be outstanding and all shares of Series B Convertible Preferred Stock shall be automatically
cancelled and cease to exist.
The foregoing summary
of the Certificate of Amendment to the Certificate of Designations does not purport to be complete and is qualified in its entirety by
reference to the full text of the Certificate of Amendment to Certificate of Designations, which is attached as Exhibit 3.1 to this
report and incorporated by reference herein.
Item 8.01 Other Events.
On May 17, 2023, the Company and Parent issued a joint press release announcing
the execution of the Merger Agreement and related matters.
A copy of the joint press
release is attached as Exhibit 99.1 to this report and incorporated by reference herein.
Cautionary Statement
Regarding Forward-Looking Statements
This
document contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of
the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements
are based on the Company’s current expectations, estimates and projections about the expected date of closing of the proposed transaction
and the potential benefits thereof, its business and industry, management’s beliefs and certain assumptions made by the Company
and Samsung Display, all of which are subject to change. In this context, forward-looking statements often address expected future business
and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,”
“plan,” “believe,” “could,” “seek,” “see,” “will,” “may,”
“would,” “might,” “potentially,” “estimate,” “continue,” “expect,”
“target,” similar expressions or the negatives of these words or other comparable terminology that convey uncertainty of future
events or outcomes. All forward-looking statements by their nature address matters that involve risks and uncertainties, many of which
are beyond our control, and are not guarantees of future results, such as statements about the consummation of the proposed transaction
and the anticipated benefits thereof. These and other forward-looking statements, including the failure to consummate the proposed transaction
or to make or take any filing or other action required to consummate the proposed transaction in a timely matter or at all, are not guarantees
of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those
expressed in any forward-looking statements. Accordingly, there are or will be important factors that could cause actual results to differ
materially from those indicated in such statements and, therefore, and you should not place undue reliance on any such statements and
caution must be exercised in relying on forward-looking statements. Important risk factors that may cause such a difference include, but
are not limited to: (i) the ability of the parties to consummate the proposed transaction in a timely manner or at all; (ii) the satisfaction
(or waiver) of closing conditions to the consummation of the proposed transaction, including with respect to the approval of the Company’s
stockholders; (iii) potential delays in the consummation of the proposed transaction; (iv) the ability of the Company to timely and successfully
achieve the anticipated benefits of the proposed transaction; (v) the occurrence of any event, change or other circumstance or condition
that could give rise to the termination of the merger agreement; (vi) the impact of the COVID-19 pandemic and the current conflict
between the Russian Federation and Ukraine on the Company’s business and general economic conditions; (vii) the Company’s
ability to implement its business strategy; (viii) significant transaction costs associated with the proposed transaction; (ix) potential
litigation relating to the proposed transaction; (x) the risk that disruptions from the proposed transaction will harm the Company’s
business, including current plans and operations; (xi) the ability of the Company to retain and hire key personnel; (xii) potential adverse
reactions or changes to business relationships resulting from the announcement or completion of the proposed transaction; (xiii) legislative,
regulatory and economic developments affecting the Company’s business; (xiv) general economic and market developments and conditions;
(xv) the evolving legal, regulatory and tax regimes under which the Company operates; (xvi) potential business uncertainty, including
changes to existing business relationships, during the pendency of the proposed transaction that could affect the Company’s financial
performance; (xvii) restrictions during the pendency of the proposed transaction that may impact the Company’s ability to pursue
certain business opportunities or strategic transactions; and (xviii) unpredictability and severity of catastrophic events, including,
but not limited to, acts of terrorism or outbreak of war or hostilities, as well as the Company’s response to any of the aforementioned
factors. These risks, as well as other risks associated with the proposed transaction, will be more fully discussed in the proxy statement
to be filed with the SEC in connection with the proposed transaction (the “Proxy Statement”). Additional risks and
uncertainties that could cause actual outcomes and results to differ materially from those contemplated by the forward-looking statements
are included under the caption “Risk Factors” in the Company’s most recent annual and quarterly reports filed with the
SEC and any subsequent reports on Form 10-K, Form 10-Q or Form 8-K filed from time to time and available at www.sec.gov. While the list
of factors presented here is, and the list of factors presented in the Proxy Statement will be, considered representative, no such list
should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional
obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated
in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal
liability and similar risks, any of which could have a material adverse effect on the Company’s financial condition, results of
operations, or liquidity. The forward-looking statements included herein are made only as of the date hereof. The Company does not assume
any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future
developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.
Additional Information and Where to Find
It
In connection with the proposed transaction between
the Company and Samsung Display, the Company will file with the SEC a Proxy Statement, the definitive version of which will be sent or
provided to Company stockholders. The Company may also file other documents with the SEC regarding the proposed transaction. This document
is not a substitute for the Proxy Statement or any other document which the Company may file with the SEC. INVESTORS AND SECURITY HOLDERS
ARE URGED TO READ THE PROXY STATEMENT AND ANY OTHER RELEVANT DOCUMENTS THAT ARE FILED OR WILL BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS
OR SUPPLEMENTS TO THESE DOCUMENTS AND DOCUMENTS INCORPORATED BY REFERENCE THEREIN, CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN
OR WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION AND RELATED MATTERS. Investors and security holders may obtain free
copies of the Proxy Statement (when it is available) and other documents that are filed or will be filed with the SEC by the Company through
the website maintained by the SEC at www.sec.gov, the Company’s investor relations website at emagin.com/investors or by contacting
the Company’s investor relations department at the following:
Investor Relations
investorrelations@emagin.com
Participants in the
Solicitation
The Company and certain of its directors and executive
officers may be deemed to be participants in the solicitation of proxies from the Company’s stockholders in respect of the proposed
transaction and any other matters to be voted on at the special meeting. Information regarding the Company’s directors and executive
officers, including a description of their direct interests, by security holdings or otherwise, will be contained in the Proxy Statement
in connection with the proposed transaction. Company stockholders may obtain additional information regarding the direct and indirect
interests of the participants in the solicitation of proxies in connection with the proposed transaction, including the interests of Company
directors and executive officers in the proposed transaction, which may be different than those of Company stockholders generally, by
reading the Proxy Statement and any other relevant documents that are filed or will be filed with the SEC relating to the proposed transaction.
You may obtain free copies of these documents using the sources indicated above.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. |
|
Description of Exhibit |
2.1* |
|
Agreement and Plan of Merger, by and among the Company, Samsung Display Co., Ltd., Emerald Intermediate, Inc. and Emerald Merger Sub, Inc., dated May 17, 2023. |
3.1 |
|
Certificate of Amendment to the Certificate of
Designations of Series B Convertible Preferred Stock.
|
10.1 |
|
Form of Support Agreement, by and among Samsung Display Co., Ltd., Emerald Intermediate, Inc. and Emerald Merger Sub, Inc., and certain
stockholders of the Company. |
10.2* |
|
Loan and Security Agreement, by and among Samsung Display Co., Ltd., Emerald Intermediate, Inc. and the Company, dated May 17, 2023. |
99.1 |
|
Joint Press Release, dated May 17, 2023. |
104 |
|
Cover Page Interactive Data file (embedded within the Inline XBRL document). |
*All schedules have been omitted pursuant to
Item 601(b)(2) of Regulation S-K. The Company hereby agrees to furnish supplementally a copy of any omitted schedule to
the Securities and Exchange Commission upon request.
SIGNATURES
Pursuant to the requirements
of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
EMAGIN CORPORATION |
|
|
|
Date: May
17, 2023 |
By: |
/s/ Mark A. Koch |
|
|
Name: Mark A. Koch |
|
|
Title: Chief Financial Officer |
Exhibit 2.1
AGREEMENT AND PLAN OF
MERGER
by and among
Samsung Display Co., Ltd.,
Emerald Intermediate, Inc.,
Emerald Merger Sub, Inc.
and
eMagin Corporation
dated as of May 17, 2023
Table
of Contents
|
|
|
Page |
|
|
|
|
|
|
Article I
The Merger |
|
2 |
|
|
|
|
|
|
Section 1.01 |
The Merger |
|
2 |
|
Section 1.02 |
Closing |
|
2 |
|
Section 1.03 |
Effective
Time |
|
2 |
|
Section 1.04 |
Effects
of the Merger |
|
2 |
|
Section 1.05 |
Certificate
of Incorporation and Bylaws |
|
3 |
|
Section 1.06 |
Directors
and Officers |
|
3 |
|
|
|
|
|
|
Article II
Effect of the Merger on the Capital Stock of the Constituent Corporations |
|
3 |
|
|
|
|
|
|
Section 2.01 |
Conversion
and Exchange of Shares of Company Common Stock |
|
3 |
|
Section 2.02 |
Adjustment
to Merger Consideration |
|
4 |
|
Section 2.03 |
Surrender
of Company Stock Certificates |
|
4 |
|
Section 2.04 |
Company
Equity Awards |
|
7 |
|
Section 2.05 |
Dissenting
Shares |
|
8 |
|
Section 2.06 |
Treatment
of Warrants |
|
9 |
|
Section 2.07 |
Filing
of Series B Charter Amendment |
|
9 |
|
|
|
|
|
|
Article III
Representations and Warranties of the Company |
|
9 |
|
|
|
|
|
|
Section 3.01 |
Due Organization
and Qualification; Subsidiaries |
|
10 |
|
Section 3.02 |
Certificate
of Incorporation and Bylaws |
|
10 |
|
Section 3.03 |
Capital
Structure |
|
11 |
|
Section 3.04 |
Authority;
Binding Nature of Agreement |
|
12 |
|
Section 3.05 |
Non-Contravention;
Consents |
|
13 |
|
Section 3.06 |
Company
SEC Documents; Financial Statements; Undisclosed Liabilities |
|
14 |
|
Section 3.07 |
Absence
of Certain Changes or Events |
|
16 |
|
Section 3.08 |
Litigation;
Orders |
|
17 |
|
Section 3.09 |
Contracts |
|
17 |
|
Section 3.10 |
Compliance
with Laws; Governmental Authorizations |
|
20 |
|
Section 3.11 |
Labor
and Employment Matters |
|
21 |
|
Section 3.12 |
Employee
Benefit Matters |
|
23 |
|
Section 3.13 |
Taxes |
|
26 |
|
Section 3.14 |
Real
Property; Personal Property |
|
28 |
|
Section 3.15 |
Intellectual
Property; Data Security and Data Privacy |
|
29 |
|
Section 3.16 |
Customers,
Suppliers, Distributors, Recalls |
|
34 |
|
Section 3.17 |
Environmental
Matters |
|
34 |
|
Section 3.18 |
Insurance |
|
35 |
|
Section 3.19 |
Trade
Compliance |
|
35 |
|
Section 3.20 |
Affiliate
Transactions |
|
36 |
|
Section 3.21 |
Anti-Corruption |
|
36 |
|
Section 3.22 |
Information
Supplied |
|
36 |
|
Section 3.23 |
Brokers
and Other Advisors |
|
36 |
|
Section 3.24 |
Opinion
of Financial Advisors |
|
36 |
|
Section 3.25 |
Backlog |
|
37 |
|
Section 3.26 |
No Other
Representations or Warranties |
|
37 |
|
|
|
|
|
|
Article IV
Representations and Warranties of Parent, Silk USA and Merger Sub |
|
37 |
|
|
|
|
|
|
Section 4.01 |
Organization,
Standing and Corporate Power |
|
37 |
|
Section 4.02 |
Authority;
Binding Nature of Agreement |
|
38 |
|
Section 4.03 |
Non-Contravention |
|
38 |
|
Section 4.04 |
Litigation |
|
39 |
|
Section 4.05 |
Information
Supplied |
|
39 |
|
Section 4.06 |
Activities
and Ownership of Silk USA and Merger Sub |
|
40 |
|
Section 4.07 |
Ownership
of Company Capital Stock |
|
40 |
|
Section 4.08 |
Interested
Stockholder |
|
40 |
|
Section 4.09 |
Sufficiency
of Funds |
|
40 |
|
Section 4.10 |
Sufficiency
of Investigation; No Other Representations or Warranties |
|
40 |
|
|
|
|
|
|
Article V
Covenants Relating to Conduct of Business |
|
41 |
|
|
|
|
|
|
Section 5.01 |
Conduct
of Business |
|
41 |
|
Section 5.02 |
Solicitation;
Takeover Proposals; Change of Company Board Recommendation |
|
46 |
|
Section 5.03 |
No Control
of Other Party’s Business |
|
52 |
|
|
|
|
|
|
Article VI
Additional Agreements |
|
52 |
|
|
|
|
|
|
Section 6.01 |
Preparation
of the Proxy Statement; Stockholders’ Meeting |
|
52 |
|
Section 6.02 |
Access
to Information; Confidentiality |
|
54 |
|
Section 6.03 |
Efforts;
Approvals; Transaction Litigation |
|
55 |
|
Section 6.04 |
State
Takeover Laws |
|
58 |
|
Section 6.05 |
Director
and Officer Insurance |
|
58 |
|
Section 6.06 |
Public
Announcements |
|
60 |
|
Section 6.07 |
Section 16
Matters |
|
60 |
|
Section 6.08 |
Merger
Sub and Surviving Corporation |
|
60 |
|
Section 6.09 |
Notification
of Certain Matters |
|
61 |
|
Section 6.10 |
Credit
Facility |
|
61 |
|
Section 6.11 |
Employee
Matters |
|
62 |
|
Section 6.12 |
Exercise
of Warrant |
|
63 |
|
Section 6.13 |
FIRPTA |
|
63 |
|
Section 6.14 |
Proprietary
Information and Inventions Assignment Agreement |
|
64 |
|
Section 6.15 |
Termination
of At the Market Offering Agreement |
|
64 |
|
|
|
|
|
|
Article VII
Conditions Precedent |
|
64 |
|
|
|
|
|
|
Section 7.01 |
Conditions
to Each Party’s Obligation to Effect the Merger |
|
64 |
|
Section 7.02 |
Conditions
to Obligation of Parent, Silk USA and Merger Sub to Effect the Merger |
|
65 |
|
Section 7.03 |
Conditions
to Obligation of the Company to Effect the Merger |
|
66 |
|
Section 7.04 |
Frustration
of Conditions Precedent |
|
66 |
|
|
|
|
|
|
Article VIII
Termination, Amendment and Waiver |
|
67 |
|
|
|
|
|
|
Section 8.01 |
Termination |
|
67 |
|
Section 8.02 |
Effect
of Termination |
|
68 |
|
Section 8.03 |
Termination
Fees and Expenses |
|
69 |
|
Section 8.04 |
Amendment |
|
70 |
|
Section 8.05 |
Extension;
Waiver |
|
70 |
|
|
|
|
|
|
Article IX
Definitions |
|
70 |
|
|
|
|
|
|
Section 9.01 |
Certain
Definitions |
|
70 |
|
Section 9.02 |
Interpretation |
|
88 |
|
|
|
|
|
|
Article X
General Provisions |
|
89 |
|
|
|
|
|
|
Section 10.01 |
Nonsurvival
of Representations and Warranties |
|
89 |
|
Section 10.02 |
Expenses |
|
89 |
|
Section 10.03 |
Notices |
|
90 |
|
Section 10.04 |
Entire
Agreement |
|
91 |
|
Section 10.05 |
No Third-Party
Beneficiaries |
|
91 |
|
Section 10.06 |
Assignment |
|
91 |
|
Section 10.07 |
Consent
to Jurisdiction; Venue; Governing Law |
|
92 |
|
Section 10.08 |
Waiver
of Jury Trial |
|
93 |
|
Section 10.09 |
Specific
Performance; Remedies |
|
93 |
|
Section 10.10 |
Severability |
|
94 |
|
Section 10.11 |
Counterparts;
Facsimile and Electronic Signatures |
|
94 |
|
Schedule
A – List of Stillwater Entities
Exhibit A
– Amended and Restated Certificate of Incorporation
Exhibit B
– Form of Series B Charter Amendment
Exhibit C
– Form of Loan and Security Agreement
AGREEMENT AND PLAN OF MERGER
This Agreement
and Plan of Merger (this “Agreement”), dated as of May 17, 2023, is entered into by and among Samsung
Display Co., Ltd., a Korean corporation (“Parent”), Emerald Intermediate, Inc., a Delaware corporation and
wholly owned subsidiary of Parent (“Silk USA”) and Emerald Merger Sub, Inc., a Delaware corporation and wholly
owned subsidiary of Silk USA (“Merger Sub”) and eMagin Corporation, a Delaware corporation (the “Company”).
Each of Parent, Silk USA, Merger Sub and the Company are referred to herein as a “Party” and together as “Parties.”
Capitalized terms used and not otherwise defined herein have the meanings set forth in Section 9.01.
RECITALS
Whereas,
Parent, Silk USA, Merger Sub and the Company intend that, upon the terms and subject to the conditions set forth in this Agreement, and
in accordance with the Delaware General Corporation Law (the “DGCL”), Merger Sub will be merged with and into the
Company, with the Company continuing as the Surviving Corporation (the “Merger”);
Whereas,
the board of directors of the Company (the “Company Board”) and the respective boards of directors of Parent, Silk
USA and Merger Sub have unanimously determined that it is in the best interests of their respective companies and stockholders, and declared
it advisable, to enter into the transactions provided for herein, and have approved this Agreement and the Merger and the other transactions
contemplated by this Agreement, upon the terms and subject to the conditions set forth in this Agreement;
Whereas,
Silk USA, as the sole stockholder of Merger Sub, has adopted this Agreement and approved the Merger and the transactions contemplated
hereby;
Whereas,
concurrently with the execution and delivery of this Agreement, as a condition and inducement to the willingness of Parent, Silk USA
and Merger Sub to enter into this Agreement, the entities listed on Schedule A hereto (“Stillwater”) shall have entered
into a Support Agreement with Parent (the “Support Agreement”), pursuant to which Stillwater shall have agreed on
behalf of the Company stockholders over which Stillwater has voting control (collectively, the “Stillwater Stockholders”),
among other things, to vote (or cause to be voted), in person or by proxy, or if applicable deliver (or cause to be delivered) a written
consent covering, all of such stockholder’s shares of Company Capital Stock in favor of the adoption of this Agreement and the
Merger;
Whereas,
concurrently with the execution and delivery of this Agreement, a majority of the holders of outstanding shares of Company Series B
Convertible Preferred Stock have approved the Series B Charter Amendment and the Company shall promptly file the Series B Charter
Amendment with the Secretary of State of the State of Delaware such that the Series B Charter Amendment is effective;
Whereas,
concurrently with the execution and delivery of this Agreement, as a condition and inducement to the willingness of the Company
to enter into this Agreement, Parent, Silk USA and the Company shall have entered into a Loan and Security Agreement, dated on the date
hereof and in the form attached hereto as Exhibit C (the “Loan and Security Agreement”), pursuant to which
Silk USA shall lend to the Company, and the Company shall borrow from Silk USA, the Loan (as defined in the Loan and Security Agreement);
and
Now,
Therefore, in consideration of the foregoing premises and the representations, warranties, covenants and agreements contained
in this Agreement, and subject to the conditions set forth herein, as well as other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, and intending to be legally bound hereby, the Parties agree as follows:
Article I
The
Merger
Section 1.01 The
Merger. Upon the terms and subject to the conditions set forth in this Agreement, and
in accordance with the DGCL, at the Effective Time, Merger Sub shall be merged with and into the Company and the separate corporate existence
of Merger Sub shall cease. The Company will continue as the surviving corporation in the Merger (the “Surviving Corporation”)
and a wholly owned subsidiary of Silk USA.
Section 1.02 Closing.
Subject to the provisions of Article VII, the closing of the Merger (the “Closing”) will take place at
8:00 a.m. New York City time, on the second (2nd) Business Day after satisfaction or (to the extent permitted by Law) waiver of
the conditions set forth in Article VII (other than those conditions that by their terms are to be satisfied at the Closing,
but subject to the satisfaction or (to the extent permitted by Law) waiver of those conditions), or at such other time or on such other
date as Parent and the Company may mutually agree consistent with the DGCL. The Closing shall be held at the offices of O’Melveny &
Myers LLP, located at Times Square Tower, 7 Times Square, New York, NY 10036, or remotely by exchange of documents and signatures (or
their electronic counterparts), unless another place is agreed to in writing by Parent and the Company. The date on which the Closing
occurs is referred to in this Agreement as the “Closing Date.”
Section 1.03 Effective
Time. Subject to the provisions of this Agreement, as promptly as practicable on the
Closing Date, the Parties shall cause a certificate of merger with respect to the Merger (the “Certificate of Merger”)
to be duly executed and filed with the Office of the Secretary of State of the State of Delaware (the “Delaware Secretary”)
as provided under the DGCL and make any other filings, recordings or publications required to be made by the Company, Merger Sub, Silk
USA or Parent under the DGCL in connection with the Merger. The Merger shall become effective at such time as the Certificate of Merger
is duly filed with the Delaware Secretary or on such other date and time as shall be agreed to by Parent and the Company and specified
in the Certificate of Merger (such date and time being referred to hereinafter as the “Effective Time”).
Section 1.04 Effects
of the Merger. The Merger shall have the effects set forth in this Agreement and the
applicable provisions of the DGCL. Without limiting the generality of the foregoing, from and after the Effective Time, all the properties,
rights, privileges, powers and franchises of the Company and Merger Sub shall vest in the Surviving Corporation, and all debts, liabilities,
obligations and duties of the Company and Merger Sub shall become debts, liabilities, obligations and duties of the Surviving Corporation.
Section 1.05 Certificate
of Incorporation and Bylaws.
(a) Certificate
of Incorporation. At the Effective Time, the Company’s restated certificate of incorporation (the “Company Certificate
of Incorporation”) shall be amended and restated to read in its entirety as set forth in Exhibit A attached hereto
and as so amended and restated shall be the certificate of incorporation of the Surviving Corporation, until thereafter amended (subject
to Section 6.05(a) hereof) as provided therein or by applicable Law.
(b) Bylaws.
At the Effective Time, the Company’s bylaws (the “Company Bylaws”) shall be amended and restated to be substantially
identical to the bylaws of Merger Sub as in effect immediately prior to the Effective Time (except that the name of the Surviving Corporation
shall be “eMagin Corporation”) and as so amended and restated shall be the bylaws of the Surviving Corporation, until thereafter
amended (subject to Section 6.05(a) hereof) as provided therein or by applicable Law.
Section 1.06 Directors
and Officers.
(a) The
directors of Merger Sub immediately prior to the Effective Time shall be the directors of the Surviving Corporation until their respective
successors are duly elected or appointed and qualified or until their earlier death, resignation or removal in accordance with the certificate
of incorporation and bylaws of the Surviving Corporation.
(b) The
officers of the Company immediately prior to the Effective Time shall be the officers of the Surviving Corporation until their respective
successors are duly appointed and qualified or until their earlier death, resignation or removal in accordance with the certificate of
incorporation and bylaws of the Surviving Corporation.
Article II
Effect
of the Merger on the Capital Stock of the Constituent Corporations
Section 2.01 Conversion
and Exchange of Shares of Company Common Stock and Company Series B Convertible Preferred Stock.
At the Effective Time, by virtue of the Merger and without any action on the part of the Company, Parent, Silk USA, Merger Sub or any
holder of any shares of Company Common Stock, Company Series B Convertible Preferred Stock or any shares of capital stock of Parent,
Silk USA or Merger Sub:
(a) Conversion
of Merger Sub Stock. Each share of capital stock of Merger Sub issued and outstanding immediately prior to the Effective Time shall
be converted into and become one (1) validly issued, fully paid and nonassessable share of common stock of the Surviving Corporation,
which shares at such time shall comprise the only outstanding shares of capital stock of the Surviving Corporation.
(b) Cancellation
of Company-Owned Stock and Parent-Owned Stock. Each share of Company Common Stock and Company Series B Convertible Preferred
Stock held by the Company or any wholly owned Subsidiary of the Company (or held in the Company’s treasury) or held by Parent,
Silk USA or Merger Sub, in each case, immediately prior to the Effective Time shall automatically be canceled and shall cease to exist,
without payment of any consideration therefor.
(c) Conversion
of Company Common Stock. Except as provided in Section 2.01(b) and subject to Section 2.02, each share
of Company Common Stock issued and outstanding immediately prior to the Effective Time (other than any Dissenting Shares, but including
Company Warrant Shares that are designated shares of Company Common Stock) shall automatically be cancelled and converted into the right
to receive $2.08 in cash, without interest (the “Per Share Merger Price”), payable to the holder thereof upon surrender
of such shares of Company Common Stock in the manner provided in Section 2.03.
(d) Conversion
of Company Series B Convertible Preferred Stock. Except as provided in Section 2.01(b) and subject to Section 2.02,
each share of Company Series B Convertible Preferred Stock issued and outstanding immediately prior to the Effective Time (other
than any Dissenting Shares) shall be converted into the right to receive cash, without interest, in an amount equal to (x) the total
number of shares of Company Common Stock issuable upon conversion of such share of Company Series B Convertible Preferred Stock
in accordance with the Company Charter Documents immediately prior to the Effective Time, multiplied by (y) the Per Share Merger
Price, payable to the holder thereof upon surrender of such shares of Company Series B Convertible Preferred Stock in the manner
provided in Section 2.03.
Section 2.02 Adjustment
to Merger Consideration. If at any time during the period between the date of this Agreement
and the Effective Time there shall be any stock split, reverse stock split, stock dividend (including any dividend or distribution of
securities convertible into Company Common Stock or Company Series B Convertible Preferred Stock), cash dividend, reorganization,
recapitalization, reclassification, combination, exchange of shares or other like change with respect to Company Common Stock or Company
Series B Convertible Preferred Stock, the applicable Merger Consideration shall be appropriately adjusted by the Parties to reflect
the effect thereof.
Section 2.03 Surrender
of Company Stock Certificates.
(a) Paying
Agent. Prior to the Effective Time, Parent shall enter into, or cause Silk USA to enter into, an agreement in form and substance
reasonably acceptable to the Company with the Company’s transfer agent or a bank or trust company that is reasonably satisfactory
to the Company to act as paying agent (the “Paying Agent”) for the payment of the aggregate Per Share Merger Price
in respect of the Company Common Stock and Company Series B Convertible Preferred Stock in accordance with this Article II.
As promptly as possible following the Effective Time (but in any event on the Closing Date), Parent shall deposit, or cause Silk USA
to deposit, with the Paying Agent in trust, for the benefit of the holders of shares of Company Common Stock and Company Series B
Convertible Preferred Stock immediately prior to the Effective Time, cash in an amount sufficient to pay the aggregate Per Share Merger
Price in respect of the Company Common Stock and Company Series B Convertible Preferred Stock. Any funds deposited with the Paying
Agent pursuant to this Section 2.03(a) shall be referred to in this Agreement as the “Exchange Fund.”
The Exchange Fund shall not be used for any other purpose. The Surviving Corporation shall pay all charges and expenses, including those
of the Paying Agent, in connection with the exchange of shares of Company Common Stock and Company Series B Convertible Preferred
Stock for the Merger Consideration.
(b) Company
Stock Certificate Exchange Procedures. As soon as reasonably practicable after the Effective Time (and in any case within five (5) Business
Days), Parent or Silk USA shall cause the Paying Agent to mail to each holder of record of a valid certificate previously representing
any shares of Company Capital Stock outstanding immediately prior to the Effective Time (a “Company Stock Certificate”)
or shares of Company Capital Stock outstanding immediately prior to the Effective Time represented by book entry (“Book Entry
Shares”) whose shares of Company Capital Stock were converted into the right to receive the applicable Merger Consideration:
(i) a letter of transmittal (which shall specify that delivery shall be effected, and risk of loss and title to the Company Stock
Certificates shall pass, only upon proper delivery of the Company Stock Certificates to the Paying Agent and which shall otherwise be
in customary form (including customary provisions with respect to delivery of an “agent’s message” with respect to
Book Entry Shares)); and (ii) instructions for use in effecting the surrender of the Company Stock Certificates, or in the case
of Book Entry Shares, the surrender of such shares, in exchange for payment of the applicable Merger Consideration. Each holder of record
of a Company Stock Certificate or Book Entry Share shall, upon surrender to the Paying Agent of such Company Stock Certificate or Book
Entry Share, together with such letter of transmittal, duly executed, and such other documents as may reasonably be required by the Paying
Agent pursuant to such instructions, be entitled to receive in exchange therefor the amount of cash which the number of shares of Company
Capital Stock previously represented by such Company Stock Certificate or Book Entry Share shall have been converted into the right to
receive pursuant to Section 2.01(c) or Section 2.01(d), as applicable, and the Company Stock Certificate
or Book Entry Share so surrendered shall be canceled. In the event of a transfer of ownership of Company Capital Stock which is not registered
in the transfer records of the Company, payment of the applicable Merger Consideration may be made to a person other than the person
in whose name the Company Stock Certificate so surrendered is registered if such Company Stock Certificate shall be properly endorsed
or otherwise be in proper form for transfer and the person requesting such payment shall pay any transfer or other similar Taxes required
by reason of the payment of the applicable Merger Consideration and any such dividends to a person other than the registered holder of
such Company Stock Certificate or establish to the reasonable satisfaction of Parent or Silk USA that such Tax has been paid or is not
applicable. Until surrendered as contemplated by this Section 2.03(b), each Company Stock Certificate and each Book-Entry
Share shall be deemed at any time after the Effective Time to represent only the right to receive upon such surrender the applicable
Merger Consideration. No interest shall be paid or will accrue on any cash payable to holders of Company Stock Certificates or Book Entry
Shares pursuant to the provisions of this Article II or otherwise.
(c) No
Further Ownership Rights in Company Capital Stock; Transfer Books. At and after the Effective Time, holders of Company Stock Certificates
(or, in the case of uncertificated shares, Book Entry Shares) shall cease to have any rights as stockholders of the Company, except for
the right to receive the applicable Merger Consideration in accordance with this Article II. Any cash paid upon the surrender
of Company Stock Certificates or Book Entry Shares in accordance with this Article II shall be deemed to have been paid in
full satisfaction of all rights pertaining to the shares of Company Capital Stock formerly evidenced by such Company Stock Certificates
or Book Entry Shares. At the Effective Time, the stock transfer books of the Company shall be closed and no transfer of shares of Company
Capital Stock that were outstanding immediately prior to the Effective Time shall thereafter be made. If, after the Effective Time, subject
to the terms and conditions of this Agreement, Company Stock Certificates or Book Entry Shares formerly evidencing shares of Company
Capital Stock are presented to the Paying Agent or the Surviving Corporation, they shall be canceled and exchanged for the applicable
Merger Consideration in accordance with this Article II.
(d) Termination
of the Exchange Fund. Any portion of the Exchange Fund that remains undistributed to the holders of Company Stock Certificates or
Book Entry Shares on the date that is one (1) year after the Effective Time shall be delivered to Parent or Silk USA, upon
demand by Parent, and any holders of Company Stock Certificates or Book Entry Shares who have not theretofore complied with this Article II
shall thereafter look only to Parent or Silk USA for, and Parent and Silk USA shall remain liable for, payment of such holders’
claims for the applicable Merger Consideration pursuant to the provisions of this Article II.
(e) No
Liability. Neither Parent, Silk USA, Merger Sub, the Company, the Surviving Corporation nor the Paying Agent shall be liable to any
person in respect of any cash from the Exchange Fund delivered to a public official in compliance with any applicable state, federal
or other abandoned property, escheat or similar Law. If any Company Stock Certificate or Book Entry Shares shall not have been surrendered
prior to the date on which the related Merger Consideration would escheat to or become the property of any Governmental Authority, any
such Merger Consideration shall, to the extent permitted by applicable Law, immediately prior to such time become the property of Silk
USA, free and clear of all claims or interest of any person previously entitled thereto.
(f) Investment
of Exchange Fund. The Paying Agent shall invest the cash in the Exchange Fund as directed by Parent or Silk USA; provided,
however, that (i) no such investment or losses thereon shall affect the applicable Merger Consideration payable to the holders
of shares of Company Capital Stock and following any losses Parent shall, or shall cause Silk USA to, promptly provide additional funds
to the Paying Agent for the benefit of the stockholders of the Company in the amount of any such losses and (ii) such investments
shall only be in short-term obligations of or guaranteed by the United States of America or any agency or instrumentality thereof with
maturities of no more than thirty (30) days and backed by the full faith and credit of the United States of America. Any interest and
other income resulting from such investments shall be paid solely to Parent or Silk USA.
(g) Lost,
Stolen or Destroyed Certificates. If any Company Stock Certificate shall have been lost, stolen or destroyed, upon the making of
an affidavit of that fact by the person claiming such Company Stock Certificate to be lost, stolen or destroyed and, if required by Parent,
Silk USA or the Paying Agent, the posting by such person of a bond in such reasonable and customary amount as Parent, Silk USA or the
Paying Agent may direct as indemnity against any claim that may be made against it with respect to such Company Stock Certificate, the
Paying Agent shall deliver in exchange for such lost, stolen or destroyed Company Stock Certificate the applicable Merger Consideration.
(h) Withholding
Rights. Notwithstanding anything in this Agreement to the contrary, Parent, Silk USA, the Surviving Corporation or the Paying Agent
shall be entitled to deduct and withhold from the consideration otherwise payable pursuant to this Agreement to any holder of any Company
Stock Certificate or Book Entry Shares (or any holder of a Company Equity Award) such amounts as Parent, Silk USA, the Surviving Corporation
or the Paying Agent are required to deduct and withhold with respect to the making of such payment under the Code or any provision of
state, local or foreign tax Law or other applicable Law. Prior to any such deduction or withholding, each of Parent, Silk USA, the Surviving
Corporation or the Paying Agent, as applicable, shall use commercially reasonable efforts to provide five (5) days’ prior
notice of any intention to withhold to the Company (other than any payment of Equity Award Amounts or amounts owed to former holders
of Company Stock Options or Company RSUs) and cooperate with the Company to reduce or eliminate any such deduction or withholding, including
by allowing the Company or the applicable holder to provide documentation to Parent, Silk USA, the Surviving Corporation or the Paying
Agent, as applicable, with a view to reducing or eliminating such withholding. To the extent such amounts are so deducted or withheld
and paid over to the appropriate Governmental Authority or other recipient by Parent, Silk USA, the Surviving Corporation or the Paying
Agent, such withheld amounts shall be treated for all purposes of this Agreement as having been paid to the person to whom such amounts
would otherwise have been paid.
Section 2.04 Company
Equity Awards.
(a) The
Company shall take all action reasonably necessary to (x) provide each holder of an outstanding Out-of-the-Money Option that is
not then exercisable, the opportunity to exercise, for a period of at least five (5) days (or such other period determined by the
Company Board) prior to the date that is three (3) days prior to the Effective Time (with such exercise conditional upon the occurrence
of the Effective Time), any portion of such Out-of-the-Money Option in full by providing the Company with a notice of exercise and full
payment of the applicable exercise price in cash or by check in accordance with and subject to the terms of the applicable Company Stock
Plan and the stock option award agreement governing such Company Stock Option and (y) ensure that no holder of any Company Stock
Option shall be entitled to exercise any such Company Stock Option at any time between the date that is three (3) days prior to
the Effective Time and the Effective Time. At the Effective Time, each unexercised Company Stock Option that is outstanding immediately
prior to the Effective Time, whether or not then exercisable or vested, shall be, by virtue of the Merger and without any action on the
part of the holder thereof, cancelled and converted into the right to receive solely the following:
(i) with
respect to each In-the-Money Option: an amount in cash equal to the product of (I) the excess, if any, of the Per Share Merger Price
over the applicable exercise price per share of Company Common Stock subject to such cancelled In-the-Money Option multiplied by (II) the
aggregate number of shares of Company Common Stock subject to such In-the-Money Option immediately prior to the Effective Time; and
(ii) notwithstanding
anything herein to the contrary, any Out-of-the-Money Options shall be cancelled at the Effective Time without any consideration payable
therefor.
The Surviving Corporation shall pay the holders of Company Stock Options
the cash payments described in this Section 2.04(a) as soon as reasonably practicable following the Effective Time or
the times specified in Section 2.04(a)(ii), as applicable. From and after the Effective Time, each Company Stock Option shall
no longer be exercisable by the former holder thereof, but shall only entitle such holder to the payment of the corresponding amount
determined in accordance with this Section 2.04(a), if any.
(b) Immediately
prior to the Effective Time, each then-outstanding restricted stock unit award (including any that vest in whole or in part based on
performance conditions) (“Company RSUs”) granted under any Company Stock Plan shall become fully earned and vested
with respect to the maximum number of shares underlying each such Company RSU as set forth in the terms of the agreement granting such
Company RSU (the “RSU Agreement”). Each grantee of each Company RSU that vests in accordance with this Section 2.04(b),
as soon as reasonably practicable following the Effective Time, shall be entitled to receive cash in an amount equal to (x) the
total number of shares of Company Common Stock issuable in settlement of such Company RSU immediately prior to the Effective Time, multiplied
by (y) the Per Share Merger Price.
(c) As
of the Effective Time, the Company Stock Plans will terminate and all rights under any other plan, program or arrangement providing for
the issuance or grant of any other interest with respect to the shares of the Company or any Company Subsidiary will be cancelled. The
Company will take, or cause to be taken, all actions necessary to effectuate this Section 2.04, including sending any requisite
notices, obtaining any necessary resolutions of the Company Board or a committee thereof, and obtaining all consents necessary to cash
out and cancel, as described in Section 2.04(a) and Section 2.04(b), all Company Stock Options and Company
RSUs so as to ensure that, after the Effective Time, no Person will have any rights under the Company Stock Plans with respect thereto
other than rights to receive the payments contemplated by Section 2.04(a) or Section 2.04(b). The Company
will provide Parent with copies of all such notices, resolutions and other materials in connection with its obligations prior to Closing
for Parent’s reasonable review and comment prior to distribution.
(d) The
payment of all Equity Award Amounts hereunder shall be subject to appropriate withholding for Taxes in accordance with Section 2.03(h) and
shall be paid through, to the extent applicable, the Surviving Corporation’s payroll.
Section 2.05 Dissenting
Shares.
(a) Notwithstanding
anything to the contrary contained in this Agreement, shares of Company Capital Stock that are outstanding immediately prior to the Effective
Time and held by a holder who is entitled to demand and properly demands an appraisal of such shares in accordance with Section 262
of the DGCL (any such shares being referred to as “Dissenting Shares” until such time as such holder fails to perfect
or otherwise loses such holder’s appraisal rights under Section 262 of the DGCL with respect to such shares) shall not be
converted into or represent the right to receive the applicable Merger Consideration in accordance with Section 2.01(c) or
Section 2.01(d) and the holder thereof shall be entitled only to such rights as are granted by Section 262 of the
DGCL to a holder of Dissenting Shares. At the Effective Time, the Dissenting Shares shall no longer be outstanding and shall automatically
be canceled and shall cease to exist.
(b) If
any Dissenting Shares shall lose their status as such (through failure to perfect or otherwise), then, as of the later of the Effective
Time or the date of loss of such status, such shares shall automatically be converted into and shall represent only the right to receive
the Merger Consideration in accordance with Section 2.01(c) or Section 2.01(d), as applicable, without interest
thereon, upon surrender of each Company Stock Certificate representing such shares.
(c) The
Company shall give Parent prompt written notice of (i) any demand for appraisal pursuant to the DGCL received by the Company prior
to the Effective Time and (ii) any withdrawal of any such demand. Parent shall have the opportunity to participate in and, after
the Closing Date, to direct all negotiations and any Proceedings with respect to any such demand. The Company shall not make any payment
or settlement with respect to, or offer to make any payment or settlement prior to the Effective Time with respect to any such demand
unless Parent shall have given its written consent to such payment or settlement offer.
Section 2.06 Treatment
of Warrants. At the Effective Time, and in accordance with the terms of each warrant
to purchase shares of Company Common Stock that is required to be listed in Part 3.03(f) of the Disclosure Letter (collectively,
the “Warrants”) and that remains issued and outstanding immediately prior to the Effective Time, unless otherwise
elected by the holder of any such Warrant, Parent shall cause the Surviving Corporation to issue a replacement warrant to each holder
thereof providing that such replacement warrant shall be exercisable for an amount in respect of each share of Company Common Stock for
which such Warrant is exercisable immediately prior to the Effective Time equal to cash in an amount equal to the product of (i) the
total number of shares of Company Common Stock subject to such Warrant immediately prior to the Effective Time, multiplied by (ii) the
excess of (A) the Per Share Merger Price over (B) the exercise price payable per share of Company Common Stock subject to such
Warrant. From and after the Closing, Parent shall cause the Surviving Corporation to comply with all of the terms and conditions set
forth in each such replacement warrant, including the obligation to make the payments contemplated thereby upon exercise thereof.
Section 2.07 Filing
of Series B Charter Amendment. The Company shall promptly, and in any event within
three (3) Business Days of the date of this Agreement, file the Series B Charter Amendment with the Secretary of State of the
State of Delaware such that the Series B Charter Amendment is effective as of such filing date.
Article III
Representations
and Warranties of the Company
Except as (i) set forth in a corresponding
numbered section of the Disclosure Letter (it being agreed that disclosure of any item in any part of the Disclosure Letter shall also
be deemed disclosure with respect to any other section of this Agreement to which the relevance of such item is reasonably apparent (other
than Part 9.01(c) of the Disclosure Letter)) or (ii) disclosed in the Company SEC Documents filed with, or furnished
by the Company to, the SEC on or after January 1, 2021 and prior to the date of this Agreement and publicly available on the date
of this Agreement (other than forward-looking disclosures set forth in any risk factor section, disclosures relating to forward-looking
statements to the extent they are predictive, cautionary or forward-looking in nature), the Company represents and warrants to Parent,
Silk USA and Merger Sub as follows:
Section 3.01 Due
Organization and Qualification; Subsidiaries.
(a) The
Company is a corporation duly organized, validly existing and in good standing under the Laws of the State of Delaware. The Company has
all requisite corporate power and authority to: (i) conduct its business in the manner in which its business is currently being
conducted; and (ii) own and use its assets in the manner in which its assets are currently owned and used, except where the failure
to have such power or authority has not, and would not be reasonably expected to have a Company Material Adverse Effect.
(b) The
Company is duly qualified or licensed to do business as a foreign corporation and is in good standing in each jurisdiction where the
nature of its business requires such qualification or license, except where the failure to be so qualified or licensed or to be in good
standing, would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.
(c) Part 3.01(c) of
the Disclosure Letter sets forth a complete list of each Subsidiary of the Company as of the date of this Agreement, and the capitalization
and jurisdiction of organization thereof. Except as set forth in Part 3.01(c) of the Disclosure Letter, each of the
Subsidiaries identified in Part 3.01(c) of the Disclosure Letter is a wholly owned direct or indirect Subsidiary of
the Company and no other person holds any equity interest (contingent or otherwise) in such Subsidiaries. Except as would not, individually
or in the aggregate, reasonably be expected to have a Company Material Adverse Effect, each Subsidiary of the Company is duly organized,
validly existing and in good standing under the Laws of the jurisdiction of its organization, and has all requisite power and authority
to: (i) conduct its business in the manner in which its business is currently being conducted; and (ii) own and use its assets
in the manner in which its assets are currently owned and used. Each Subsidiary of the Company is duly qualified or licensed to do business
as a foreign corporation and is in good standing in each jurisdiction where the nature of its business requires such qualification or
license, except where the failure to be so qualified or licensed or to be in good standing, would not reasonably be expected to have,
individually or in the aggregate, a Company Material Adverse Effect. Except for the capital stock of, or other equity or voting interests
in, its Subsidiaries, the Company does not own, directly or indirectly, any capital stock of, any securities convertible into or exchangeable
or exercisable for, or options, warrants, calls, commitments or rights of any kind to acquire, any shares of capital stock or other equity
or voting interests in, any person that would be material to the Company and its Subsidiaries, taken as a whole.
Section 3.02 Certificate
of Incorporation and Bylaws. The Company has made available to Parent accurate and complete
copies of the Company Certificate of Incorporation, the Company Bylaws (collectively, the “Company Charter Documents”),
and the charter and organizational documents of each of its Subsidiaries, including all amendments thereto (collectively, the “Subsidiary
Charter Documents”). The Company is not in material violation of the Company Charter Documents. Except as would not, individually
or in the aggregate, reasonably be expected to have a Company Material Adverse Effect, the Company’s Subsidiaries are not in violation
of any Subsidiary Charter Documents.
Section 3.03 Capital
Structure.
(a) The
authorized capital stock of the Company consists of 200,000,000 shares of Company Common Stock, and 10,000,000 shares of preferred
stock, par value $0.001 per share (“Company Preferred Stock”). As of May 16, 2023 (the “Capitalization
Date”): (i) 83,041,694 shares of Company Common Stock were issued and outstanding; (ii) 10,000 shares of Company Preferred
Stock were designated as Company Series B Convertible Preferred Stock, of which 5,356 shares were issued or outstanding;
(which, for the avoidance of doubt, does not include shares of Company Common Stock held in the treasury of the Company) (iii)
162,066 shares of Company Common Stock were held in the treasury of the Company; (iv) 3,229,952 shares of Company Common Stock were
subject to issuance pursuant to outstanding options to purchase shares of Company Common Stock granted under the Company Stock Plans
(stock options granted by the Company pursuant to such plans or otherwise are referred to collectively herein as “Company
Stock Options”); (v) 1,832,130 shares of Company Common Stock were subject to issuance pursuant to outstanding Company
RSUs; (vi) no shares of Company Common Stock were subject to issuance pursuant to outstanding share appreciation rights granted
under the Company Stock Plans; (vii) 4,364,206 shares of Company Common Stock were authorized and reserved for future issuance
pursuant to the Company Stock Plans and (viii) 1,947,491 shares of Company Common Stock and no shares of Company Series B
Convertible Preferred Stock were subject to issuance pursuant to outstanding Company Warrants. All of the outstanding shares of
Company Capital Stock have been, and all shares that may be issued pursuant to any Company Stock Plan or as contemplated or
permitted by this Agreement will be, when issued in accordance with the respective terms thereof, duly authorized, validly issued,
fully paid and nonassessable. There are no shares of Company Capital Stock held by any of the Company’s Subsidiaries. None of
the outstanding shares of Company Capital Stock are entitled or subject to any preemptive right, right of participation, right of
maintenance or any similar right or subject to any right of first refusal in favor of the Company, and there is no Company Contract
(other than the Support Agreements) relating to the voting or registration of, or restricting any person from purchasing, selling,
pledging or otherwise disposing of (or granting any option or similar right with respect to), any shares of Company Capital Stock.
The Company is not bound by any Contract requiring it to repurchase, redeem or otherwise acquire any outstanding shares of Company
Capital Stock, and no share repurchase program exists with respect to the Company. Part 3.03(a)(i) of the
Disclosure Letter sets forth a schedule as of the Capitalization Date of all outstanding Company Equity Awards, including the
relevant Company Stock Plan, type of award, date of grant, vesting start date, expiration date, number of shares underlying the
award, and the exercise price of each such Company Equity Award, and, solely with respect to any Company RSU that vests in whole or
in part based on performance conditions and is not vested as of the date hereof, the vesting schedule and vesting acceleration terms
thereof. The Company hereby makes the representations and warranties set forth in Part 3.03(a)(ii) of the
Disclosure Letter.
(b) As
of the Capitalization Date, other than as set forth in Section 3.03(a) herein or Part 3.03(b) of
the Disclosure Letter, there are: (i) no outstanding shares of capital stock of, or other equity or voting interest in, the Company;
(ii) no outstanding securities of the Company or any of its Subsidiaries convertible into or exchangeable or exercisable for shares
of capital stock of, or other equity or voting interest in, the Company; (iii) no outstanding options, warrants, restricted stock
units, call options, rights or other commitments or agreements to acquire from the Company or any of its Subsidiaries, or put rights
or other commitments or agreements that obligate the Company or any of its Subsidiaries to issue, any capital stock of, or other equity
or voting interest in, or any securities convertible into or exchangeable or exercisable for shares of capital stock of, or other equity
or voting interest in, the Company; (iv) no obligations of the Company or any of its Subsidiaries to grant, extend or enter into
any subscription, warrant, right, convertible or exchangeable security, call options, put rights or other similar agreement or commitment
relating to any capital stock of, or other equity or voting interest in, the Company (the items in clauses (i), (ii), (iii) and
(iv), together with the capital stock of the Company, being referred to collectively as “Company Securities”); and
(v) no other obligations by the Company or any of its Subsidiaries to make any payments based on the price or value of the Company
Securities. As of the date hereof, there is no rights agreement or stockholders rights plan (or similar plan commonly referred to as
a “poison pill”) in effect with respect to the Company.
(c) No
bonds, debentures, notes or other Indebtedness issued by the Company or any of its Subsidiaries and outstanding at the date of this Agreement
have the right to vote on any matters on which stockholders or equityholders of the Company or any of its Subsidiaries may vote (or are
convertible into, or exchangeable for, securities having such right).
(d) All
of the outstanding shares of Company Capital Stock, Company Equity Awards and other securities of the Company have been issued and granted
in material compliance with applicable Laws. No Company Equity Awards have been granted other than pursuant to the Company Stock Plans.
(e) All
of the shares of capital stock of each of the Company’s Subsidiaries have been duly authorized and validly issued, are fully paid
and nonassessable and free of preemptive rights, and are owned beneficially and of record by the Company or another wholly owned Subsidiary
of the Company, free and clear of any Liens, other than restrictions on transfer imposed by applicable securities Laws.
(f) Part 3.03(f) of
the Disclosure Letter set forth a list, as of the Capitalization Date, of each holder of a Company Warrant, together with the number
and type of shares of Company Capital Stock issuable upon the exercise or conversion of such Company Warrant, the exercise price of such
Company Warrant, the issuance date of such Company Warrant and the termination date of such Company Warrant.
Section 3.04 Authority;
Binding Nature of Agreement.
(a) The
Company has all requisite corporate power and authority, subject to (A) the adoption of this Agreement by the holders of a majority
of the voting power of the outstanding shares of Company Common Stock and Company Series B Convertible Preferred Stock entitled
to vote on such matter at a stockholders’ meeting duly called and held for such purpose, voting together as a single class on an
as-converted to Company Common Stock basis, and (B) the approval of this Agreement and the Merger by an affirmative vote or consent
of the holders of a majority of the outstanding shares of Company Series B Convertible Preferred Stock ((A) and (B) collectively,
“Company Stockholder Approval”), to enter into this Agreement, consummate the Merger and the other transactions contemplated
hereby and perform its obligations hereunder. The Company Stockholder Approval is the only vote of the holders of any class or series
of the Company’s or any of its Subsidiaries’ capital stock or other securities necessary to adopt this Agreement and approve
the transactions contemplated hereby, including the Merger. The Company Board has duly and unanimously adopted resolutions by which the
Company Board has: (i) approved and declared advisable this Agreement (including the agreement of merger, as such term is used in
Section 251 of the DGCL) and the transactions contemplated hereby, including the Merger and the Series B Charter Amendment;
(ii) determined that the Merger and the other transactions contemplated by this Agreement are in the best interests of the Company
and the stockholders of the Company, (iii) authorized and approved the execution, delivery and performance of this Agreement and
the Merger on the terms and subject to the conditions set forth herein; (iv) resolved to recommend that the stockholders of the
Company adopt this Agreement (such recommendation, the “Company Board Recommendation”); and (v) directed that
this Agreement be submitted to the stockholders of the Company for their approval and adoption at a duly held meeting of such stockholders
for such purpose. As of the date of this Agreement, the resolutions referred to in the preceding sentence have not been rescinded, modified,
amended or withdrawn.
(b) Other
than obtaining the Company Stockholder Approval, no other corporate proceedings on the part of the Company or any of its Subsidiaries
are necessary to authorize, adopt or approve, as applicable, this Agreement or to consummate the Merger and the transactions contemplated
hereby (other than the filing of the appropriate merger documents under the DGCL). Assuming due authorization, execution and delivery
by Parent, Silk USA and Merger Sub, this Agreement constitutes the valid and binding obligation of the Company, enforceable against the
Company in accordance with its terms, subject to: (i) bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and
other similar Laws of general application relating to or affecting creditors’ rights; and (ii) general equitable principles,
including specific performance, injunctive and other relief (clauses (i) and (ii), collectively, the “Bankruptcy and Equity
Exception”). Assuming the accuracy of the representations contained in Section 4.08, the Company Board has taken
appropriate actions so that the restrictions on business combinations contained in Section 203 of the DGCL will not apply with respect
to or as a result of the execution, delivery or performance of this Agreement or the consummation of the transactions contemplated hereby,
including the Merger, without any further action on the part of the stockholders or the Company Board. Assuming the accuracy of the representations
contained in Section 4.07 and Section 4.08, there are no “fair price,” “moratorium,”
“control share acquisition” or other anti-takeover Laws applicable to this Agreement or the Merger.
Section 3.05 Non-Contravention;
Consents.
(a) Except
as set forth in Part 3.05(a) of the Disclosure Letter, the execution and delivery of this Agreement by the Company does
not, and the consummation of the Merger and the other transactions contemplated by this Agreement and compliance with the provisions
of this Agreement will not, in the case of each of the following clauses (i), (ii) and (iii), assuming compliance, approval, satisfaction,
completion and acceptance (as applicable) with respect to all of the matters and requirements referred to in Section 3.05(b)(i) (including
receipt of the Company Stockholder Approval): (i) violate or conflict with the Company Charter Documents or the Subsidiary Charter
Documents; (ii) violate or conflict with any Law applicable to the Company or any of its Subsidiaries or any of their respective
properties or assets; or (iii) violate, conflict with or result in a breach of, constitute a default (or an event that, with notice
or lapse of time or both, would constitute a default) under, result in the termination of, accelerate the performance required by the
Company or any of its Subsidiaries under, give rise to any obligation to make payments or provide compensation under, result in the creation
of any Lien (other than Permitted Liens) upon any of the properties or assets of the Company or any of its Subsidiaries under, or give
rise to any obligation to obtain any third-party consent or provide any notice to any person under any of the terms, conditions or provisions
of any Material Contract to which the Company or any of its Subsidiaries is a party except, with respect to clauses (i) (solely
with respect to the Subsidiary Charter Documents), (ii) and (iii), such failures to comply, conflicts, violations, triggering of
payments, terminations, accelerations, Liens, encumbrances, notices, Governmental Authorizations, authorizations, consents, approvals,
breaches or defaults that would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.
(b) Except
as set forth in Part 3.05(b) of the Disclosure Letter, no declaration, filing or registration with, or notice to, or
authorization, permit, consent or approval, of any Governmental Authority or any stock market or stock exchange on which shares of Company
Capital Stock are listed is required to be obtained or made by or with respect to the Company or any of its Subsidiaries in connection
with the execution and delivery of this Agreement by the Company or the consummation by the Company of the Merger or the other transactions
contemplated by this Agreement except: (i) (A) for the filing of a premerger notification and report form by the Company under
the HSR Act and the filings and receipt, termination or expiration, as applicable, of such other approvals or waiting periods as may
be required under the competition, merger control, foreign investment screening, antitrust or similar Law of any non-U.S. jurisdiction
(collectively, the “Foreign Merger Control Laws”), including obtaining each of the clearances and approvals identified
in Part 3.05(b)(i)(A) of the Disclosure Letter, (B) obtaining CFIUS Clearance, ITAR Clearance, NSIA Clearance
and each of the clearances and approvals identified in Part 3.05(b)(i)(B) of the Disclosure Letter, (C) the filing
with the United States Securities and Exchange Commission (the “SEC”) of the Proxy Statement and such reports and
filings under Section 13(a), 13(d), 14(a), 15(d) or 16(a) of the Exchange Act and the rules and regulations thereunder,
as may be required in connection with this Agreement and the transactions contemplated hereby and such filings as may be required by
state securities, takeover and “blue sky” laws, (D) as may be required by the NYSE American or any other applicable
national securities exchange in connection with the delisting of the Company Common Stock and (E) for the filing of the Certificate
of Merger with the Delaware Secretary (and the receipt of the Company Stockholder Approval); or (ii) where the failure to make such
declaration, filing or registration or notifications to obtain such authorization, permits, consents or approvals would not reasonably
be expected to have, individually or in the aggregate, a Company Material Adverse Effect.
Section 3.06 Company
SEC Documents; Financial Statements; Undisclosed Liabilities.
(a) Since
January 1, 2021, the Company has filed or furnished (as applicable) on a timely basis all forms, reports, schedules, statements
and other documents (including all exhibits and other information incorporated therein, amendments and supplements thereto) with the
SEC that have been required to be filed or furnished by it under applicable Laws (all such forms, reports, schedules, statements and
other documents filed and publicly available or furnished prior to the date of this Agreement, including all exhibits and other information
incorporated therein, amendments and supplements thereto, collectively, the “Company SEC Documents”). As of their
respective filing dates or, if amended or superseded by a subsequent filing prior to the date hereof, as of the date of the last such
amendment or superseding filing, each Company SEC Document complied as to form in all material respects with the applicable requirements
of the Sarbanes-Oxley Act, the Securities Act or the Exchange Act, as the case may be, each as in effect on the date such Company SEC
Document was filed. As of its filing date (or, if amended or superseded by a filing prior to the date of this Agreement, on the date
of the last such amended or superseded filing), none of the Company SEC Documents contained any untrue statement of a material fact or
omitted to state any material fact necessary in order to make the statements made therein, in light of the circumstances under which
they were made, not misleading. None of the Company’s Subsidiaries is subject to the periodic reporting requirements of the Exchange
Act. As of the date of this Agreement, there are no outstanding or unresolved comments in comment letters from the SEC staff with respect
to any of the Company SEC Documents or any registration statement filed by the Company with the SEC received by the Company from the
SEC or its staff. To the Knowledge of the Company, as of the date of this Agreement, there is no investigation being conducted by the
SEC of any Company SEC Documents.
(b) The
financial statements (including any related notes) contained in the Company SEC Documents: (i) were prepared in accordance with
GAAP applied on a consistent basis throughout the periods covered (except as may be indicated in the notes to such financial statements
or, in the case of unaudited statements, as permitted by Form 10-Q or Form 8-K under the Exchange Act, and except that the
unaudited financial statements may not contain footnotes and other presentation items and are subject to normal year-end adjustments,
or as otherwise permitted by the rules and regulations of the SEC); and (ii) fairly present in all material respects the consolidated
financial position of the Company and its consolidated Subsidiaries as of the respective dates thereof and the consolidated results of
operations and cash flows of the Company and its consolidated Subsidiaries for the periods covered thereby.
(c) The
“disclosure controls and procedures” (as defined by Rules 13a-15(e) and 15d-15(e) of the Exchange Act) utilized
by the Company are reasonably designed to ensure that all material information required to be disclosed by the Company in the reports
that it files or submits to the SEC under the Exchange Act is recorded, processed, summarized and reported within the time periods specified
in the rules and forms of the SEC and that all such material information required to be disclosed is accumulated and communicated
to the management of the Company, as appropriate, to allow timely decisions regarding required disclosure and to enable the principal
executive officer and principal financial officer of the Company to make the certifications required under the Exchange Act with respect
to such reports.
(d) The
Company maintains a system of “internal control over financial reporting” (as defined in Rules 13a-15(f) and 15d-15(f) of
the Exchange Act) sufficient in all material respects to provide reasonable assurance: (i) regarding the reliability of financial
reporting and the preparation of financial statements for external purposes in conformity with GAAP; and (ii) that transactions
are executed only in accordance with the authorization of management or the Company Board. To the Knowledge of the Company, since January 1,
2021, there has been no written complaint, allegation, assertion or claim that the Company or any Subsidiary of the Company has engaged
in illegal accounting or auditing practices.
(e) Based
on its most recent evaluation of internal controls over financial reporting prior to the date hereof, the Company has disclosed to the
Company’s auditors and the audit committee of the Company Board: (i) to the Knowledge of the Company, all “significant
deficiencies” and “material weaknesses” in the design or operation of internal controls over financial reporting that
are reasonably likely to adversely affect in material respects the Company’s ability to record, process, summarize and report financial
information; and (ii) to the Knowledge of the Company, any fraud that involves management or other employees who have a significant
role in the Company’s internal controls. For purposes of this Agreement, the terms “significant deficiency” and “material
weakness” shall have the meanings assigned to them by the Public Company Accounting Oversight Board in Auditing Standard No. 2.
(f) Neither
the Company nor any of its Subsidiaries has any liabilities required to be recorded or reflected on or reserved for or disclosed in a
consolidated balance sheet of the Company and its Subsidiaries, including the notes thereto, under GAAP, other than liabilities that:
(i) are reflected or recorded on the Company Balance Sheet (including in the notes thereto); (ii) were incurred since the Company
Balance Sheet Date in the Ordinary Course of Business; (iii) are incurred in connection with the transactions contemplated by this
Agreement; (iv) have been discharged or paid in full prior to the execution of this Agreement; (v) are permitted, required
or contemplated by this Agreement or disclosed in the Disclosure Letter; or (vi) would not reasonably be expected to have, individually
or in the aggregate, a Company Material Adverse Effect.
(g) Neither
the Company nor any of its Subsidiaries is a party to, or has any commitment to become a party to, any joint venture, partnership agreement
or any similar Contract (including “off-balance sheet arrangements” as defined in Item 303(a) of Regulation S-K promulgated
under the Securities Act) where the result, purpose or intended effect of such arrangement is to avoid disclosure of any material transaction
involving the Company or any of its Subsidiaries in the Company’s consolidated financial statements.
Section 3.07 Absence
of Certain Changes or Events.
(a) Since
the Company Balance Sheet Date to the date of this Agreement, except for actions taken in connection with the execution and delivery
of this Agreement and the transaction contemplated hereby, the business of the Company and each of its Subsidiaries has been conducted
in all material respects in the Ordinary Course of Business, and there has not been or occurred any Effect that, if it occurred during
the period from the date of this Agreement through the Effective Time, would constitute a breach of any of the covenants set forth in
Sections 5.01(b)(i), (ii), (vii), (viii), (xi), (xiv), (xxii) or (xxiii) (as
it relates to the foregoing subsections of Section 5.01(b)).
(b) Since
the Company Balance Sheet Date through the date hereof, except for actions taken in connection with the execution and delivery of this
Agreement and the transaction contemplated hereby, there has been no Effect that is continuing and, individually or in the aggregate,
has had, or would reasonably be expected to have, a Company Material Adverse Effect.
Section 3.08 Litigation;
Orders. Except as set forth in Part 3.08 of the Disclosure Letter, there
are no, and since January 1, 2021 there have been no, Proceedings pending (it being understood that, with respect to any Proceeding
that is an audit, examination or investigation, any representation herein shall be deemed to be to the Knowledge of the Company) or,
to the Knowledge of the Company, threatened in writing against the Company or any of its Subsidiaries or any of their respective properties
or assets that resulted in, or would reasonably be expected to result in, individually or in the aggregate, a Company Material Adverse
Effect. Except as set forth on Part 3.08 of the Disclosure Letter, neither the Company nor any of its Subsidiaries is subject
to any Order, whether temporary, preliminary, or permanent, which would reasonably be expected to have, individually or in the aggregate,
a Company Material Adverse Effect.
Section 3.09 Contracts.
(a) Except
as set forth in Part 3.09(a) of the Disclosure Letter, as of the date of this Agreement, neither the Company nor any
of its Subsidiaries is a party to any Contract (other than this Agreement) required to be filed by the Company as a “material contract”
pursuant to Item 601(b)(10) of Regulation S-K under the Securities Act (a “Filed Company Contract”) that has
not been so filed.
(b) Except
for (i) this Agreement and (ii) any Contracts publicly filed by the Company with the SEC, Part 3.09(b) of
the Disclosure Letter sets forth a true and complete list of, as of the date of this Agreement:
(i) each
Contract that contains covenants binding upon the Company or any of its Subsidiaries that materially restrict the ability of the Company
or any of its Subsidiaries to compete in any business or with any person or in any geographic area (except for any such Contract that
may be canceled without any penalty or other liability to the Company or any of its Subsidiaries upon notice of ninety (90) days or fewer);
(ii) each
Contract to which the Company or any of its Subsidiaries is a party that constitutes a collective bargaining agreement or similar labor
agreement with any labor organization, works council, trade union, employee association, or other employee representatives or employee
representative body representing, purporting to represent, or to the Knowledge of the Company, seeking to represent any employee of the
Company or its Subsidiaries (a “Collective Bargaining Agreement”);
(iii) other
than with respect to any Contract solely between the Company and its wholly owned Subsidiaries or among the Company’s wholly owned
Subsidiaries, each Contract that is a joint venture, partnership, limited liability or other similar agreement or arrangement relating
to the formation, creation, operation, management or control of any partnership or joint venture, in each case that is material to the
business of the Company and its Subsidiaries, taken as a whole;
(iv) each
Contract that is an indenture, mortgage, credit agreement, loan agreement, security agreement, guarantee, bond or similar Contract pursuant
to which there is any outstanding Indebtedness (excluding clause (d) of the definition thereof) of the Company or any of its Subsidiaries,
whether as borrower or lender, in each case in excess of $100,000, other than (a) accounts receivables and payables in the Ordinary
Course of Business and (b) any such Contract between or among any of the Company and any of its Subsidiaries;
(v) each
Contract, the value of which exceeds $100,000, (A) that obligates the Company or any of its Subsidiaries to conduct business on
an exclusive basis with any third party, or (B) that includes a “most-favored nation” or other similar clause;
(vi) each
Contract that by its terms calls for aggregate payments by the Company and its Subsidiaries under such Contract of more than $100,000
per fiscal year over the remaining term of such Contract (other than this Agreement, Contracts between or among any of the Company and
any of its Subsidiaries, Contracts that are subject of another subsection of this Section 3.09(b) or Company Leases);
(vii) each
Government Contract that (A) has not reached the end of its term or period of performance or (B) that has not yet been subject
to final payment or closeout;
(viii) each
Contract to which the Company or any of its Subsidiaries is a party with a Major Customer or a Major Supplier in each case other than
quotes, purchase orders, statements of work, sales orders, supplements, invoices or similar agreements or Contracts that are listed elsewhere
in Part 3.09(b) of the Disclosure Letter;
(ix) each
Contract between the Company or any of its Subsidiaries, on the one hand, and any executive officer or director of the Company or any
of its Subsidiaries, on the other hand, other than any contract covered by clause (iii) above or any Company Benefit Plan;
(x) each
Contract with respect to any acquisition and divestiture pursuant to which the Company or any of its Subsidiaries has continuing indemnification,
“earn-out” or other contingent payment obligations, in each case, that would reasonably be expected to result in future payments
by the Company in excess of $100,000;
(xi) other
than any Company Benefit Plan listed on Part 3.12(a)(ii) of the Disclosure Letter or at-will offer letters on the Company’s
standard form containing no severance provisions or consulting Contracts which may be cancelled on less than ninety (90) days’
notice without penalty to the Company, each employment or independent contractor Contract (in each case, under which the Company has
continuing obligations as of the date hereof) with any current or former executive officer, consultant, independent contractor, or employee
of the Company or its Subsidiaries or member of the Company Board providing for an annual base compensation in excess of $100,000;
(xii) each
Contract or plan that has not been listed on Part 3.12(f) of the Disclosure Letter, including any stock option plan,
stock appreciation right plan or stock purchase plan, any of the benefits of which will be increased, or the vesting of benefits of which
will be accelerated, by the consummation of the Transactions or the value of any of the benefits of which will be calculated on the basis
of any of the transactions contemplated by this Agreement (including the Merger);
(xiii) each
Contract, the value of which exceeds $100,000, providing for indemnification or any guaranty (in each case, under which the Company has
continuing obligations as of the date hereof and that is material to the Company and its Subsidiaries, taken as a whole), other than
(A) any guaranty by the Company of any of its Subsidiary’s obligations, (B) any Contract entered into in the Ordinary
Course of Business or (C) any Contract otherwise listed in the Disclosure Letter, in each case of (A) through (C), with the
exception of any Contract providing for indemnification or guaranty that is not capped (for the avoidance of doubt, such Contract with
uncapped indemnification or guaranty obligations shall be deemed to be required to be listed in Part 3.09(b) of the
Disclosure Letter pursuant to this clause (xiii));
(xiv) each
Contract, the value of which exceeds $100,000, between the Company or any of its Subsidiaries, on the one hand, and any resellers or
distributors of the Company or any of its Subsidiaries, on the other hand, that is a reseller, distribution or other similar agreement
or arrangement;
(xv) each
Contract that involves the resolution of a legal Proceeding (A) that has been entered into by the Company or any of its Subsidiaries
since January 1, 2021, or (B) that includes a material payment obligation of the Company or any of its Subsidiaries that has
not yet been performed by the Company or its Subsidiaries, in each case of (A) and (B), other than (x) releases immaterial
in nature or amount entered into with former employees or independent contractors of the Company in the Ordinary Course of Business that
did not resolve any actual or threatened Proceeding or (y) settlement agreements for cash only (which has been paid) and does not
exceed $100,000 as to such settlement;
(xvi) each
Company Lease; and
(xvii) each
Intellectual Property Contract.
Each Contract required to be listed in Part 3.09(b) of
the Disclosure Letter, and each Filed Company Contract is referred to herein as a “Material Contract.”
(c) Each
Material Contract is valid and binding on the Company and each of its Subsidiaries that are a party thereto and, to the Knowledge of
the Company, each other party thereto, and is in full force and effect and enforceable in accordance with its respective terms against
the Company and its Subsidiaries, and to the Knowledge of the Company, each other party thereto, subject to the Bankruptcy and Equity
Exception, except (i) to the extent that any Material Contract expires in accordance with its terms and (ii) as would not,
individually or in the aggregate, be material to the Company and its Subsidiaries. Except as would not, individually or in the aggregate,
be material to the Company and its Subsidiaries, taken as a whole, neither the Company nor any of its Subsidiaries, or to the Knowledge
of the Company, any other party, is in violation or breach of or in default under any Material Contract to which the Company or any of
its Subsidiaries is a party or by which any of them or any of their respective properties, rights or assets is bound. No third party
to any Material Contract has, to the Knowledge of the Company, alleged that the Company or any Subsidiary is in violation or breach of,
or in default under, any such Material Contract or has notified the Company or any Subsidiary of an intention to modify any material
terms of, or not to renew, any such Material Contract.
(d) Neither
the Company nor any of its Subsidiaries or, to the Knowledge of the Company, the Company’s Principals (as that term is presently
defined in Section 52.209-5, Title 48, Code of Federal Regulations) have in the prior three (3) years been suspended, debarred,
or proposed for debarment from bidding on material contracts or subcontracts with any Governmental Authority, and to the Knowledge of
the Company, no such suspension or debarment has been initiated or threatened. Neither the Company nor any of its Subsidiaries or, to
the Knowledge of the Company, the Company’s Principals, is presently indicted or has been convicted or, had a civil judgment rendered
against them, or have had a finding of fault or liability rendered against them in any administrative or civil proceeding for (i) commission
of fraud or a criminal offense in connection with the obtaining, attempting to obtain, or performing a Government Contract, or (ii) commission
of embezzlement, theft, forgery, bribery, falsification or destruction of records, tax evasion, violating U.S. federal criminal tax laws,
or receiving stolen property. To the Knowledge of the Company, the consummation of the Merger and the other transactions contemplated
by this Agreement will not result in any such suspension or debarment.
(e) With
respect to the Company’s Government Contracts, except as would not, individually or in the aggregate, reasonably be expected to
have a Company Material Adverse Effect, as of the date of this Agreement:
(i) the
Company has not received written notice that any Government Contracts are the currently the subject of bid, award, or size protest proceedings;
(ii) the
Company does not need any “Facility Security Clearance” (as that term is defined by Part 117, Title 32, Code of Federal
Regulations) to perform its Government Contracts; and
(iii) the
Company, to the extent applicable, is currently in compliance with all Government Contract terms and conditions relating to counterfeit
electronic parts and the sources of electronic parts, and is currently in compliance with all higher-level contract quality (as defined
in Section 46.202-4, Title 48, Code of Federal Regulations) provisions of its Government Contracts.
Section 3.10 Compliance
with Laws; Governmental Authorizations.
(a) Except
as set forth in Part 3.10(a) of the Disclosure Letter or where the effect of any such noncompliance would not, individually
or in the aggregate, reasonably be expected to have a Company Material Adverse Effect: (i) the Company and its Subsidiaries are
in compliance with all applicable Laws; and (ii) since January 1, 2021, neither the Company nor any of its Subsidiaries has,
(A) received any written notice or, to the Knowledge of the Company, other communication from any Governmental Authority regarding
any actual or alleged violation of, or failure to comply with, any applicable Law, or (B) provided any written notice to any Governmental
Authority regarding any violation by the Company or any of its Subsidiaries of any Law, and no such violation or failure to comply remains
outstanding or unresolved as of the date of this Agreement.
(b) Except
as would not, individually or in the aggregate, reasonably be expected to have a Company Material Adverse Effect: (i) the Company
and its Subsidiaries hold all Governmental Authorizations necessary to enable the Company and its Subsidiaries to conduct their respective
businesses in the manner in which such businesses are currently being conducted; (ii) all such Governmental Authorizations are valid
and in full force and effect; and (iii) the Company and its Subsidiaries are, and have been, in compliance with the terms and requirements
of such Governmental Authorizations.
(c) With
respect to the Company’s Government Contracts:
(i) in
the past six (6) years, the Company has complied in all material respects with all applicable Laws pertaining to all Government
Contracts (and proposals and quotations submitted that led to the formation of such Government Contracts), including but not limited
to: the Truthful Cost and Pricing Data Statute, the Anti-Kickback Act of 1986, the Procurement Integrity Act, the Buy American Act, the
Trade Agreements Act, the Walsh-Healy Public Contracts Act;
(ii) in
the past three (3) years, the Company has not received a subpoena, search warrant, or civil investigative demand with respect to
any Government Contract; and
(iii) in
the past three (3) years, the Company has not made a written disclosure with respect to any alleged, potential, or actual irregularity,
misstatement, noncompliance, or omission arising under or relating to a Government Contract (or proposal or quotation that led to the
formation of a Government Contract), and to the Knowledge of the Company, no facts and circumstances exist that would require a mandatory
disclosure pursuant to Section 52.203-13, Title 48, Code of Federal Regulations.
Section 3.11 Labor
and Employment Matters.
(a) As
of the date of this Agreement, except as set forth in Part 3.11(a) of the Disclosure Letter: (i) neither the Company
nor any of its Subsidiaries is a party to any Collective Bargaining Agreement; (ii) there are no labor organizations, works councils,
trade unions or other employee representatives representing or purporting to represent any employee or former employee of the Company
or its Subsidiaries; (iii) there is no pending demand for recognition or certification to the Company or any of its Subsidiaries
by any labor organization or group of employees of the Company or any of its Subsidiaries; (iv) there are no representation or certification
proceedings or petitions seeking a representation proceeding presently pending or threatened before the National Labor Relations Board
or any other labor relations tribunal or authority (foreign or domestic) with respect to the Company or any of its Subsidiaries; (v) there
is no pending or, to the Knowledge of the Company, threatened, labor strike, work stoppage, slowdown or lockout due to labor disagreements
by or with respect to any employee or former employee of the Company or its Subsidiaries, against or involving the Company or any of
its Subsidiaries, and no such event has occurred within the two (2) years preceding the date of this Agreement; and (vi) the
execution of this Agreement and the consummation of the transactions contemplated by this Agreement will not result in any breach or
other violation of any Collective Bargaining Agreement or any notice, information or consultation obligations under applicable labor
Law and, to the Knowledge of the Company, no such breaches or violations have occurred previously.
(b) Except
as would not reasonably be expected to result in, individually or in the aggregate, a material liability to the Company or any of its
Subsidiaries, taken as a whole, (i) no Proceedings are pending, or to the Knowledge of the Company, threatened against the Company
or any of its Subsidiaries that are related to unfair labor practices, discrimination, harassment, retaliation, wrongful discharge or
violation of any foreign, state and/or federal statute or common law relating to employment, employment practices, wages, hours, mandatory
insurance, benefits, leaves of absence, employee classification, exemptions from overtime and minimum wage requirements, immigration
control, employee safety, employee privacy, bonuses and terms and conditions of employment, including laws relating to termination of
employment and relating to job applicants and employee background checks, or (ii) there is no claim against the Company or any of
its Subsidiaries in respect of which any current or former employee, officer, non-employee director, independent contractor, consultant,
or other service provider of the Company or any of its Subsidiaries is or may be entitled to claim indemnification from the Company or
any of its Subsidiaries. Since January 1, 2021, the Company and its Subsidiaries have complied in all material respects with all
applicable Laws relating to employment, employment practices, wages, hours, mandatory insurance, benefits, leaves of absence, employee
classification, exemptions from overtime and minimum wage requirements, immigration control, employee safety, employee privacy, bonuses
and terms and conditions of employment, including laws relating to termination of employment and relating to job applicants and employee
background checks.
(c) As
of the date of this Agreement, no director or executive officer of the Company or its Subsidiaries has expressed to the Company or its
Subsidiaries in writing any present intention to terminate his or her employment with the Company or any of its Subsidiaries. No key
employee of the Company or its Subsidiaries has notified the Company or its Subsidiaries, in writing, of any confidentiality, customer
non-solicitation or non-competition obligations of such employee to any other person(s) that conflict with such employee’s
work for, or obligations to, Parent, the Company, the Surviving Corporation, or any of their Subsidiaries.
(d) Except
as set forth in Part 3.11(d) of the Disclosure Letter, no notice to any employees of the Company or its Subsidiaries
or any of such employees’ respective Representatives and /or bargaining or consulting obligations are required with respect to
the Merger and the other transactions contemplated by this Agreement under applicable Law or any Collective Bargaining Agreement or other
similar agreement. Any such obligations set forth in Part 3.11(d) of the Disclosure Letter have been, or prior to the
Closing Date will be, timely satisfied, in each case.
(e) Except
as would not reasonably be expected to result in, individually or in the aggregate, a material liability to the Company or any of its
Subsidiaries, taken as a whole, the Company and each of its Subsidiaries are, and since January 1, 2021 (i) have been in compliance
with the WARN Act and any similar applicable Law, (ii) have not effected a “plant closing” (as defined in the WARN Act)
affecting any site of employment or one or more facilities or operating units within any site of employment or facility of its business,
(iii) have not implemented a “mass layoff” (as defined in the WARN Act) affecting any site of employment or facility
of the Company, and (iv) have not affected by any transaction or engaged in layoffs or employment terminations sufficient in number
to trigger application of the WARN Act or any similar applicable Law.
(f) Since
January 1, 2021, no investigation, review, complaint, grievance, controversy or proceeding by any Governmental Authority or current
or former employee with respect to any of the Company or any of its Subsidiaries in relation to any actual or alleged violation of any
Law involving any current or former employee or other service provider of the Company or any of its Subsidiaries is or has been pending
or, to the Knowledge of the Company, threatened in writing.
Section 3.12 Employee
Benefit Matters.
(a) Part 3.12(a)(i) of
the Disclosure Letter contains a true and complete list, as of the date of this Agreement, of all U.S. employees of the Company and its
Subsidiaries, including their position, duration of service and salary, and Part 3.12(a)(ii) of the Disclosure Letter
contains a true and complete list, as of the date of this Agreement, of each “employee benefit plan” within the meaning of
Section 3(3) of ERISA, whether or not subject to ERISA, all material equity or equity-based (including the Company Stock Plans),
change in control, bonus or other incentive compensation, disability, salary continuation, employment, consulting, indemnification, severance,
retention, retirement, pension, profit sharing, savings or thrift, deferred compensation, health or life insurance, employee discount
or free product, vacation, sick pay or paid time off plans, programs, policies, contracts, agreements, or arrangements (other than any
immaterial fringe benefits), and each other material benefit or compensation plan, program, policy, contract, agreement or arrangement
(or, in the case of employee offer letters or employment agreements, the Company’s and any Subsidiary’s forms of offer letter
or employment agreement and any individual letter or agreement that materially deviates from the form for the applicable jurisdiction),
in each case, established, maintained, sponsored or contributed to (or with respect to which any obligation to contribute has been undertaken)
by the Company or any of its Subsidiaries or with respect to which the Company or any of its Subsidiaries has, or reasonably would be
expected to have, any liability or obligation that is subject to the Laws of the United States or primarily for the benefit of individuals
regularly employed in the United States (collectively, the “Company Benefit Plans”). Other than the Company’s
Subsidiaries, there are no ERISA Affiliates of the Company. Neither the Company nor any of its Subsidiaries nor any of their current
or former ERISA Affiliates has ever maintained, contributed to, or sponsored (or had any obligation of any sort, contingent or otherwise,
with respect to) (1) a Multiemployer Plan or the local equivalent thereof under applicable Laws, (2) a plan described in Section 413
of the Code, (3) a plan subject to Title IV of ERISA, (4) a plan subject to the minimum funding standards of Section 412
of the Code or Section 302 of ERISA, or (5) a plan maintained in connection with any trust described in Section 501(c)(9) of
the Code. No Company Benefit Plan provides any post-retirement health or welfare benefits for any current or former employee of the Company
or its Subsidiaries (or their dependents), other than as required under the Consolidated Omnibus Reconciliation Act of 1985, as amended
(“COBRA”) or similar state law or for a limited period of time following a termination of employment pursuant to the
terms of an existing employment, severance or similar agreement in effect as of the date hereof that has been made available to Parent
and is set forth on Part 3.12(a)(ii) of the Disclosure Letter. Neither the Company nor any of its Subsidiaries has made
any promises or commitments to create any additional Company Benefit Plan or to modify or change in any material way any existing Company
Benefit Plan other than those amendments or modifications required by applicable Law.
(b) The
Company has made available to Parent current, complete and accurate copies of: (i) all documents setting forth the terms of each
material Company Benefit Plan (or with respect to any unwritten Company Benefit Plan, a written description of each material term thereof)
and all material documents relating to each such Company Benefit Plan, including the plan document, all amendments thereto and all related
trust documents and funding instruments; (ii) for the most recent year (A) reports on Form 5500 required to be filed with
the Internal Revenue Service (the “IRS”) or any other Governmental Authority with respect to each Company Benefit
Plan (if any such report was required) and all schedules and attachments thereto, including audited financial statements (if any such
statements were required) and Tax Return (Form 990), if any, and (B) actuarial valuation reports (if any such reports exist);
(iii) the most recent summary plan description for each Company Benefit Plan and all summaries of material modification (if such
exist) and, within the past three (3) years, all material written employee communications related to each Company Benefit Plan;
(iv) each trust Contract and insurance or group annuity Contract, services Contract, or other material Contract relating to any
Company Benefit Plan including all amendments thereto; (v) the most recent favorable IRS determination letter or opinion letter,
to the extent applicable; (vi) all material, non-routine correspondence to or from any Governmental Authority within the past three
(3) years with respect to any Company Benefit Plan; and (vii) all nondiscrimination and coverage tests for the three (3) most
recent full plan years (if any).
(c) Except
as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, each Company Benefit
Plan has been administered in compliance with its terms and the Company, its Subsidiaries and all the Company Benefit Plans are in compliance
with the applicable provisions of, and have made or accrued, as applicable, all payments (including, without limitation, all contributions
and insurance premiums) with respect to all prior periods required under, ERISA, the Code and all other applicable Laws, including Laws
of foreign jurisdictions as applicable, and the terms of all Collective Bargaining Agreements. Except as would not be material, none
of the Company, any of its Subsidiaries, and, to the Knowledge of the Company, its third party fiduciaries have engaged in a non-exempt
“prohibited transaction,” within the meaning of Section 4975 of the Code and Section 406 of ERISA with respect
to the Company Benefit Plans. No Company Benefit Plan has failed to comply with Section 409A of the Code in a manner that would
result in any material tax, interest or penalty thereunder.
(d) All
Company Benefit Plans intended to be “qualified” within the meaning of Section 401(a) of the Code have received
favorable determination or approval letters from the IRS, to the effect that such Company Benefit Plans are so qualified or may rely
on an opinion letter issued by the IRS with respect to a prototype plan adopted in accordance with the requirements for such reliance
and exempt from federal income Taxes under Section 401(a) of the Code and their related trusts are so exempt under Section 501(a) of
the Code, no such determination, approval or opinion letter has been revoked (nor, to the Knowledge of the Company, has revocation been
threatened) and, to the Knowledge of the Company no event has occurred since the date of the most recent determination letter relating
to any such Company Benefit Plan that would reasonably be expected to materially adversely affect the qualification of such Company Benefit
Plan or related trust.
(e) There
are no Proceedings by any Governmental Authority with respect to or other claims, suits or Proceedings against or involving any Company
Benefit Plan or Foreign Benefit Plan or, with respect to either, any of their fiduciaries or administrators, or asserting any rights
or claims to benefits or assets under any Company Benefit Plan or Foreign Benefit Plan that could result in a material liability to the
Company, in each case, that are pending or, to the Knowledge of the Company, threatened (excluding claims for benefits incurred in the
ordinary course). To the Knowledge of the Company, there are no facts that could give rise to any material liability in the event of
any such Proceeding and no written or oral communication has been received from the Pension Benefit Guaranty Corporation in respect of
any Company Benefit Plan subject to Title IV of ERISA in connection with the transactions contemplated herein.
(f) Except
as set forth in Part 3.12(f) of the Disclosure Letter, none of the execution and delivery of this Agreement, the obtaining
of the Company Stockholder Approval or the consummation of the transactions contemplated by this Agreement (either alone or in conjunction
with any other event, including as a result of any termination of employment before, on or following the Effective Time) will: (i) entitle
any employee, officer, non-employee director, independent contractor, consultant, or other service provider of the Company or any of
its Subsidiaries (whether current, former or retired), or their beneficiaries, to severance or termination or other pay; (ii) accelerate
the time of payment or vesting, or trigger any payment or funding (through a grantor trust or otherwise) of, compensation or benefits
under, increase the amount payable or trigger any other material obligation pursuant to, any Company Benefit Plan or Foreign Benefit
Plan; (iii) result in any breach or violation of, or a default under, any Company Benefit Plan or Foreign Benefit Plan; or (iv) result
in any amounts payable to any “disqualified individual” failing to be deductible for federal income tax purposes by virtue
of Section 280G of the Code or subject to an excise tax under Section 4999 of the Code. Neither the Company nor any of its
Subsidiaries has any obligation to gross-up, indemnify or otherwise reimburse any employee, officer, non-employee director, independent
contractor, consultant, or other service provider of the Company or any of its Subsidiaries (whether current, former or retired) for
any Tax incurred by such individual under Section 409A or 4999 of the Code or otherwise.
(g) Part 3.12(g) of
the Disclosure Letter contains a list of all material Foreign Benefit Plans. Current, complete and accurate copies of each material Foreign
Benefit Plan and all related material Contracts have been made available to Parent. All Foreign Benefit Plans have been established,
maintained and administered in material compliance with their terms and all applicable Laws and Orders of any controlling Governmental
Authority, and all applicable Collective Bargaining Agreements, and all Foreign Benefit Plans that are required to be funded are fully
funded in accordance with applicable Law, applicable plan documents and Collective Bargaining Agreements, past practice, and generally
accepted accounting principles in the local jurisdiction and, with respect to all other Foreign Benefit Plans, adequate reserves therefor
have been established on the accounting statements of the Company or the applicable Subsidiary to the extent so required.
Section 3.13 Taxes.
(a) (i) All
income and other material Tax Returns required to be filed by or on behalf of the Company and its Subsidiaries with any Governmental
Authority on or before the Closing Date, (A) have been or will be filed on or before the applicable due date (taking into account
any extensions of such due date), and (B) have been, or will be when filed, true, correct and complete in all material respects;
and (ii) all income and other material Taxes required to be paid by the Company and its Subsidiaries on or before the Closing Date
have been or will be timely paid on or before the Closing Date.
(b) The
Company has made adequate provision for income and other material Taxes not yet due and payable on the Company Balance Sheet as of the
date of the Company Balance Sheet. Since the date of the Company Balance Sheet, any income and other material Taxes of the Company and
its Subsidiaries have been accrued on the books and records of the Company in accordance with GAAP.
(c) The
Company has delivered or otherwise made available to the Parent (i) complete and correct copies of all income and other material
Tax Returns of the Company and its Subsidiaries relating to Taxes for the preceding five (5) taxable periods, and (ii) complete
and correct copies of all private letter rulings, notices of proposed deficiencies, closing agreements, settlement agreements and pending
ruling requests relating to Taxes submitted by, received by, or agreed to by or on behalf of the Company and its Subsidiaries for all
taxable periods for which the statute of limitations has not yet expired.
(d) No
extension or waiver of the limitation period applicable to any Taxes or Tax Returns of the Company or its Subsidiaries has been granted
(by the Company or any other person), which currently remains in effect.
(e) The
Company and its Subsidiaries have withheld all material Taxes required to be withheld from amounts payable to their employees, agents,
contractors, creditors, stockholders and third parties, and remitted such amounts to the proper taxing authorities.
(f) The
Company and its Subsidiaries have collected all material sales, value-added and use Taxes required to be collected, and have remitted,
or will remit on a timely basis, such amounts to the appropriate Governmental Authority (or have been furnished properly completed exemption
certificates with respect to any such material Taxes and have complied in all material respects with applicable sales and use Tax statutes
and regulations requiring the maintenance of records and supporting documents).
(g) (i) No
audit, examination, claim or Proceeding in respect of any Tax has been conducted within the past three (3) years or is being conducted,
pending or, to the Knowledge of the Company, contemplated with respect to the Company or any of its Subsidiaries; and (ii) there
are no Liens for Taxes upon any of the assets of the Company or its Subsidiaries, except Liens for current Taxes not yet due and payable
or for Taxes being contested in good faith by appropriate proceedings by the Company or one of its Subsidiaries and with respect to which
adequate reserves for payment have been established on the Company Balance Sheet.
(h) Neither
the Company nor its Subsidiaries will be required to include any material item of income in, or exclude any material item of deduction
from, taxable income for any taxable period or portion thereof ending after the Closing Date as a result of any: (i) change in a
method of accounting under Section 481 of the Code (or any comparable provision of state, local or foreign tax Laws) for a taxable
period ending on or prior to the Closing Date; (ii) use of an improper method of accounting for a taxable period ending on or prior
to the Closing Date; (iii) installment sale or open transaction occurring prior to the Closing; (iv) intercompany transaction
or excess loss account described in Treasury Regulation Section 1502 (or any corresponding or similar provision of state, local
or foreign income tax Law); (v) closing agreement under Section 7121 of the Code, or similar provision of state, local or foreign
tax Law; or (vi) deferred revenue, unearned revenue or prepaid amount received on or before the Closing Date.
(i) No
written claim has been made within the past five (5) years by any Governmental Authority in a jurisdiction where the Company, or
any of its Subsidiaries, does not file a Tax Return that the Company or such Subsidiary is or may be subject to taxation by that jurisdiction.
(j) Neither
the Company nor any of its Subsidiaries is a party to or bound by any Company Contract relating to allocation, sharing or indemnification
of Taxes with any person other than the Company or any of its Subsidiaries, except for commercial Contracts not primarily related to
Taxes entered into in the Ordinary Course of Business.
(k) Neither
the Company nor any of its Subsidiaries (i) has ever been a member of an affiliated group filing a consolidated federal income Tax
Return or any similar group for federal, state, local or foreign Tax purposes (other than a group the common parent of which was the
Company); or (ii) has, or will have, any liability for Taxes (A) of any other person under Treasury Regulation Section 1.1502-6
(or any similar provision of state, local or foreign Law) or as a transferee or successor (other than for Taxes for any member of any
group the common parent of which was the Company) or (B) by written contract (except commercial agreements not primarily relating
to Taxes entered into in the Ordinary Course of Business).
(l) The
Company has not participated in, nor is it currently participating in, a “Listed Transaction” within the meaning of Treasury
Regulation Section 1.6011-4(b)(2).
(m) The
Company has not constituted either a “distributing corporation” or a “controlled corporation” within the meaning
of Section 355(a)(1)(A) of the Code in a distribution occurring during the past two (2) years ending on the date of this
Agreement in which the parties to such distribution treated the distribution as one to which Section 355 of the Code is applicable.
(n) The
Company is not, nor has it been, a U.S. real property holding corporation within the meaning of Section 897(c)(2) of the Code
during the past five (5) years ending on the date of this Agreement.
(o) None
of the Company or any of its Subsidiaries has had a permanent establishment (within the meaning of an applicable Tax treaty), or has
otherwise become subject to net income Tax in a country other than such entity’s jurisdiction of incorporation, organization or
formation.
(p) None
of the Company or any of its Subsidiaries has (i) deferred any Taxes (including payroll Taxes those imposed by Sections 3101(a) and
3201 of the Code) pursuant to Section 2302 of the CARES Act or any other corresponding or similar provision of applicable Tax Law
enacted in connection with COVID-19 that have not been paid in full or (ii) claimed any tax credit under Section 2301 of the
CARES Act (including employee retention credits under the CARES Act) or otherwise taken any action to elect or avail itself to any provision
of the CARES Act related to Taxes.
(q) The
representations and warranties of the Company made in this Section 3.13 and in Section 3.12 are the only representations
and warranties made by the Company with respect to matters relating to Taxes.
Section 3.14 Real
Property; Personal Property.
(a) The
Company and its Subsidiaries do not own any real property.
(b) Part 3.14(b) of
the Disclosure Letter contains a complete and accurate list of all of the leases, lease guaranties, licenses (other than Intellectual
Property licenses), subleases, agreements, including all amendments, terminations and modifications thereof (collectively, the “Company
Leases”) for the leasing, use or occupancy of, or otherwise granting a right in or relating to, any real property currently
leased, subleased or licensed by or from the Company or any of its Subsidiaries or otherwise used or occupied by the Company or any of
its Subsidiaries as of the date of this Agreement (such property, the “Leased Real Property”). Except as would not,
individually or in the aggregate, reasonably be expected to have a Company Material Adverse Effect: (i) all Company Leases are in
full force and effect and are valid, binding and enforceable in accordance with their respective terms; and (ii) there is not, under
any Company Leases, any existing default or event of default (or event that, with or without notice or lapse of time, or both, would
constitute a default) of the Company or any of its Subsidiaries, or to the Knowledge of the Company, any other party thereto.
(c) Except
as set forth in Part 3.14(c) or Part 6.03(f) of the Disclosure Letter, the execution and delivery of
this Agreement by the Company does not, and the consummation of the transactions contemplated hereby will not: (i) (A) result
in any breach of or constitute a default (or event that, with or without notice or lapse of time, or both, would become a default), (B) materially
impair the rights of the Company or any of its Subsidiaries (whether as a result of any Order or otherwise), (C) alter the rights
or obligations of the lessor or licensor, or (D) to the Knowledge of the Company, give any person any rights of termination, amendment,
acceleration or cancellation, in each case, under any Company Leases; or (ii) otherwise adversely affect the continued use and possession
of the Leased Real Property, which is the subject of any Company Leases for the conduct of business as presently conducted.
(d) Except
where it would not reasonably be expected to be material to the Company and its Subsidiaries taken as a whole, each Leased Real Property
and all of its operating systems are (i) in good operating condition and repair and (ii) are suitable for the conduct of the
business of the Company and its Subsidiaries as presently conducted.
(e) The
Company has not received any written notice from any insurance company of any defects or inadequacies in any Leased Real Property or
any part thereof which would reasonably be expected to adversely affect the insurability of such Leased Real Property or the premiums
for the insurance thereof. No written notice has been received from any insurance company which has issued a policy with respect to any
portion of any Leased Real Property or by any board of fire underwriters (or other body exercising similar functions) requesting the
performance of any repairs, alterations or other work with which compliance has not been made.
(f) Except
as set forth in Part 3.14(f) of the Disclosure Letter: (i) to the Knowledge of the Company there is no pending
or threatened condemnation or similar proceeding affecting any Leased Real Property or any portion thereof, (ii) there are no Proceedings
pending or, to the Knowledge of the Company, threatened against the Company, or, to the Knowledge of the Company, against third parties
affecting any Leased Real Property, and the Company is not aware of any facts which might result in any such Proceeding.
Section 3.15 Intellectual
Property; Data Security and Data Privacy.
(a) Part 3.15(a)(1) of
the Disclosure Letter sets forth a true and complete list, as of the date of this Agreement, of: (i) Patents, Marks, Copyrights,
and Internet domain names that are registered with or issued by any Governmental Authority or authorized private registrar, or subject
to a pending application for any of the foregoing that are Owned Intellectual Property (indicating for each, as applicable, the owner(s),
jurisdiction, registration number, and relevant date(s)) (the “Company Registered IP”); and (ii) all Company
Products currently made commercially available as “off-the-shelf” products or under development to be released as “off-the-shelf”
products. Except as disclosed in Part 3.15(a)(2) of the Disclosure Letter, all necessary documents and certificates
currently due for filing as of the date hereof in connection with all Company Registered IP have been filed with the relevant patent,
copyright, trademark or other authorities in the United States or foreign jurisdictions, as the case may be, for the purposes of maintaining
such Company Registered IP. Each item of Company Registered IP is subsisting, and to the Knowledge of the Company, valid and (other than
applications) enforceable. The prosecution, recording, filing and maintenance of the Company Registered IP have at all times been conducted
in compliance with applicable Law and the rules of the applicable registrar. Neither the Company nor any of its Subsidiaries has
taken any action or failed to take any action that would adversely affect the enforceability of any Company Registered IP.
(b) The
Company and its Subsidiaries have not and, to the Company’s Knowledge, no other party to any Intellectual Property Contract has
materially breached such Intellectual Property Contract. The Company has made available to Parent complete and accurate copies of all
of the Intellectual Property Contracts, other than (i) such redactions as are apparent on the face of the Intellectual Property
Contract, and (ii) purchase orders issued by customers of the Company providing only for the purchase by such customers of “off-the-shelf”,
unmodified Company Products that are subject to customary, non-negotiated terms and conditions that would not be reasonably expected
to have a material adverse effect upon the benefits of the Merger reasonably expected to be received by Parent. None of the Company nor
any of its Subsidiaries has received notice, or has any Knowledge, that any party to any Intellectual Property Contract intends to cancel,
terminate or refuse to renew (if renewable) any Intellectual Property Contract, or to exercise or decline to exercise any option or right
thereunder.
(c) Except
as disclosed in Part 3.15(c)(1) of the Disclosure Letter, the Company or one of its Subsidiaries (i) is the sole
and exclusive owner of all right, title and interest in and to all Owned Intellectual Property and Owned Technology, and (ii) to
the Knowledge of the Company, has the valid and enforceable right to use all other Intellectual Property and Technology used in or necessary
for or held for use for the conduct of the business of the Company or any of its Subsidiaries as currently conducted free and clear of
any Liens, except Permitted Liens. Other than as disclosed in Part 3.15(c)(2) of the Disclosure Letter, the Company
exclusively owns all Owned Intellectual Property free and clear of any joint ownership interests and free and clear of any Liens, other
than Permitted Liens, and all Owned Intellectual Property is freely transferable, licensable and assignable with any requirement of consent
from or notice to any third person, subject to any Permitted Liens. Except as set forth in Part 3.15(c)(3) of the Disclosure
Letter, neither the Company nor any of its Subsidiaries has transferred ownership of, or granted any exclusive license or rights in,
or authorized the retention of any exclusive rights in or joint ownership of any Intellectual Property or Technology material to the
business of the Company and its Subsidiaries, taken as a whole, or agreed to do any of the foregoing.
(d) Except
as set forth in Part 3.15(d) of the Disclosure Letter, neither the execution, delivery or performance of this Agreement
nor the consummation of any of the transactions contemplated hereby will, pursuant to a Contract to which the Company or any of its Subsidiaries
is a party or otherwise bound: (i) result in the Company, any of its Subsidiaries or Parent granting, assigning or transferring
to any other person any license or other right or interest under, to or in any Intellectual Property, Technology or Company Products
that would not be granted, assigned or transferred in the absence of this Agreement and the transactions contemplated hereby; (ii) require
the consent of any other person in respect of the Company’s and its Subsidiaries’ rights to continue to own or use any Company
Intellectual Property or Company Technology that it would have had rights to own or use in the absence of this Agreement and the transactions
contemplated hereby; (iii) impair the right of the Company or any of its Subsidiaries, or cause the Company or any of its Subsidiaries
to lose any rights, to Exploit any Company Intellectual Property or Company Technology that it would have had rights to Exploit in the
absence of this Agreement and the transactions contemplated hereby; (iv) result in the Company, any of its Subsidiaries or Parent
being bound by, or subject to, any non-compete or other restriction on the operation or scope of its business that it would not be bound
by or subject to in the absence of this Agreement and the transactions contemplated hereby; or (v) result in the Company or any
of its Subsidiaries being obligated to pay (or increase the amount of) any royalties or other amounts to any person that it would not
be obligated to pay in the absence of this Agreement and the transactions contemplated hereby.
(e) Except
as set forth in Part 3.15(e) of the Disclosure Letter, no Patent or other Intellectual Property that is Owned Intellectual
Property: (i) has been, or is required to be, disclosed or contributed by the Company or any of its Subsidiaries to any industry
standards bodies, patent pools, standard setting organization, organization managing a de facto industry standard, or similar organizations
(“Standards Organizations”); (ii) is subject to any commitment by the Company or any of its Subsidiaries to a
Standards Organization that would require the grant of any license or other right to any person or otherwise limit the Company’s
or any of its Subsidiaries’ control of any Patents or other Owned Intellectual Property; or (iii) has been identified by the
Company or any of its Subsidiaries or, to the Knowledge of the Company, any other person as essential to any Standards Organization or
any standard promulgated by any Standards Organization. Neither the Company nor any of its Subsidiaries is a founder, member or promoter
of, or a contributor to, any Standards Organization.
(f) No
Proceedings are pending or, to the Knowledge of the Company, threatened against the Company or any of its Subsidiaries alleging that
the Company or any of its Subsidiaries infringed, misappropriated, or violated any Intellectual Property of any other person or that
challenge, question, or contest the validity, use, ownership or enforceability of any of the Owned Intellectual Property, including the
Company’s and its Subsidiaries’ ownership, internal transfers or assignments of, or right to use, any Owned Intellectual
Property or Owned Technology and neither the Company nor any of its Subsidiaries have, in the past six (6) years preceding the date
of this Agreement, received any written request or demand for indemnification or defense of an infringement claim from any reseller,
distributor, channel partner, end-customer or other third party, in each case, which remains unresolved as of the date of this Agreement,
in each case except as specified in Part 3.15(f) of the Disclosure Letter.
(g) (i) to
the Knowledge of the Company, neither the Company’s nor any of its Subsidiaries’ use of any Company Intellectual Property
or Company Technology, nor the operation of the Company’s or any of its Subsidiaries’ respective businesses as previously
or currently conducted, has within the six (6) years preceding the date of this Agreement infringed, misappropriated, diluted or
otherwise violated, or does infringe, misappropriate, dilute or otherwise violate, any Intellectual Property of any other person or has
constituted or does constitute unfair competition or unfair trade practices, and neither the Company or any of its Subsidiaries received,
within the six (6) years preceding the date of this Agreement, any notice alleging any of the foregoing (including any invitation
to license Intellectual Property); (ii) to the Knowledge of the Company, no person (including any current or former employee or
consultant of the Company or its Subsidiaries) has within the six (6) years preceding the date of this Agreement or is infringing,
misappropriating or violating any Owned Intellectual Property or Owned Technology; (iii) the Owned Intellectual Property and Owned
Technology are not subject to any outstanding consent, settlement, decree, Order, injunction, judgment or ruling restricting the use
thereof; and (iv) none of the Company or its Subsidiaries has within the six (6) years preceding the date of this Agreement
brought, or threatened to bring, any claim before any Governmental Authority or arbitral tribunal against any person with respect to
any of the Owned Intellectual Property or Owned Technology.
(h) (i) Each
employee of the Company and its Subsidiaries that has created or developed any Intellectual Property or Technology for Company or its
Subsidiaries has and (ii) each contractor, subcontractor, and consultant of the Company and its Subsidiaries that has created or
developed any Intellectual Property or Technology for Company or its Subsidiaries in the research or development of Company Products
has, in each case, executed and delivered a written agreement that is, to the Knowledge of the Company, valid, binding and enforceable:
(A) assigning to the Company or the applicable Subsidiary of the Company all of such employee’s, contractor’s, subcontractor’s,
or consultant’s right, title and interest in any Intellectual Property or Technology created by such employee, contractor, subcontractor,
or consultant within the scope of his or her employment or engagement (or ownership of all right, title and interest in such Intellectual
Property or Technology vests in the Company or the applicable Subsidiary by operation of law); and (B) requiring such employee,
contractor, subcontractor or consultant to maintain as confidential, and not use other than on behalf of the Company and its Subsidiaries,
all confidential information and Trade Secrets disclosed or accessible to such employee, contractor, subcontractor or consultant in connection
with her or employment or engagement (including confidential information or Trade Secrets disclosed to the Company or any of its Subsidiary
by a third person). To the Knowledge of the Company, no employee, contractor, subcontractor or consultant of the Company or its Subsidiaries
is in breach of any duty or obligation owed to any prior employer or other third party relating to Intellectual Property or confidentiality
in connection with his or her employment or engagement with the Company or any of its Subsidiaries.
(i) Neither
the Company nor any of its Subsidiaries has embedded or otherwise incorporated in any manner any Open Source Software in any Company
Product, or technology used within a Company Product, that is currently made commercially available or is under development.
(j) To
the Knowledge of the Company, the Company Products as sold by the Company do not contain any disabling codes or instructions, spyware,
Trojan horses, worms, viruses or other harmful, malicious, or destructive code or any software routines that are designed to permit or
cause unauthorized access to, or material disruption, impairment, disablement, or destruction of, software, data, systems or other materials.
The Company has taken reasonable precautions designed to prevent the incorporation of any such code into the Company Products.
(k) Other
than as set forth in Part 3.15(k) of the Disclosure Letter, no Governmental Authority, research center or educational
institution has provided any funding, facilities or other resources in connection with the development of any Owned Intellectual Property
or Owned Technology. The Company has not developed any Owned Intellectual Property under (x) Other Transaction Agreement W52P1J-20-9-3020
dated June 8, 2020 between the Company and the U.S. Army Contracting Command, (y) Other Transaction Agreement CS-20-1101 dated
March 14, 2023 between the Company and the U.S. Army, and (z) Technology Investment Agreement FA8650-20-2-5533 dated March 10,
2021 between the Company and the U.S. Air Force Research Laboratory.
(l) (i) No
source code for any software within the Owned Technology (“Company Software”) has been delivered, licensed or made
available to any escrow agent or other person who was not or is not, as of the date of this Agreement, an employee, contractor, subcontractor,
or consultant of the Company or one of its Subsidiaries, (ii) neither the Company nor any of its Subsidiaries has any duty or obligation
(whether present, contingent or otherwise) to deliver, license or make available the source code for any Company Software to any escrow
agent or other person who is not, as of the date of this Agreement, an employee contractor, subcontractor, and consultant of the Company
or a Subsidiary of the Company, and (iii) no event has occurred, and no circumstance or condition exists, that (with or without
notice or lapse of time) will, or could reasonably be expected to, result in the delivery, license or disclosure of any source code for
any Company Software to any person.
(m) The
IT Systems are adequate and sufficient (including with respect to working condition and capacity) for the operations of the Company and
its Subsidiaries. Each of the Company and its Subsidiaries has taken reasonable measures designed to preserve and maintain the performance,
security and integrity of the IT Systems (and all software, information and data stored on any IT Systems). To the Company’s Knowledge,
there have been (i) no Security Incidents, or other adverse incidents related to data in the custody and control of the Company,
its Subsidiaries or, any third party acting on behalf of the Company or any of its Subsidiaries; (ii) no material breach or violation
of the IT Systems or threat of such breach or violation in writing; or (iii) no events that would require the Company or any of
its Subsidiaries to notify customers, consumers, employees, Governmental Authorities, or any other persons of any Security Incident or
other breach or violation of the IT Systems under any Privacy Commitment.
(n) Except
as would not, individually or in the aggregate, reasonably be expected to result in a Company Material Adverse Effect, the data, privacy
and security practices and Processing of Personal Information of the Company and its Subsidiaries conform in all material respects to
all Privacy Laws. Except as would not reasonably be expected to result in, individually or in the aggregate, a Company Material Adverse
Effect, to the Company’s Knowledge, each of the Company and its Subsidiaries as of the date of this Agreement: (A) provides
notice and obtains any necessary consents from data subjects required for the processing of Personal Information as conducted by or for
the Company and its Subsidiaries; and (B) abides by any privacy choices (including opt-out preferences) of data subjects relating
to Personal Information and any obligations contained in the Company’s Contracts, data privacy and security policies, or published
on the Company’s websites or otherwise made available by the Company to any person (“Privacy Commitments”).
(o) Except
as set forth in Part 3.15(o)(i) of the Disclosure Letter, there are no Contracts to which the Company or any of its
Subsidiaries is a party or is otherwise bound that purport to expressly grant to any person, or require the grant to any person of, a
license, covenant not to sue, or other immunity or right of any kind, in each case, with respect to any Intellectual Property owned by
Parent or its Affiliates (other than the Company (including the Surviving Corporation) or any of its Subsidiaries following the Effective
Time as a result of the Merger). Except as set forth in Part 3.15(o)(ii) of the Disclosure Letter, the Company has made
available to Parent complete and accurate copies of (x) all of the Outbound Intellectual Property Contracts entered into since January 1,
2013, and (y) to the Knowledge of the Company, all of the Outbound Intellectual Property Contracts entered between January 1,
2008 and December 31, 2012, other than, in each case, (i) such redactions as are apparent on the face of the Outbound Intellectual
Property Contract, (ii) any purchase orders, including terms or conditions governing such purchase orders, except for (1) purchase
orders governed by terms or conditions expressly negotiated by the Company with respect to the assignment of, or granting of any licenses,
covenants not to sue or other rights or immunities of any kind under, any Intellectual Property owned, created or developed by the Company
or (2) purchase orders pursuant to which the Company created or developed, or was obligated to create or develop, any Technology
or Intellectual Property, and (iii) those Outbound Intellectual Property Contracts that would not be material to Parent, the Company
or the benefits of the Merger reasonably expected to be received by Parent.
Section 3.16 Customers,
Suppliers, Distributors, Recalls
(a) Part 3.16(a) of
the Disclosure Letter lists the ten (10) largest customers (each, a “Major Customer”) of the Company and its
Subsidiaries, taken as a whole, determined on the basis of the aggregate revenues received by the Company and/or its Subsidiaries, taken
as a whole, for the twelve (12) month period ending on December 31, 2022.
(b) Part 3.16(b) of
the Disclosure Letter lists the ten (10) largest suppliers (each, a “Major Supplier”) of the Company and its
Subsidiaries, taken as a whole, including original design manufacturers that manufacture Company Products for or on behalf of the Company
and its Subsidiaries, determined on the basis of cost of goods or services purchased for the twelve (12) month period ending on December 31,
2022.
(c) No
Major Customer or Major Supplier has other than in the Ordinary Course of Business (i) ceased or materially reduced its payments
or sales or provision of services to the Company or its Subsidiaries since the beginning of the twelve (12) month period ending on December 31,
2022; or (ii) threatened in writing to cease or materially reduce such payments or sales or provision of services.
(d) Each
Company Product sold or delivered by the Company or any Subsidiary of the Company has been in conformity with all applicable contractual
commitments, customers’ specifications and all express and implied warranties, except as has not had, and would not reasonably
be expected to have a Company Material Adverse Effect.
Section 3.17 Environmental
Matters.
(a) Except
as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, and except as disclosed
in Part 3.17(a) of the Disclosure Letter: (i) each of the Company and its Subsidiaries is, and has for the past
five (5) years been, in compliance with all applicable Environmental Laws, and neither the Company nor any of its Subsidiaries has
received any written communication alleging that the Company or any of its Subsidiaries is in violation of, or has any liability under,
any applicable Environmental Law; (ii) each of the Company and its Subsidiaries possesses and is in compliance with all Governmental
Authorizations required under applicable Environmental Laws to conduct its business as presently conducted; and (iii) there are
no Environmental Claims pending or, to the Knowledge of the Company, threatened against the Company or any of its Subsidiaries and none
of the Company or any of its Subsidiaries has Released or exposed any person to any Hazardous Materials and no Hazardous Materials have
been Released at, on, under or from any of the Leased Real Property, which is the subject of any Company Leases, in any case, in a manner
for which the Company or any of its Subsidiaries is required to undertake any remedial action or clean-up action pursuant to applicable
Environmental Law.
(b) Except
as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, and except as disclosed
in Part 3.17(b) of the Disclosure Letter: (i) the Company possesses, and has at all times for the past five (5) years
possessed, all permits required by any Governmental Authority pursuant to Environmental Law for the operation of the business of the
Company and its Subsidiaries, including the ownership, use or occupation of their respective assets; and (ii) all such current permits
are in full force and effect and to the Knowledge of the Company, there are no facts or circumstances that would reasonably be expected
to result in the termination, revocation or withdrawal or any such permit.
Section 3.18 Insurance.
Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect: to the Knowledge
of the Company, (i) all material insurance policies of the Company and its Subsidiaries are in full force and effect and are valid
and enforceable and provide insurance in such amounts and against such risks as is sufficient to comply with applicable Law and there
is no existing default or event which, with or without the giving of notice or lapse of time or both, would constitute a default, by
any insured thereunder; and (ii) all premiums due with respect to such insurance policies have been paid.
Section 3.19 Trade
Compliance. The Company and its Subsidiaries are, and have been in the past five (5) years,
in compliance in all material respects with all applicable trade compliance Laws, including but not limited to: (a) U.S. Laws governing
the exportation of goods, technology, software, and services, including the Export Administration Regulations (“EAR”)
(15 C.F.R. § 730 et seq.), and the ITAR; (b) U.S. Laws governing the importation of goods, including laws administered by U.S.
Customs and Border Protection; (c) U.S. Laws governing economic sanctions, including those administered by the U.S. Treasury Department’s
Office of Foreign Assets Control (“OFAC”) codified at 31 C.F.R. Part 500 et. seq., and the U.S. Department of
State; and (d) U.S. Laws governing international boycotts administered by the U.S. Department of Commerce and the Internal Revenue
Service (collectively, “Trade Compliance Laws”). Part 3.19 of the Disclosure Letter sets forth a summary
of the Company’s ITAR-controlled “technical data” for the production, development, design, manufacture, or use of the
Company’s products. In the past five (5) years, none of the Company, its Subsidiaries, and their respective directors, officers,
employees, and to the Knowledge of the Company, agents or other Third Parties acting on behalf of the Company and its Subsidiaries, has
been the target of any economic sanctions administered or enforced by the United States Government, including, without limitation, OFAC
and the U.S. Department of State (collectively, “Sanctions”). In the past five (5) years, none of the Company,
its Subsidiaries, and their respective directors, officers, employees, and to the Knowledge of the Company, agents or other Third Parties
acting on behalf of the Company and its Subsidiaries, has engaged in any unlawful dealings or transactions, directly or, to the Knowledge
of the Company, indirectly: (a) with any person that at the time of the dealing or transaction was the subject of Sanctions; or
(b) in any jurisdiction that is, or in the last five years was, the subject of comprehensive territorial Sanctions at the time of
the dealing or transaction, including Cuba, Iran, North Korea, Syria, and the Russian-occupied areas of Crimea, Donetsk, or Luhansk
regions of Ukraine. None of the Company or its Subsidiaries are subject, and in the past five years has not been subject, to any Proceedings,
or made any voluntary disclosures to any Governmental Authority, involving the Company or its Subsidiaries relating to Trade Compliance
Laws. The Company and its Subsidiaries have implemented and administer internal controls, policies, and procedures designed to promote
compliance with Trade Compliance Laws.
Section 3.20 Affiliate
Transactions. Except as disclosed in Part 3.20 of the Disclosure Letter,
since January 1, 2021 there have not been any transactions, Contracts, agreements, arrangements or understandings that would be
required to be disclosed under Item 404 of Regulation S-K promulgated under the Securities Act that have not been disclosed in the Company
SEC Documents filed prior to the date of this Agreement.
Section 3.21 Anti-Corruption(a) .
The Company, its Subsidiaries, and their respective directors, officers, employees, and to the Knowledge of the Company, agents and third
parties acting on behalf of the Company or its Subsidiaries, are and have been for the past five (5) years, in compliance with the
anti-corruption laws of each jurisdiction in which the Company and its Subsidiaries operate or have operated, including the U.S. Foreign
Corrupt Practices Act (“Anti-Corruption Laws”). In the past five (5) years, the Company, its Subsidiaries, and
their respective directors, officers, employees, and to the Knowledge of the Company, agents and third parties acting on behalf of the
Company or its Subsidiaries, have not paid, offered or promised to pay, authorized or ratified the payment or transfer of, directly or
indirectly, any monies or anything of value to any Public Official, or any other person, for the purpose of corruptly influencing any
act or decision of such Public Official, of a Governmental Authority, or any other person, to obtain or retain business, to direct business
to any person, or to secure any other improper benefit or advantage, in each case, in violation of Anti-Corruption Laws. Neither the
Company nor its Subsidiaries are subject, or in the past five (5) years have been subject, to any Proceedings, made any voluntary
disclosures to any Governmental Authority, or conducted or initiated any internal investigation relating to the Anti-Corruption Laws.
The Company and its Subsidiaries have implemented and administer internal controls, policies, and procedures designed to promote compliance
with Anti-Corruption Laws.
Section 3.22 Information
Supplied. None of the information supplied or to be supplied by or on behalf of the Company
for inclusion or incorporation by reference in the Proxy Statement will, at the date it is first mailed to the stockholders of the Company
and at the time of the Stockholders’ Meeting, contain any untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they are
made, not misleading, except that no representation is made by the Company with respect to statements made in or omitted from the Proxy
Statement relating to Parent or any of its Affiliates based on information supplied by Parent or any of its Affiliates for inclusion
or incorporation by reference in the Proxy Statement.
Section 3.23 Brokers
and Other Advisors. No broker, investment banker, financial advisor or other person,
other than Nomura Securities International, Inc. (“Nomura”), is entitled to any broker’s, finder’s
or financial advisor’s fee or commission in connection with the Merger and the transactions contemplated by this Agreement based
upon arrangements made by or on behalf of the Company.
Section 3.24 Opinion
of Financial Advisors. The Company has, as of the date of the Agreement, received
the opinion of Nomura (the “Fairness Opinion”), which, if delivered orally, shall be accompanied by a written
opinion to be delivered promptly following the execution of this Agreement, to the effect that, as of the date of such opinion and
based upon and subject to the qualifications, limitations and assumptions set forth therein, the Per Share Merger Price to be
received pursuant to, and in accordance with, the terms of this Agreement by the holders of shares of Company Common Stock (other
than Parent, the Company, or any Subsidiary of the Company (or held in the Company’s treasury) the Affiliates of Parent or
Silk USA, the Stillwater Stockholders upon conversion of the Company Series B Convertible Preferred Stock prior to the Closing and
holders of Dissenting Shares) is fair, from a financial point of view, to such holders of shares of Company Common Stock and, as of
the date of this Agreement, such opinion has not been withdrawn, revoked or modified.
Section 3.25 Backlog.
The estimated backlog amount of awarded business of the Company and its Subsidiaries, as set forth in the Company’s annual report
on Form 10-K filed with the SEC on March 10, 2023, was calculated in good faith consistent with past practices as set forth
therein. Since the Company Balance Sheet Date through the date hereof, the Company has not received any written notice of any material
change, cancellation or deviation from such awarded business.
Section 3.26 No
Other Representations or Warranties. Except for the representations and warranties expressly
set forth in this Article III (as qualified by the Disclosure Letter and the Company SEC Documents), none of the Company,
any of its Affiliates or any other person makes any express or implied representation or warranty (and there is and has been no reliance
by Parent, Silk USA or Merger Sub or any of their respective Representatives or Affiliates on any such representation or warranty) with
respect to the Company, any of its Subsidiaries or their respective businesses or with respect to any other information provided, or
made available, to Parent, Silk USA or Merger Sub or their respective Representatives or Affiliates in connection with the transactions
contemplated hereby, including the accuracy or completeness thereof. Without limiting the foregoing, neither the Company nor any other
person will have or be subject to any liability or other obligation to Parent, Silk USA, Merger Sub or their respective Representatives
or Affiliates or any other person resulting from Parent’s, Silk USA’s, Merger Sub’s or their respective Representatives’
or Affiliates’ use of any information, documents, projections, forecasts or other material made available to Parent, Silk USA,
Merger Sub or their respective Representatives or Affiliates, including any information made available in management or other presentations
or in the electronic or other data rooms maintained by or on behalf of the Company or its Representatives in connection with the transactions
contemplated by this Agreement, unless and to the extent any such information is expressly included in a representation or warranty contained
in this Article III (as qualified by the Disclosure Letter and the Company SEC Documents).
Article IV
Representations
and Warranties of Parent, Silk USA and Merger Sub
Except as set forth in a corresponding numbered
section of the Parent Disclosure Letter, it being agreed that disclosure of any item in any part of the Parent Disclosure Letter shall
also be deemed disclosure with respect to any other section of this Agreement to which the relevance of such item is reasonably apparent,
Parent, Silk USA and Merger Sub jointly and severally represent and warrant to the Company as follows:
Section 4.01 Organization,
Standing and Corporate Power.
(a) Parent
is a corporation duly organized, validly existing and in good standing under the Laws of the Republic of Korea and has the requisite
corporate power and authority to conduct its business as it is presently being conducted and to own, lease or operate its properties
and assets. Silk USA is a corporation duly organized, validly existing and in good standing under the Laws of the State of Delaware and
has the requisite corporate power and authority to conduct its business as it is presently being conducted and to own, lease or operate
its properties and assets. Merger Sub is a corporation duly organized, validly existing and in good standing under the Laws of the State
of Delaware and has the requisite corporate power and authority to conduct its business as it is presently being conducted and to own,
lease or operate its properties and assets.
(b) Each
of Parent, Silk USA and Merger Sub is duly qualified to do business and is in good standing in each jurisdiction where the nature of
its activities make such qualification necessary, except where the failure to be so qualified would reasonably be expected to have a
Parent Material Adverse Effect. Neither Parent, Silk USA nor Merger Sub is in violation of its organizational documents to the extent
such violation would reasonably be expected to have a Parent Material Adverse Effect.
Section 4.02 Authority;
Binding Nature of Agreement. Each of Parent, Silk USA and Merger Sub has all requisite
corporate power and authority to execute and deliver this Agreement and to perform its respective obligations hereunder, including the
Merger. The execution, delivery and performance by Parent, Silk USA and Merger Sub of this Agreement and the consummation of the transactions
contemplated hereby, including the Merger, have been duly authorized by any necessary action on the part of Parent, Silk USA and Merger
Sub and their respective boards of directors, and Silk USA has approved and adopted this Agreement and the consummation of the transactions
contemplated hereby, including the Merger, in its capacity as sole stockholder of Merger Sub, and no other corporate proceedings or vote
or consent of the holders of any class or series of capital stock of Parent, Silk USA, Merger Sub or any of their Affiliates or similar
action on the part of Parent, Silk USA or Merger Sub or any of their Affiliates are necessary to authorize this Agreement, to perform
their respective obligations hereunder, or to consummate the transactions contemplated hereby. This Agreement has been duly executed
and delivered by Parent, Silk USA and Merger Sub and, assuming the due and valid authorization, execution and delivery of this Agreement
by the Company, constitutes the valid and binding obligation of Parent, Silk USA and Merger Sub, enforceable against each of Parent,
Silk USA and Merger Sub in accordance with its terms, subject to the Bankruptcy and Equity Exception.
Section 4.03 Non-Contravention.
(a) The
execution and delivery of this Agreement by each of Parent, Silk USA and Merger Sub do not, and the consummation of the Merger and the
other transactions contemplated by this Agreement and compliance with the provisions of this Agreement will not, in the case of each
of the following clauses (i), (ii), and (iii), assuming compliance, approval, clearance, satisfaction, completion and acceptance (as
applicable) with respect to all of the matters and requirements referred to in Section 4.03(b)(i): (i) violate or conflict
with the organizational documents of Parent, Silk USA or Merger Sub; (ii) violate or conflict with any Law applicable to Parent,
Silk USA, Merger Sub or any of their respective properties or assets; or (iii) violate, conflict with or result in a breach of,
constitute a default (or an event that, with notice or lapse of time or both, would constitute a default) under or give rise to any obligation
to obtain any third-party consent or provide any notice to any person under, any of the terms, conditions or provisions of any Governmental
Authorization or Contract to which any of Parent, Silk USA or Merger Sub is a party except, with respect to clauses (ii) and (iii),
such violations, conflicts, breaches, defaults, consents or notices that would not reasonably be expected to have, individually or in
the aggregate, a Parent Material Adverse Effect.
(b) No
declaration, filing or registration with, or notice to, or authorization, permit, consent or approval, of any Governmental Authority
is required to be obtained or made by or with respect to Parent, Silk USA or Merger Sub in connection with the execution and delivery
of this Agreement by Parent, Silk USA or Merger Sub or the consummation by Parent, Silk USA or Merger Sub of the Merger or the other
transactions contemplated by this Agreement, except: (i) (A) for the filing of a premerger notification and report form by
Parent, Silk USA and Merger Sub under the HSR Act and the filings and receipt, termination or expiration, as applicable, of such other
approvals or waiting periods as may be required under any Foreign Merger Control Laws, including obtaining each of the clearances and
approvals identified in Part 3.05(b)(i)(A) of the Disclosure Letter, (B) obtaining CFIUS Clearance, ITAR Clearance,
NSIA Clearance and each of the clearances and approvals identified in Part 3.05(b)(i)(B) of the Disclosure Letter, (C) as
may be required by the Securities Act, the Exchange Act and the rules and regulations thereunder and state securities, takeover
and “blue sky” Laws, (D) for the filings required by the DGCL (including the filing of the Certificate of Merger), (E) for
the overseas direct investment report filings to be filed with a designated Korean foreign exchange bank under the Foreign Exchange Transaction
Act of Korea and the regulations thereunder; or (ii) where the failure to make such declaration, filing or registration or notifications
to obtain such authorization, permits, consents or approvals, would not, individually or in the aggregate, reasonably be expected to
have a Parent Material Adverse Effect.
Section 4.04 Litigation.
There are no Proceedings pending or, to the Knowledge of Parent, threatened against Parent, Silk USA or Merger Sub that would reasonably
be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. None of Parent, Silk USA or Merger Sub is subject
to any Order, whether temporary, preliminary, or permanent, which would reasonably be expected to have, individually or in the aggregate,
a Parent Material Adverse Effect. There are no Proceedings pending, or threatened, to which Parent, Parent’s Subsidiaries, Silk
USA or Merger Sub is a party seeking to prohibit or delay the transaction contemplated by the Agreement.
Section 4.05 Information
Supplied. None of the information supplied or to be supplied by or on behalf of Parent,
Silk USA or Merger Sub or any of their respective Subsidiaries for inclusion or incorporation by reference in the Proxy Statement will,
at the date it is first mailed to the stockholders of the Company and at the time of the Stockholders’ Meeting, contain any untrue
statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they are made, not misleading. Parent, Silk USA and Merger Sub will take all reasonable
best efforts to supply any information necessary for the Proxy Statement as promptly as practicable.
Section 4.06 Activities
and Ownership of Silk USA and Merger Sub.
(a) Merger
Sub has been formed solely for the purpose of engaging in the transactions contemplated hereby and, prior to the Effective Time, will
not have engaged in any business activities, other than activities pursuant to this Agreement. Silk USA has been formed solely for the
purpose of engaging in the transactions contemplated hereby and, prior to the Effective Time, will not have engaged in any business activities,
other than activities pursuant to this Agreement
(b) As
of the date of this Agreement, (i) the authorized capital stock of Merger Sub consists of 1,000 shares of common stock, par value
$0.001 per share, all of which are validly issued and outstanding, (ii) Silk USA owns beneficially all of the outstanding shares
of capital stock of Merger Sub, and (iii) Parent owns beneficially all of the outstanding shares of capital stock of Silk USA free
and clear of all Liens.
Section 4.07 Ownership
of Company Capital Stock. Neither Parent, Silk USA, Merger Sub nor any of their Affiliates
owns (directly or indirectly, beneficially, constructively or of record) any shares of Company Capital Stock, or other securities of
the Company or any options or warrants, and neither Parent, Silk USA, Merger Sub nor any of their Affiliates holds any rights to acquire
or vote any shares of Company Capital Stock or other securities of the Company or any options or warrants except pursuant to the transactions
contemplated by this Agreement.
Section 4.08 Interested
Stockholder. Prior to the date of this Agreement, none of Parent, Silk USA, Merger Sub,
any of Parent’s other Subsidiaries or any of their respective “affiliates” or “associates” (as such terms
are defined in Section 203 of the DGCL) is, or has been at any time during the period commencing three (3) years prior to the
date that the Company Board approved this Agreement, an “interested stockholder” of the Company (as such term is defined
in Section 203 of the DGCL).
Section 4.09 Sufficiency
of Funds. As of the date hereof, Parent has, and Parent will have at the Closing, cash
resources in immediately available funds and in an amount sufficient to (i) consummate the Merger and the other transactions contemplated
under this Agreement and (ii) pay all related fees, costs and expenses incurred in connection therewith.
Section 4.10 Sufficiency
of Investigation; No Other Representations or Warranties.
Each of Parent, Silk USA and Merger Sub has conducted its own independent review and analysis
of the business, operations, assets, Contracts, Intellectual Property, real estate, Technology, liabilities, results of operations,
financial condition and prospects of the Company and its Subsidiaries, and each of them acknowledges that it and its Representatives
have received access to such books and records, facilities, equipment, Contracts and other assets of the Company and its Subsidiaries
that it and its Representatives have requested to review and that it and its Representatives have had the opportunity to meet with the
management of the Company and to discuss the business and assets of the Company and its Subsidiaries. Each of Parent, Silk USA and Merger
Sub acknowledges that neither the Company nor any Person on behalf of the Company makes, and none of Parent, Silk USA or Merger Sub has
relied in any manner whatsoever upon, any express or implied representation or warranty with respect to the Company or any of its Subsidiaries
or with respect to any other information provided to Parent, Silk USA, Merger Sub or any of their respective Representatives or Affiliates
in connection with the transactions contemplated by this Agreement including the accuracy, completeness or currency thereof other than
the representations and warranties contained in Article III (as qualified by the Disclosure Letter and the Company SEC Documents).
Without limiting the foregoing, each of Parent, Silk USA and Merger Sub acknowledges and agrees that neither the Company nor any other
person will have or be subject to any liability or other obligation to Parent, Silk USA, Merger Sub or any of their respective Representatives
or Affiliates or any other Person resulting from Parent’s, Silk USA’s, Merger Sub’s or their respective Representatives’
or Affiliates’ use of any information, documents, projections, forecasts or other material made available to Parent, Silk USA,
Merger Sub or their respective Representatives or Affiliates, including any information made available in management or other presentations
or in the electronic or other data rooms maintained by or on behalf of the Company or its Representatives in connection with the transactions
contemplated by this Agreement, unless and to the extent any such information is expressly included in a representation or warranty contained
in Article III (as qualified by the Disclosure Letter and the Company SEC Documents).
Article V
Covenants
Relating to Conduct of Business
Section 5.01 Conduct
of Business. During the period from the date of this Agreement to the earlier of the
Effective Time and the valid termination of this Agreement in accordance with Article VIII (the “Pre-Closing Period”),
except (i) as otherwise set forth in Part 5.01 of the Disclosure Letter, (ii) as required to comply with
COVID-19 Measures or for any actions otherwise taken (or not taken) reasonably and in good faith in response to or as a result of
COVID-19, (iii) as required by applicable Law or Governmental Authorization or as may be required or requested by a Governmental
Authority, (iv) as consented to in writing in advance by Parent (such consent not to be unreasonably withheld, conditioned or delayed)
or (v) as otherwise required, contemplated or expressly permitted by this Agreement:
(a) the
Company shall, and shall cause each of its Subsidiaries to, use its commercially reasonable efforts (x) to carry on its business
in the Ordinary Course of Business in all material respects, (y) preserve intact its current business organization, maintain its
material assets and properties in good repair and condition, and (z) keep available the services of its current key officers and
other key employees and maintain its existing material business relationships with customers, suppliers, distributors, licensors, licensees
and others having material business dealings with the Company and its Subsidiaries, and Governmental Authorities having regulatory dealings
with the Company and its Subsidiaries; provided, that any action taken or failed to be taken by the Company and its Subsidiaries
that is specifically addressed in Section 5.01(b) shall not, in and of itself, constitute a breach under this Section 5.01(a);
and
(b) the
Company shall not, and shall not permit any of its Subsidiaries to:
(i) amend
(A) any Company Charter Documents (except for the Series B Charter Amendment and immaterial or ministerial amendments) or (B) Subsidiary
Charter Documents, except, in the case of this clause (B) for any changes that would not be materially adverse to Parent;
(ii) (A) declare,
accrue, set aside or pay any dividend or make any other actual, constructive or deemed distribution (whether in cash, stock or property)
in respect of any shares of capital stock of the Company or any of its Subsidiaries other than any dividend or distribution by a Subsidiary
of the Company to the Company or another wholly owned Subsidiary of the Company but only if such distribution or dividend does not give
rise to any material Tax liability of any kind; (B) authorize any split, combination or reclassification of any capital stock of
the Company or any of its Subsidiaries, or any issuance of any other securities in lieu of or in substitution for shares of capital stock
of the Company or any of its Subsidiaries; or (C) repurchase, redeem or otherwise acquire any shares of its capital stock or any
options, warrants or other rights to acquire any such shares, in the case of each of the foregoing clauses (A)–(C) other than
(1) the acquisition by the Company of shares of Company Common Stock in connection with the surrender of shares of Company Common
Stock by holders of Company Stock Options in order to pay the exercise price of such Company Stock Options or Tax obligations in connection
therewith, (2) the withholding of shares of Company Common Stock to satisfy Tax obligations with respect to awards granted pursuant
to the Company Stock Plans, (3) the acquisition by the Company of shares of Company Common Stock underlying Company Stock Options,
Company RSUs and any other awards issued under the Company Stock Plans in connection with the forfeiture of such awards, and (4) transactions
between or among the Company and its Subsidiaries or between or among Subsidiaries of the Company;
(iii) issue,
sell, pledge, grant, transfer, encumber or otherwise dispose of any shares of capital stock or other equity interests of the Company
or any of its Subsidiaries, or securities convertible into or exchangeable or exercisable for, or options, warrants, calls, commitments
or rights of any kind to acquire, any shares of capital stock or other equity interests of the Company or any of its Subsidiaries, in
each of the foregoing cases other than (A) upon the exercise or settlement of awards under the Company Stock Plans outstanding on
the date of this Agreement in accordance with the terms thereof, (B) as required to comply with any Company Benefit Plan as in effect
on the date of this Agreement (or expressly permitted by this Agreement to be entered into after the date hereof), (C) transactions
between or among the Company and a Subsidiary of the Company or between Subsidiaries of the Company, (D) the issuance of shares
of Company Common Stock upon the conversion of shares of Company Series B Convertible Preferred Stock issued and outstanding on
the date of this Agreement in accordance with the Company Charter Documents and (E) the issuance of shares of Company Common Stock
upon the conversion of shares of Company Warrants issued and outstanding on the date of this Agreement in accordance with the terms thereof;
(iv) except
as required by any Company Benefit Plan set forth in Part 3.12(a)(ii) of the Disclosure Letter or any Collective Bargaining
Agreement or in order to comply with Section 6.05(b) of this Agreement, (A) grant, pay, or promise to pay any severance
or termination pay or any increase in severance, retention or termination pay or benefits to any employee, executive officer, non-employee
director, independent contractor, consultant, or other service provider of the Company or any of its Subsidiaries (whether current, former
or retired), including agreeing to any obligation to gross-up, indemnify or otherwise reimburse any such individual for any Tax incurred
by any such individual, including under Section 409A or 4999 of the Code or making any such payment (other than, with respect to
employees who are not directors or officers of the Company or any of its Subsidiaries, scheduled payments consistent with the Ordinary
Course of Business before the date of this Agreement), (B) pay any bonus or make any profit-sharing or similar payment to, or increase
the accrual rate or amount of the wages, salary, commissions, fringe benefits (including vacation and other forms of paid leave) or other
compensation (including equity-based compensation, whether payable in stock, cash or other property), benefits, or remuneration payable
to, any employee, officer, non-employee director, independent contractor or consultant of the Company or its Subsidiaries (whether current,
former or retired), other than salary increases, commissions and bonuses to non-officer employees made in the Ordinary Course of Business,
(C) adopt, enter into, grant, terminate or amend in a material respect any Company Benefit Plan or Foreign Benefit Plan or awards
made thereunder (or any plan, agreement, program, policy, trust, fund or other arrangement that would be a Company Benefit Plan if it
were in existence as of the date of this Agreement), (D) other than in the Ordinary Course of Business, or as mandated by accounting
or tax standards or rules, materially change any actuarial or other assumption used to calculate funding obligations with respect to
any Company Benefit Plan or Foreign Benefit Plan or materially change the manner in which contributions to any Company Benefit Plan or
Foreign Benefit Plan are made or the basis on which such contributions are determined, in any case which would result in a material increase
in the amount of annual contributions to any trust maintained for any Company Benefit Plan or Foreign Benefit Plan, (E) loan or
advance any money or other property to any employee, officer, non-employee director, independent contractor or consultant of the Company
or its Subsidiaries (whether current, former or retired), other than consistent with a written or oral advancement or expenses policy
of the Company that exists on the date hereof, (F) enter into any employment, consulting, severance or termination agreement with
any director or executive officer of the Company or any Subsidiary of the Company, or (G) terminate the employment of any current
employee of the Company or any of its Subsidiaries at a level of vice president or above or terminate the engagement of any consultant
of the Company or any of its Subsidiaries, other than for cause or for performance-related reasons or a non-Merger related reason;
(v) waive,
release, limit or condition any restrictive covenant obligation of any employee of the Company or any of its Subsidiaries at a level
of vice president or above (whether current, former or retired);
(vi) (A) enter
into any Contract with respect to any labor dispute, any activity or Proceeding by a labor union or Representative thereof, (B) recognize
any new labor organization, union, employee association, trade union, works council or other similar employee representative, or (C) negotiate,
enter into, amend, modify or terminate any Collective Bargaining Agreement;
(vii) effect
or permit any “plant closing,” “mass layoff,” “termination” or “relocation” as those
terms are defined in the WARN Act or other event that would require advance notice to employees of the Company or any of its Subsidiaries
or pay in lieu thereof under the WARN Act;
(viii) acquire
by merger, consolidation, acquisition of stock or assets, or otherwise any equity ownership interest in, or a substantial portion of
the assets of, any person or any division or business thereof, other than (A) any such action solely between or among the Company
and its Subsidiaries or between or among Subsidiaries of the Company, (B) purchases of inventory or other assets in the Ordinary
Course of Business or pursuant to existing Contracts, or (C) acquisitions or investments not in excess of $100,000 individually
or $200,000 in the aggregate;
(ix) sell,
lease, license, abandon or otherwise dispose of, or subject to any Lien (other than Permitted Liens) any of its material properties,
assets, product lines or businesses (including capital stock or other equity interests in any Subsidiary of the Company and any Owned
Intellectual Property and Owned Technology that is material to the conduct of the business of the Company or any of its Subsidiaries
as currently conducted), or terminate, fail to renew, allow to lapse or otherwise not maintain any Inbound Intellectual Property Contracts,
other than (A) sales, leases or other dispositions of assets or Liens thereon in the Ordinary Course of Business, (B) the granting
of nonexclusive licenses solely as part of the sale of products or services in the Ordinary Course of Business, or (C) pursuant
to Contracts existing as of the date of this Agreement; provided that, notwithstanding anything to the contrary herein, neither
the Company nor any of its Subsidiaries shall be permitted to sell, exclusively license, assign, transfer or otherwise dispose of any
Owned Intellectual Property (other than pursuant to a present assignment of Intellectual Property created or developed under an Intellectual
Property Contract listed in Part 5.01(b)(ix) of the Disclosure Letter); and, provided further, that (i) stand-alone
licensing of any Patents, (ii) the stand-alone licensing of any Owned Technology or (iii) any other sale, assignment, grant
or license of or under any Patents or of Owned Technology (with respect to (ii) and (iii) only, other than as provided in clause
(B) above) shall not be deemed to be conduct in the Ordinary Course of Business solely for the purposes of this Section 5.01(b)(ix);
(x) (A) enter
into or amend any Inbound Intellectual Property Contracts or Outbound Intellectual Property Contracts, (B) fail to maintain, allow
to lapse or abandon any Company Registered IP or allow any Owned Company IP to enter the public domain, (C) enter into any agreement
or modify any existing agreement with respect to the development of any Intellectual Property or rights to Intellectual Property with
a third party other than entry into agreements with new employees, contractors, subcontractors, or consultants entered into in the Ordinary
Course of Business, (D) change pricing or royalties set or charged by the Company or any of its Subsidiaries to its customers or
licensees, or the pricing or royalties set or charged by persons who have licensed Intellectual Property or rights to Intellectual Property
to the Company or any of its Subsidiaries, (E) enter into or amend any agreement pursuant to which any other party is granted marketing,
distribution, or similar rights of any type or scope with respect to any products or technology of the Company or any of its Subsidiaries,
or (F) enter into or amend any agreement pursuant to which any other party is granted development, manufacturing or similar rights
of any type or scope with respect to any products or technology of the Company or any of its Subsidiaries;
(xi) adopt
a plan of complete or partial liquidation, dissolution, restructuring, recapitalization or other reorganization of the Company or any
of its Subsidiaries (other than solely in respect of wholly owned Subsidiaries of the Company and the transactions contemplated hereby,
including the Merger);
(xii) (A) except
for (1) borrowings under the Company’s Existing Revolver (which will not exceed $3,000,000 in the aggregate), and (2) transactions
between or among the Company and its Subsidiaries or between or among Subsidiaries of the Company, and in each case guarantees thereof,
incur any Indebtedness for borrowed money (including by way of issuing any debt securities) or assume or guarantee any Indebtedness for
borrowed money or the obligations of any person (except with respect to obligations of direct or indirect wholly owned Subsidiaries of
the Company) or (B) make any loans or advances or capital contributions to, or investments in, any other Person (other than in respect
of acquiring any material equity interest in any other Person, which shall be governed by Section 5.01(b)(viii)) in excess
of $100,000, except for (1) extensions of credit to customers in the Ordinary Course of Business substantially consistent with past
practice and (2) loans, advances or capital contributions to, or investments in, direct or indirect wholly owned subsidiaries of
the Company;
(xiii) other
than in the Ordinary Course of Business (A) enter into or assume any Contract that would have been a Material Contract had it been
entered into prior to the date of this Agreement or (B) terminate, materially amend or waive any material rights under any Material
Contract or any Contract that would have been a Material Contract had it been entered into prior to the date of this Agreement, excluding
any termination upon expiration of a term in accordance with the terms of such Material Contract; provided, however, that,
in no event shall the Company or any of its Subsidiaries enter into any Contract that would constitute a Material Contract (if entered
into prior to the date hereof) under, or amend any Material Contract such that it would constitute a Material Contract (if entered into
prior to the date hereof) under, any of Section. 3.09(b)(i), Section 3.09(b)(ii), Section 3.09(b)(iii),
Section 3.09(b)(iv) (except as otherwise permitted under and in accordance with Section 5.01(b)(xii)), Section 3.09(b)(v),
Section 3.09(b)(vii) or Section 3.09(b)(xv) (except as otherwise permitted under and in accordance
with Section 5.01(b)(xiv)); provided, further, that in no event shall the Company or any of its Subsidiaries
terminate any Contract with a customer of the Company or its Subsidiaries with a contract value in excess of $50,000 per calendar year,
or any Intellectual Property Contract;
(xiv) (A) institute
any Proceeding other than (1) in respect of any such Proceeding that seeks less than $100,000, or (2) in such cases where the
Company reasonably determines in good faith that the failure to commence suit would result in a material impairment of a valuable aspect
of its business (provided that the Company consults with Parent and considers the views and comments of Parent with respect to
such Proceeding prior to commencement thereof) (3) in connection with a breach of this Agreement or any other agreements contemplated
hereby, or (B) settle or compromise any Proceeding pending or threatened against the Company or any of its Subsidiaries, other than
(1) with respect to Transaction Litigation, which shall be governed by Section 6.03 or any Proceeding or other claim
relating to Taxes, which shall be governed by Section 5.01(b)(xvi), (2) the settlement or compromise of Proceedings
in the Ordinary Course of Business or (3) such settlements or compromises that require payments by the Company or any of its Subsidiaries
(net of insurance coverage and indemnification proceeds actually received or recoverable) in an amount not to exceed $100,000 individually
or $200,000 in the aggregate;
(xv) make
any change in financial accounting methods, principles or practices of the Company or any of its Subsidiaries materially affecting the
consolidated assets, liabilities or results of operations of the Company, except as may be appropriate to conform to changes in GAAP
or regulatory requirements with respect thereto or as required by GAAP or applicable Law or statutory or regulatory accounting rules or
interpretations with respect thereto or by any Governmental Authority;
(xvi) make
any material Tax election, file an amendment to any material Tax Return, consent to any extension or waiver of the statute of limitations
period applicable to any material Tax claim or assessment, settle or compromise any liability for a material amount of Taxes other than
filing any Tax Return or paying any Tax due and payable in the Ordinary Course of Business, surrender any claim for refund for a material
amount of Taxes, or change a material annual accounting method or period for Tax purposes;
(xvii) enter
into, or amend, any affiliate transaction of the nature described in Section 3.20;
(xviii) make
any capital expenditures in excess of $1,000,000 individually or $4,000,000 in the aggregate on an annual basis;
(xix) adopt
a stockholder rights plan or similar agreement;
(xx) fail
to use commercially reasonable efforts to (A) maintain the Company’s existing material insurance policies or (B) replace
such insurance policies with reasonably comparable insurance policies in the event of their termination or cancellation;
(xxi) except
as required by applicable Laws and as expressly required by this Agreement, convene any regular or special meeting (or any adjournment
or postponement thereof) of the stockholders of the Company, other than (A) the Company’s annual meeting to be held in the
year of 2023 at which the stockholders of the Company will be asked to vote on the election of directors, the ratification of appointment
of the Company’s independent auditors, and the approval of the compensation of the Company’s executive officers, and (B) any
special meeting of the Company to be held in accordance with Section 6.01 of this Agreement;
(xxii) hire
any employee without requiring them to execute the Company’s standard form of confidentiality and inventions assignment agreement
applicable to similarly situated employees of the Company, if any; or
(xxiii) agree,
authorize or commit to do any of the foregoing.
Section 5.02 Solicitation;
Takeover Proposals; Change of Company Board Recommendation.
(a) No
Solicitation. From the date of this Agreement until the Effective Time, or, if earlier, the valid termination of this Agreement in
accordance with Section 8.01:
(i) the Company shall, and shall
cause its Subsidiaries, and shall direct its or their respective Representatives to:
(A) immediately cease and promptly, but in any event
on the date hereof, cause to be terminated any solicitation, discussion or negotiation with any person or group conducted on or prior
to the date of this Agreement by the Company, its Subsidiaries or any of their respective Representatives with respect to any Acquisition
Proposal,
(B) promptly, but in any event within one (1) Business
Day after the date hereof, request the prompt return or destruction of any confidential information previously furnished by the Company,
any of its Subsidiaries or any of their respective Representatives to any person (other than Parent and its Representatives) which has
executed a confidentiality agreement within the last twelve (12) months for the purposes of evaluating a possible Acquisition Proposal,
and, if so requested by Parent, use its commercially reasonable efforts (which such commercially reasonable efforts shall be limited
to sending follow-up letters) to confirm return or destruction (to the extent destruction of such information is permitted by such confidentiality
agreement) of such information, and
(C) promptly, but in any event on the date hereof, terminate
access to all persons (other than Parent and its Representatives) to any physical or electronic data rooms relating to a possible Acquisition
Proposal; and
(ii) the Company shall not, and
shall cause its Subsidiaries not to, and shall direct its or their respective Representatives not to, directly or indirectly:
(A) solicit, initiate, or knowingly encourage or knowingly
facilitate the making, submission or announcement by any person of any proposal, offer or inquiry that constitutes, or would reasonably
be expected to lead to, an Acquisition Proposal,
(B) enter into, continue or participate in any discussions
or negotiations with any person regarding any Acquisition Proposal,
(C) furnish to any person (other than Parent, Silk USA,
Merger Sub, or any designees of Parent, Silk USA or Merger Sub, including their respective Representatives) any information relating
to the Company or any of its Subsidiaries, or afford access to the business, properties, assets, books or records of the Company or any
of its Subsidiaries to any person (other than Parent, Silk USA, Merger Sub, or any designees of Parent, Silk USA or Merger Sub), in each
case, to knowingly facilitate or knowingly encourage the making of any proposal that constitutes or would be reasonably expected to lead
to an Acquisition Proposal; provided, however, that press releases and filings with the SEC shall not be prohibited by
this clause so long as such press releases are issued, and such filings are made, in the Ordinary Course of Business and are unrelated
to any Acquisition Proposal or any inquiries that would reasonably be expected to result in an Acquisition Proposal,
(D) approve, endorse or recommend any Acquisition Proposal
or any Acquisition Agreement or other agreement requiring the Company to abandon or terminate its obligations under this Agreement,
(E) other than an Acceptable Confidentiality Agreement
entered into in accordance with this Section 5.02, execute or enter into any letter of intent, memorandum of understanding
or Contract contemplating or otherwise relating to an Acquisition Proposal, or
(F) resolve, propose or agree to do any of the foregoing.
Without limiting the foregoing, the Company agrees that any violation
of the restrictions on the Company set forth in this Section 5.02 by any director or officer of the Company or any of its
Subsidiaries or by any other Representative of the Company acting on behalf of the Company shall be deemed a breach of this Section 5.02
by the Company.
(b) Notwithstanding
anything to the contrary contained in Section 5.02(a), if at any time following the date of this Agreement and prior to the
receipt of Company Stockholder Approval, but not after: (i) the Company receives an unsolicited bona fide written Acquisition
Proposal from any Third Party that has not resulted from a material breach of this Section 5.02; and (ii) the Company
Board determines in good faith, after consultation with its outside legal advisor and financial advisor, that such Acquisition Proposal
constitutes, or would reasonably be expected to lead to, result in or constitute a Superior Proposal, then the Company may, upon a good
faith determination by the Company Board (after consultation with its outside legal advisor) that failure to do so would reasonably be
expected to be inconsistent with the directors’ fiduciary duties under applicable Law, and subject to compliance with Section 5.02(c):
(A) furnish any information, including non-public information, with respect to the Company and its Subsidiaries to the Third Party
making such Acquisition Proposal pursuant to an Acceptable Confidentiality Agreement; provided, that the Company shall, substantially
concurrently with providing any non-public information to any Third Party making such Acquisition Proposal, provide to Parent copies
of all non-public information concerning the Company or its Subsidiaries that is provided to any such Third Party to the extent that
such information was not previously provided to Parent or its Representatives (or if such information is provided orally, then the Company
shall provide to Parent a reasonably detailed summary of the information so provided); and (B) subject to entering into an Acceptable
Confidentiality Agreement, engage in discussions or negotiations with the person making such Acquisition Proposal or such Third Party’s
Representatives.
(c) In
addition to the obligations set forth in Section 5.02(b), the Company shall, during the period commencing on the date hereof
and continuing until the earlier of the Effective Time or, if earlier, the valid termination of this Agreement in accordance with Section 8.01,
promptly (and in any event within one (1) Business Day) notify Parent in writing of the receipt of any Acquisition Proposal or the
receipt of any inquiries that would reasonably be expected to lead to an Acquisition Proposal. Such notice to Parent shall indicate the
identity of the Third Party making the Acquisition Proposal or inquiries and the material terms and conditions of such Acquisition Proposal,
including unredacted copies of all written requests and proposed agreements (including copies of any material amendments to such agreements)
with respect to any Acquisition Proposal (and if such Acquisition Proposal is in written form, the Company shall give Parent a copy thereof).
The Company shall thereafter keep Parent reasonably informed as promptly as reasonably practicable of any developments affecting the
financial and other material terms and conditions (including any copies of any proposed amendments to such financial or other material
terms and conditions) of any such Acquisition Proposal or inquiry which would reasonably expected to lead to an Acquisition Proposal.
Without limiting the foregoing, the Company shall promptly (and in any event within one (1) Business Day) advise Parent in writing
if the Company provides any non-public information or engages in discussions or negotiations concerning an Acquisition Proposal pursuant
to Section 5.02(b).
(d) Except
as set forth in Section 5.02(e), neither the Company Board nor any committee thereof shall: (i) fail to include the
Company Board Recommendation in the Proxy Statement when disseminated to the Company’s stockholders; (ii) withhold, withdraw,
amend, qualify or modify or publicly propose to withhold, withdraw, amend, qualify or modify in a manner adverse to Parent, Silk USA
or Merger Sub the Company Board Recommendation; (iii) adopt, approve, recommend, endorse or otherwise declare advisable the adoption
of, or enter into, any Acquisition Proposal or Acquisition Agreement (other than those relating to the Merger); (iv) following the
date any Acquisition Proposal or any material modification thereto is first made public fail to publicly reaffirm the Company Board Recommendation
within ten (10) Business Days after a written request by Parent to do so, which request may be made only once with respect to any
such Acquisition Proposal and only once with respect to any such material modifications thereto (or, if earlier, by the second (2nd)
Business Day prior to the then-scheduled Stockholders’ Meeting) (each such foregoing action or failure to act in clauses (i) through
(iv) being referred to herein as a “Change in Company Board Recommendation”).
(e) Notwithstanding
any provision of Section 5.02(d), at any time prior to the receipt of the Company Stockholder Approval, but not after, the
Company Board may, subject to compliance with the other provisions of this Section 5.02:
(i) make
a Change in Company Board Recommendation under clauses (i) or (ii) of the definition thereof in connection with an Intervening
Event (but not in connection with a Superior Proposal), if the Company Board determines in good faith, after consultation with its outside
legal advisor, that failure to do so would reasonably be expected to be inconsistent with the directors’ fiduciary duties under
applicable Law (it being understood and agreed that such determination in and of itself shall not be deemed a Change in Company Board
Recommendation); provided, however, that prior to making such Change in Company Board Recommendation:
(A) the Company provides Parent with written notice of
its intention to take such action at least four (4) Business Days in advance of taking such action, specifying in reasonable detail
the reasons for taking such action and the facts relating thereto,
(B) the Company shall, and shall direct its Representatives
to, negotiate in good faith with Parent during such four (4) Business Day period, if requested by Parent, to enable Parent to propose
revisions or modifications to the terms of this Agreement such that it would permit the Company Board not to make a Change in Company
Board Recommendation pursuant to this Section 5.02(e)(i), and
(C) at the end of such four (4) Business Day period,
the Company Board shall consider in good faith any revisions or modifications to the terms of this Agreement proposed in writing by Parent,
and determines in good faith, after consultation with its outside legal advisor and financial advisor, that the Company Board’s
failure to make a Change in Company Board Recommendation under clauses (i) or (ii) of the definition thereof would reasonably
be expected to be inconsistent with the directors’ fiduciary duties under applicable Law, or
(ii) if
the Company receives an Acquisition Proposal that did not result from a material breach of Section 5.02(a) and that
the Company Board determines in good faith (after consultation with its outside legal advisor and its financial advisor) constitutes
a Superior Proposal, either:
(A) terminate this Agreement pursuant to Section 8.01(f),
provided that prior to or concurrently with any such termination, the Company shall pay or cause to be paid to Parent any Company
Termination Fee required to be paid pursuant to Section 8.03(b) in connection with such termination, or
(B) make a Change in Company Board Recommendation;
provided,
however, that prior to making a Change in Company Board Recommendation or prior to terminating this Agreement in each case, pursuant
to this clause (ii), (1) the Company provides Parent with written notice of its intention to take such action at least four (4) Business
Days in advance of taking such action, and the reasons therefor, and provides to Parent a summary of the material terms and conditions
of such Superior Proposal and an unredacted copy of any and all Acquisition Agreements related to such Superior Proposal, it being agreed
that the provision of such notice shall not, in and of itself, constitute a Change in Company Board Recommendation, (2) the Company
shall, and shall direct its Representatives to, negotiate in good faith with Parent during such four (4) Business Day period, if
requested by Parent, to enable Parent to propose revisions or modifications to the terms of this Agreement such that it would cause such
Superior Proposal to no longer constitute a Superior Proposal, (3) at the end of such four (4) Business Day period, the Company
Board shall consider in good faith any revisions or modifications to the terms of this Agreement proposed in writing by Parent, and shall
have determined in good faith, after consultation with its outside legal advisor and financial advisor, that the Superior Proposal would
continue to constitute a Superior Proposal even if the revisions or modifications proposed in writing by Parent were to be given effect,
and (4) in the event of any change in any of the financial terms (including the amount, form and timing of payment of any consideration)
or any other material terms of such Superior Proposal, the Company shall, in each case, deliver to Parent an additional notice consistent
with that described in clause (1) of this proviso and a new notice period under clause (1) of this proviso shall commence (except
that the four (4) Business Day notice period referred to in clause (1) of this proviso shall instead be equal to the longer
of (x) two (2) Business Days, and (y) the period remaining under the notice period under clause (1) of this proviso
immediately prior to the delivery of such additional notice under this clause (4)) during which time the Company shall be required to
comply with the requirements of this Section 5.02(e)(ii) anew with respect to such additional notice (including clauses
(1) through (4) of this proviso). Notwithstanding anything herein to the contrary, neither the Company nor any Subsidiary of
the Company shall enter into any Acquisition Agreement unless this Agreement has been or is concurrently terminated in accordance with
its terms.
(f) The
Company shall not release any Third Party from, or waive any provisions of, any “standstill” or similar agreement in favor
of the Company unless the Company Board determines in good faith, after consultation with its outside legal counsel, that taking or failing
to take such action, as the case may be, would reasonably be expected to be inconsistent with the directors’ fiduciary duties under
applicable Law; provided, however, without limiting the foregoing, the Company shall promptly, and in any event within
twenty-four (24) hours after, advise Parent in writing if the Company determines to release or waive any Third Party from any “standstill”
or similar agreement. The Company shall enforce, and shall not release or permit the release of any person from, or amend, waive, terminate
(other than any expiration based on the passage of time or termination by the counterparty thereto in accordance with its terms) or modify,
and shall not permit the amendment, waiver, termination (other than any expiration based on the passage of time or otherwise in accordance
with its terms) or modification of, any provision of, any confidentiality or similar agreement or provision to which the Company or any
of its Subsidiaries is a party or under which the Company or any of its Subsidiaries has any rights unless the Company Board determines,
only with respect to information regarding the negotiation, execution or consummation of an Acquisition Proposal, in good faith, after
consultation with its outside legal counsel, that taking or failing to take such action, as the case may be, would reasonably be expected
to be inconsistent with the directors’ fiduciary duties under applicable Law. The Company shall not, and shall not permit any of
its Subsidiaries or any of its or their Representatives to, enter into any confidentiality agreement subsequent to the date of this Agreement
that prohibits the Company or any of its Subsidiaries from providing to Parent the information specifically required to be provided to
Parent pursuant to this Section 5.02.
(g) Nothing
contained in this Section 5.02 shall prohibit the Company or the Company Board or any committee thereof from: (i) taking
and disclosing to the stockholders of the Company a position contemplated by Rule 14e-2(a) promulgated under the Exchange Act
or making a statement contemplated by Item 1012(a) of Regulation M-A or Rule 14d-9 promulgated under the Exchange Act (or any
similar communication to stockholders in connection with the making or amendment of a tender offer or exchange offer); (ii) making
any disclosure to the stockholders of the Company if the Company Board determines in good faith, after consultation with its outside
legal advisor, that failure to do so would reasonably be expected to be inconsistent with the directors’ fiduciary duties under
applicable Law; or (iii) making any “stop-look-and-listen” communication to its stockholders pursuant to Rule 14d-9(f) promulgated
under the Exchange Act (or any similar communications to its stockholders); provided, however, that any public disclosure
(other than any “stop, look and listen” statement made under Rule 14d-9(f) under the Exchange Act) by the Company
or the Company Board (or any committee thereof) relating to any determination, position or other action by the Company, the Company Board
or any committee thereof with respect to any Intervening Event or Acquisition Proposal shall be deemed to be a Change in Company Board
Recommendation unless the Company Board expressly and publicly reaffirms the Company Board Recommendation in such disclosure.
Section 5.03 No
Control of Other Party’s Business. Nothing contained in this Agreement shall give
Parent, directly or indirectly, the right to control or direct the Company’s or its Subsidiaries’ operations prior to the
Effective Time, and nothing contained in this Agreement shall give the Company, directly or indirectly, the right to control or direct
Parent’s or its Subsidiaries’ operations prior to the Effective Time. Prior to the Effective Time, each of Parent and the
Company shall exercise, consistent with the terms and conditions of this Agreement, complete control and supervision over its and its
Subsidiaries’ respective operations.
Article VI
Additional
Agreements
Section 6.01 Preparation
of the Proxy Statement; Stockholders’ Meeting.
(a) Preparation
of Proxy Statement. As soon as practicable after the date of this Agreement (and in any event, within fifteen (15) Business Days
hereof, assuming the Company has received all information from Parent as the Company has reasonably requested), the Company shall prepare
and shall cause to be filed with the SEC in preliminary form a proxy statement relating to the Stockholders’ Meeting (together
with any amendments thereof or supplements thereto, the “Proxy Statement”). Except as expressly contemplated by Section 5.02(e),
the Proxy Statement shall include the Company Board Recommendation. Each of Parent, Silk USA and Merger Sub will cooperate with the Company
in connection with the preparation of the Proxy Statement, including by furnishing to the Company the information relating to it and/or
its Affiliates or Representatives reasonably requested by the Company or otherwise required by the Exchange Act and the rules and
regulations promulgated thereunder to be set forth in the Proxy Statement promptly following any request therefor from the Company. The
Company shall use its reasonable best efforts, assuming Parent’s compliance with its obligations under Section 6.01(b),
to cause the Proxy Statement, at the date of mailing to the Company’s stockholders, to comply as to form in all material respects
with the provisions of the Exchange Act and the rules and regulations promulgated thereunder. Notwithstanding the foregoing, the
Company shall not file the Proxy Statement, or any amendment or supplement thereto, without providing Parent, Silk USA, Merger Sub or
their counsel a reasonable opportunity to review and comment thereon (and such comments shall be reasonably considered by the Company);
provided, that, following a Change in Company Board Recommendation, the Company’s only obligation shall be to provide to
Parent a copy of such filing, or amendment or supplement thereto, in advance of filing. The Company shall, promptly: (i) notify
Parent of the receipt of any written or oral comments or substantive inquiries received by the Company from the SEC or the staff thereof
related to the Proxy Statement or any request for additional information; and (ii) provide Parent with copies of all written correspondence
between the Company and its Representatives, on the one hand, and the SEC or the staff thereof, on the other hand, with respect to the
Proxy Statement. The Company shall provide Parent, Silk USA, Merger Sub and their counsel with copies of any written comments or responses
to be submitted by the Company in response to any comments or substantive inquiries from the SEC or the staff thereof and shall provide
Parent, Silk USA and Merger Sub and their counsel a reasonable opportunity to review and comment thereon (and such comments shall be
reasonably considered by the Company); provided, that, following a Change in Company Board Recommendation, the Company’s
only obligation shall be to provide to Parent a copy of such written response in advance of submission to the SEC or its staff. The Company
shall use its reasonable best efforts to resolve, and each Party agrees to consult and cooperate with the other Parties and use reasonable
best efforts in resolving, all SEC comments with respect to the Proxy Statement as promptly as practicable after receipt thereof and
to cause the Proxy Statement in definitive form to be cleared by the SEC as promptly as reasonably practicable following the filing thereof.
(b) Covenants
of the Parties with Respect to the Proxy Statement. Each Party will use its reasonable best efforts to ensure that the information
relating to such Party supplied by it for inclusion in the Proxy Statement, at the time of the mailing of the Proxy Statement or any
amendments thereof or supplements thereto, and at the time of the Stockholders’ Meeting, does not to contain any untrue statement
of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein,
in light of the circumstances under which they were made, not misleading; provided, however, that: (i) no representation
or warranty is made by Parent, Silk USA or Merger Sub with respect to information supplied by or on behalf of the Company for inclusion
or incorporation by reference in the Proxy Statement; and (ii) no representation or warranty is made by the Company with respect
to information supplied by or on behalf of Parent, Silk USA or Merger Sub for inclusion or incorporation by reference in the Proxy Statement.
(c) Mailing
of Proxy Statement; Stockholders’ Meeting. The Company shall, in accordance with applicable Law and the Company Charter Documents,
(i) as promptly as reasonably practicable after the filing of the preliminary Proxy Statement, establish a single record date (subject
to any changes pursuant to this Section 6.01) for a meeting of its stockholders, for the purpose of voting upon the approval
and adoption of this Agreement and the Merger (the “Stockholders’ Meeting”), (ii) as promptly as reasonably
practicable following the earlier to occur of (x) in the event the preliminary Proxy Statement is not reviewed by the SEC or the
staff thereof, the expiration of the waiting period in Rule 14a-6(a) under the Exchange Act and (y) in the event the preliminary
Proxy Statement is reviewed by the SEC or the staff thereof, the receipt of oral or written notification of the completion of the review
by the SEC or the staff thereof, (A) cause the Proxy Statement to be filed in definitive form, (B) mail to the holders of Company
Capital Stock as of the record date established for the Stockholders’ Meeting the Proxy Statement and (C) in accordance with
applicable Law, the Company Charter Documents, and NYSE American rules, duly call, give notice of to its stockholders, convene and hold
the Stockholders’ Meeting, subject to the Company’s ability as provided herein to postpone or adjourn the Stockholders’
Meeting; provided, however, that in no event shall such meeting be held later than forty (40) calendar days following
the date the Proxy Statement is mailed to the Company’s stockholders. Notwithstanding the foregoing, once the Stockholders’
Meeting has been noticed and called, any postponement or adjournment of the Stockholders’ Meeting shall require the prior written
consent of Parent (not to be unreasonably withheld, conditioned or delayed) other than in the event that (i) such postponement or
adjournment is advisable to allow reasonable additional time for the filing and mailing of any supplemental or amended disclosure which
the Company and its counsel reasonably determine is necessary under applicable Law and for such supplemental or amended disclosure to
be disseminated and reviewed by the Company’s stockholders prior to the Stockholders’ Meeting; (ii) such postponement
or adjournment is required to obtain the Company Stockholder Approval (including to allow additional time to solicit additional proxies);
or (iii) the Company Board concludes in good faith, after consultation with its outside legal counsel, that the failure to take
such action would reasonably be expected to be inconsistent with the directors’ fiduciary duties under applicable Law; provided,
that, if the Stockholders’ Meeting is postponed or adjourned pursuant to clause (i), (ii), or (iii) of this sentence
to a date that is later than three (3) Business Days prior to the Outside Date, then the Outside Date shall be extended until the
third (3rd) Business Day after the date to which the Stockholders’ Meeting has been postponed or adjourned. Once the Company has
established a record date for the Stockholders’ Meeting, the Company shall not change such record date or establish a different
record date for the Stockholders’ Meeting without the prior written consent of Parent (such consent not to be unreasonably withheld,
conditioned or delayed), unless required to do so by applicable Law or the Company Charter Documents. Notwithstanding the foregoing,
Parent may require the Company to adjourn or postpone the Stockholders’ Meeting one time (for a reasonable time as determined by
Parent, and not to exceed ten (10) Business Days in the aggregate but not past the date that is five (5) Business Days prior
to the Outside Date) in the event that such postponement or adjournment is required to obtain the Company Stockholder Approval (including
to allow additional time to solicit additional proxies), unless prior to such adjournment the Company shall have received an aggregate
number of proxies voting for the adoption of this Agreement and the Merger, which have not been withdrawn, such that the condition in
Section 7.01(a) will be satisfied at such meeting. Unless a Change in Company Board Recommendation has occurred pursuant
to Section 5.02 or this Agreement has been terminated pursuant to Section 8.01, the Company shall use reasonable
best efforts to solicit proxies in favor of the approval of this Agreement. Unless this Agreement is validly terminated in accordance
with Section 8.01, the Company shall submit this Agreement to its stockholders at the Stockholders’ Meeting even if
the Company Board shall have effected a Change in Company Board Recommendation or proposed or announced any intention to do so. The Company
shall, upon the reasonable request of Parent, direct the proxy solicitor or other agent of the Company to advise Parent (or, in case
the proxy solicitor or such other agent of the Company does not so advise Parent, shall advise Parent (to the extent the relevant information
is in its possession)) at least on a daily basis on each of the last seven (7) Business Days prior to the date of the Stockholders’
Meeting as to the aggregate tally of proxies received by the Company with respect to the Company Stockholder Approval; provided
that this sentence shall not apply in the event that there shall have been a Change in Company Board Recommendation that has not been
publicly withdrawn. Without the prior written consent of Parent, the adoption of this Agreement and the transactions contemplated hereby
(including the Merger) shall be the only matter which the Company shall propose to be acted on by the stockholders of the Company at
the Stockholders’ Meeting.
(d) Amendments
to Proxy Statement. If at any time prior to the Effective Time any event or circumstance relating to the Company or any of its Subsidiaries
or its or their respective officers or directors or Parent or any of its Affiliates or its or their respective officers or directors,
should be discovered by the Company or Parent which, pursuant to the Securities Act or the Exchange Act, should be set forth in an amendment
or a supplement to the Proxy Statement, the Company or Parent, as applicable, shall promptly inform Parent or the Company, respectively.
Each of Parent, Silk USA, Merger Sub and the Company agree to use reasonable efforts to correct any material information provided by
it for use in the Proxy Statement which shall have become false or misleading.
Section 6.02 Access
to Information; Confidentiality. During the period from the date of this Agreement until
the Effective Time or the earlier termination of this Agreement pursuant to Section 8.01, and subject to applicable Law and
the Confidentiality Agreement (as defined below), the Company shall (and the Company shall cause its Subsidiaries to), solely in connection
with the consummation of the Merger and the other transactions contemplated hereby, including any post-closing integration, subject to
applicable Law, afford to Parent, and to Parent’s officers, employees, accountants, counsel, consultants, financial advisors and
other Representatives, reasonable access as promptly as practicable (including for the purpose of coordinating transition planning related
to the matters contemplated in this Agreement), during normal business hours and upon reasonable prior notice to the Company, to all
of the Company’s and its Subsidiaries’ properties, personnel, Contracts, books and records as Parent may from time to time
reasonably request, and during such period, the Company shall (and the Company shall cause its Subsidiaries to) furnish as promptly as
practicable to Parent (i) a copy of each report, schedule, registration statement and other document filed by it during such period
pursuant to the requirements of federal or state securities Laws other than such documents publicly filed with or furnished to the SEC
(provided that the Company will promptly notify Parent of any such filing), and (ii) all other information concerning the
Company’s and its Subsidiaries’ business, properties and personnel as Parent may reasonably request. All requests for information
made pursuant to this Section 6.02 shall be directed to an executive officer of the Company or other person designated by
the Company in writing. Notwithstanding any of the foregoing, any such investigation or consultation shall be conducted in such a manner
as not to interfere unreasonably with the business or operations of the Company or its Subsidiaries or otherwise result in any significant
interference with the prompt and timely discharge by their respective employees of their normal duties, and the Company and its Subsidiaries
shall not be required to conduct, or permit Parent or any of its officers, employees, accountants, counsel, consultants, financial advisors
and other Representatives to conduct, any invasive environmental investigation or sampling of soil, air, surface water, building material,
groundwater or other environmental media at or relating to any Leased Real Property. Furthermore, notwithstanding anything to the contrary
in this Section 6.02, the Company shall not be required to provide Parent or its Representatives with access to or to disclose
information (a) that is subject to the terms of a confidentiality agreement with a third party entered into prior to the date of
this Agreement or entered into after the date of this Agreement in the Ordinary Course of Business, (b) the disclosure of which
would violate any applicable Law or duty, (c) that is subject to any attorney-client, attorney work product doctrine or any other
applicable privilege concerning pending or threatened Proceedings or governmental investigations or (d) that in the reasonable,
good faith judgment of the Company is competitively sensitive; provided, in the case of clauses (a)–(d), that the Company
shall use its commercially reasonable efforts to make alternative arrangements to afford such access or furnish such information without
creating the issues described in such clauses (including if applicable pursuant to the use of “clean room” arrangements pursuant
to which certain Representatives of Parent and the Company could be provided access to such information), and to keep Parent reasonably
informed of the type and nature of the information that the Company reserves from providing to Parent or its Representatives pursuant
to clauses (a)–(d) of this sentence (to the extent such disclosure is not prohibited under applicable Law or the applicable
confidentiality agreement). If any of the information or material furnished pursuant to this Section 6.02 includes material
or information subject to the attorney-client privilege, work product doctrine or any other applicable privilege concerning pending or
threatened Proceedings or governmental investigations, each Party understands and agrees that the Parties have a commonality of interest
with respect to such matters and it is the desire, intention and mutual understanding of the Parties that the sharing of such material
or information is not intended to, and shall not, waive or diminish in any way the confidentiality of such material or information or
its continued protection under the attorney-client privilege, work product doctrine or other applicable privilege. All such information
provided by the Company that is entitled to protection under the attorney-client privilege, work product doctrine or other applicable
privilege shall remain entitled to such protection under these privileges, this Agreement and the joint defense doctrine. No information
or knowledge obtained by Parent in any investigation conducted pursuant to this Section 6.02 shall affect or be deemed to
modify any representation or warranty of the Company set forth herein or the conditions to the obligations of Parent, Silk USA and Merger
Sub to consummate the Merger and the other transactions contemplated hereby, or the remedies available to the parties hereunder. Without
limiting the generality of this Section 6.02, the Company and Parent, as each deems advisable and necessary, after consultation
with their respective outside legal counsel, may reasonably designate competitively sensitive information and documents as “Outside
Counsel Only Information.” Such information and documents shall only be provided to the outside legal counsel of the Company or
Parent (as the case may be), or subject to such other similar restrictions mutually agreed to by the Company and Parent, and subject
to any amendment, supplement or other modification to the Confidentiality Agreement (as defined below) or additional confidentiality
or joint defense agreement between or among the Company and Parent; provided, however, that, subject to any applicable Laws relating
to the exchange of information, and in a manner that is not reasonably likely to waive any applicable legal privilege, the outside legal
counsel receiving such information and documents may prepare one or more reports summarizing the results of any analysis of any such
shared information and documents, and disclose such reports, other summaries or aggregated information derived from such shared information
and documents to Representatives of such outside legal counsel’s client. The Parties acknowledge that Parent and the Company have
previously executed a confidentiality agreement, dated as of November 1, 2022 (the “Confidentiality Agreement”),
which Confidentiality Agreement shall continue in full force and effect in accordance with their terms (as such terms may have been amended),
except as expressly modified herein, and, for the avoidance of doubt, all information and documents disclosed or otherwise made available
to Parent pursuant to this Section 6.02 or otherwise in connection with this Agreement shall be governed by the terms and
conditions thereof.
Section 6.03 Efforts;
Approvals; Transaction Litigation.
(a) Upon
the terms and subject to the terms and conditions set forth in this Agreement, each of the Parties agrees to use its reasonable best
efforts to take, or cause to be taken, all actions and to do, or cause to be done, and to assist and cooperate with the other Parties
in doing, all things necessary, proper or advisable to consummate, as promptly as reasonably practicable, the Merger and the other transactions
contemplated by this Agreement. Each of the Parties shall cooperate in good faith with any Governmental Authority and undertake as promptly
as reasonably practicable any and all actions required to complete the transactions contemplated by this agreement expeditiously and
lawfully. Without limiting the generality of the foregoing, each of the Parties agrees to use its reasonable best efforts to: (i) take
all actions necessary to cause (A) in the case of the Company, the conditions to the Closing set forth in Section 7.01
and Section 7.02 to be satisfied, or (B) in the case of Parent, Silk USA and Merger Sub, the conditions to the Closing
set forth in Section 7.01 and Section 7.03 to be satisfied, in each case, as promptly as reasonably practicable;
(ii) obtain all necessary, Orders and Governmental Authorizations of any U.S. Governmental Authority or Governmental Authority pursuant
to the Foreign Merger Control Laws (including, but not limited to, the jurisdictions set forth in Part 6.03(a) of the
Disclosure Letter (the “Specified Foreign Merger Control Laws”)), make all necessary registrations, declarations and
filings with, and provide all necessary notices to, any U.S. Governmental Authority (including pursuant to the HSR Act) or any Governmental
Authority pursuant to the Foreign Merger Control Laws, including CFIUS and the DDTC; (iii) resolve, avoid, or eliminate impediments
or objections, if any, that may be asserted with respect to the transactions contemplated by this Agreement under any Antitrust Law,
CFIUS, ITAR and NSIA, (iv) avoid the entry of, effect the dissolution of, and have vacated, lifted, reversed or overturned,
any decree, order or judgment that would prevent, prohibit, restrict or delay the consummation of the Merger and the other transactions
contemplated by this Agreement, so as to enable the Parties to close the contemplated transactions expeditiously (but in no event later
than the Outside Date), and (v) execute and deliver any additional instruments necessary to consummate the Merger and the other
transactions contemplated by this Agreement.
(b) In
furtherance and not in limitation of the efforts referenced in Section 6.03(a) to obtain all necessary Orders and Governmental
Authorizations of any Governmental Authority required pursuant to the HSR Act and each Specified Foreign Merger Control Law, each Party
shall use its reasonable best efforts to: (i) make the appropriate filings under (A) the HSR Act, which shall be made within
ten (10) Business Days of the date of this Agreement, and (B) each Specified Foreign Merger Control Law, each of which filings
shall be made formally or in draft form (where pre-filing consultation is required) as soon as reasonably practicable but in no event
later than thirty (30) Business Days following the date of this Agreement; (ii) cooperate in all respects with each other in connection
with any filing or submission and in connection with any investigation or other inquiry, including any Proceeding initiated by a private
party and to supply as promptly as reasonably practicable any additional information and documentary material that may be reasonably
requested pursuant to the HSR Act or any Foreign Merger Control Law and to take other action necessary, proper or advisable to cause
the expiration or termination of the applicable waiting periods and the receipt of any applicable Governmental Authorizations under the
HSR Act or any Foreign Merger Control Law as soon as practicable; (iii) keep the other Party reasonably informed of the status of
matters related to the transactions contemplated by this Agreement, including furnishing the other with any written notices or other
material communications (including the receipt of any no-action, action, clearance, consent, approval or waiver) received by such Party
from, or given by such Party to, the Federal Trade Commission (the “FTC”), the Antitrust Division of the Department
of Justice (the “DOJ”), or any other Governmental Authority and of any communication received or given in connection
with any Proceeding by a private party, in each case regarding any of the transactions contemplated hereby; and (iv) provide the
other Party with any material communications received from the FTC, the DOJ, or any other Governmental Authority, permit the other Party
to review and provide input on any submissions to or material communications with the FTC, the DOJ or any other Governmental Authority,
and consult with each other in advance of any substantive meeting or conference with the FTC, the DOJ or any other Governmental Authority,
or, in connection with any Proceeding by a private party, with any other person, make available the Representatives of such Party as
may be reasonably necessary for attendance by such Representatives in person at such meetings and conferences, and to the extent permitted
by the FTC, the DOJ or such other applicable Governmental Authority or other person, give the other Party the opportunity to attend and
participate in such meetings and conferences in accordance with the any Antitrust Law. Each Party shall consider in good faith any input
or comments provided by the other Party regarding any material communications with or submissions to the FTC, the DOJ, or any other Governmental
Authority. Parent shall, or shall cause Silk USA to, pay all filing fees incurred in connection with filings made in connection with
this Section 6.03(b).
(c) Pursuant
to the DPA, the Company shall, and shall cause its controlled Affiliates to, and Parent shall, and shall cause its controlled Affiliates
to, cooperate to prepare and file with CFIUS: (1) a draft joint voluntary notice with respect to the Merger and the other transactions
contemplated by this Agreement (the “Draft CFIUS Notice”) as soon as practicable following (and in any event within
20 Business Days) the date of this Agreement, and (2) the CFIUS Notice as soon as practicable following the receipt of CFIUS’s
comments on the Draft CFIUS Notice or confirmation by CFIUS that it has no comments. Company and Parent shall permit counsel for the
other Party reasonable opportunity to review in advance, and consider in good faith, the views of the other Party in connection with,
any proposed written communication to CFIUS pertaining to the substance of the CFIUS Notice or substantive matters related to the CFIUS
process, and any Party engaging in telephonic discussions with CFIUS shall promptly inform the other Party of such discussion; provided
that this Section 6.03(c) shall not apply to the extent such communications (i) involve confidential business
information, or (ii) relate purely to administrative matters such as the scheduling of calls, submission logistics, and non-substantive
process steps. No Party shall independently participate in any in-person meeting or video conference with any Governmental Authority
with respect to any filings, review, investigation or other inquiry without giving the other Party sufficient prior notice of the meeting
and, to the extent permitted by such Governmental Authority, the opportunity to attend and/or participate in such meeting. Parent shall,
or shall cause Silk USA to, pay all filing fees incurred in connection with the filing of a CFIUS Notice. Notwithstanding anything in
this Agreement to the contrary, in no event shall any of Parent, Silk USA or Merger Sub be required to take, and the Company shall not
take (without the prior written consent of Parent), any actions required or requested by CFIUS that limits or could be expected to limit
the right of Parent to own or operate all or any portion of the businesses, product lines, or assets of Parent or Subsidiaries of Parent,
or the Company or the Subsidiaries of the Company, except for any such actions required or requested by CFIUS that would not be material
to Parent, the Company or the benefits of the Merger reasonably expected to be received by Parent (it being understood and agreed that
the actions set forth on Part 6.03(c) of the Disclosure Letter are not material to Parent, the Company or the benefits
of the Merger reasonably expected to be received by Parent), provided such actions do not take effect until the Closing.
(d) Notwithstanding
anything in this Agreement to the contrary, in no event shall any of Parent, Silk USA or Merger Sub be required to take, and the Company
shall not take (without the prior written consent of Parent), any actions required or requested by any non-CFIUS Governmental Authority,
including the FTC or DOJ, that limits or could be expected to limit the right of Parent to own or operate all or any portion of the businesses,
product lines, or assets of Parent or Subsidiaries of Parent, or the Company or the Subsidiaries of the Company, including, but not limited
to, (i) selling, divesting, licensing or otherwise disposing of, or holding separate and agreeing to sell, divest, license or otherwise
dispose of, assets, categories of assets or businesses of the Company its Subsidiaries, Parent or its Subsidiaries; (ii) terminating,
amending, or modifying existing relationships, contractual rights or obligations of the Company or its Subsidiaries; (iii) terminating,
amending, or modifying any venture or other arrangement of the Company or its Subsidiaries; (iv) agreeing to any undertaking affecting
or creating any relationship, contractual rights or obligations of the Company or Parent or their respective Subsidiaries; (v) agreeing
to any limitation on the ability of Parent, the Company or any of their respective Subsidiaries or Affiliates to conduct their respective
businesses (including with respect to market practices and structure) or own such assets or to acquire, hold or exercise full rights
of ownership of the business of Parent, the Company or their respective Subsidiaries or Affiliates or (vi) effectuating any other
change or restructuring of the Company or its Subsidiaries, except for any such actions required or requested by such Governmental Authority
that would not be material to the Company, Parent or the benefits of the Merger reasonably expected to be received by Parent, provided
such actions do not take effect until the Closing (collectively, a “Burdensome Condition”).
(e) In
addition, in the event that any administrative or judicial action or proceeding is instituted (or threatened to be instituted) by any
Governmental Authority, including but not limited to the FTC, DOJ, or CFIUS, challenging the transactions contemplated by this Agreement,
each of the Parties shall cooperate with each other in all respects and to use their respective reasonable best efforts to contest and
defend on the merits any claim asserted in court by any Governmental Authority in order to avoid entry of, or to have vacated or terminated,
any decree, Order or judgment (whether temporary, preliminary or permanent) that would prevent the Closing.
(f) Prior
to the Closing Date, the Company shall use commercially reasonable efforts to obtain any approval or consent required from the other
party (other than the Company’s Subsidiaries) as a result of the Merger to any material Company Contract or Company Lease listed
on Part 6.03(f) of the Disclosure Letter, and use commercially reasonable efforts to effect the other items listed in
Part 6.03(f) of the Disclosure Letter; provided, that (i) the Company shall not be required to pay any fee
to any such other party for the purposes of obtaining any such approval or consent or effecting such other items, (ii) the Company
shall not pay any fee for purposes of obtaining any such approval or consent or effecting such other items without Parent’s prior
written consent, and (iii) the failure to obtain any such approval or consent or effect any such other items, in and of itself,
shall not in any case be taken into account as to whether any of the conditions set forth in Article VII have been satisfied.
Notwithstanding the foregoing, the Company shall not be required to agree to any term or take any action in connection with its obligations
pursuant to this Section 6.03(f) that is not conditioned upon consummation of the Merger. Parent agrees that it will
cooperate in good faith with the Company in connection with the Company’s efforts under this Section 6.03(f).
(g) Prior
to the earlier of the Effective Time and the termination of this Agreement pursuant to Section 8.01, the Company shall promptly
advise Parent in writing of any Transaction Litigation, shall keep Parent reasonably informed regarding any such Transaction Litigation,
and permit Parent and its Representatives to participate in (but not control), the defense, negotiation or settlement of any Transaction
Litigation, and shall give consideration to Parent’s reasonable advice with respect to such Transaction Litigation. With respect
to any settlement in connection with any Transaction Litigation which is proposed to be settled solely for monetary damages not entirely
paid for with proceeds of insurance (other than the deductible under any insurance policy(ies)), no such settlement shall be agreed to
without Parent’s prior written consent, which consent shall not be unreasonably withheld, conditioned or delayed.
(h) Each
of the Parties shall reasonably cooperate with the others in taking, or causing to be taken, all actions and doing, or causing to be
done, all things reasonably necessary, proper or advisable on its part under applicable Laws and rules and policies of the NYSE
American to cause the delisting of the Company and of the Company Common Stock from the NYSE American as promptly as practicable after
the Effective Time and the deregistration of the Company Common Stock under the Exchange Act as promptly as practicable after such delisting
provided that any such delisting or deregistration shall be conditional upon and shall occur after the Effective Time.
(i) Within
twenty (20) Business Days of the date of this Agreement, the Company shall make any amendments to its Company Benefit Plans necessary
to permit the treatment of equity rights described in Section 2.04.
(j) Pursuant
to the ITAR, the Company and Parent shall cooperate to timely prepare and submit the ITAR Notice to DDTC as soon as practicable (and
in any event within twenty (20) Business Days). The Company shall be responsible for preparation and submission of the ITAR Notice, and
Parent shall promptly provide the Company with all necessary information related thereto or related to any other filings as required
of the Company under the ITAR.
Section 6.04 State
Takeover Laws. Assuming the accuracy of the representations and warranties of Parent,
Silk USA and Merger Sub set forth in Section 4.07, if any Takeover Law becomes or may purport to be applicable to the Merger
or any other transaction contemplated by this Agreement, then each of Parent and the Company and their respective boards of directors,
as applicable, shall take all action reasonably necessary to ensure that the Merger and the other transactions contemplated by this Agreement
may be consummated as promptly as practicable on the terms contemplated herein and therein and otherwise act to lawfully eliminate, or,
if not possible, minimize to the maximum extent possible, the effects of such Takeover Law on this Agreement, the Merger and the other
transactions contemplated by this Agreement. Nothing in this Section 6.04 shall be construed to permit Parent, Silk USA or
Merger Sub to do any act that would constitute a violation or breach of, or as a waiver of any of the Company’s rights under, any
other provision of this Agreement. No Change in Company Board Recommendation shall change the approval of the Company Board for purposes
of causing any Takeover Law to be inapplicable to the transactions contemplated by this Agreement.
Section 6.05 Director
and Officer Insurance.
(a) For
six (6) years after the Effective Time, Parent and Silk USA shall cause the Company, the Surviving Corporation or any of their
respective Subsidiaries, as the case may be, including by providing sufficient funds to the Company, the Surviving Corporation or any
of such respective Subsidiaries, as the case may be, to satisfy their obligations under this Section 6.05, in each case subject
to the limitations of applicable Law or the Company Charter Documents or Subsidiary Charter Documents, to ensure that, to the fullest
extent permitted under applicable Law, all rights to indemnification, advancement of expenses and exculpation from liabilities for acts
or omissions occurring at or prior to the Effective Time now existing in favor of the current or former directors and officers of the
Company and its Subsidiaries, and the fiduciaries currently indemnified under benefit plans of the Company and its Subsidiaries (collectively,
the “Indemnified Parties”), as provided in their respective charter and organizational documents or other agreements
providing indemnification, advancement or exculpation (in any such case, so long as such agreements were made available to Parent prior
to the date hereof or are entered into after the date hereof in accordance with Part 5.01(b)(iv) of the Disclosure Letter),
shall survive the Merger and shall continue in full force and effect for a period of six (6) years after the Effective Time in accordance
with their terms. If the Company or the Surviving Corporation, as the case may be, or any of their respective successors or assigns shall:
(x) consolidate with or merge into any other corporation or entity and shall not be the continuing or surviving corporation or entity
of such consolidation or merger; or (y) transfer all or substantially all of its properties and assets to any individual, corporation
or other entity, then and in each such case, to the extent necessary, Parent shall ensure that the successors and assigns of the Company
or the Surviving Corporation, as the case may be, shall assume all of the obligations set forth in this Section 6.05.
(b) The
Company shall be permitted to, at or prior to the Effective Time (and if the Company does not, then Parent shall or shall cause the Surviving
Corporation to, effective as of the Effective Time), purchase a six (6) year “tail” prepaid policy on the same
terms and conditions as the existing directors’ and officers’ liability (and fiduciary) insurance maintained by the Company,
for the benefit of the Indemnified Parties from insurance carriers with comparable credit ratings, covering, without limitation, the
Merger, and Parent shall and shall cause the Surviving Corporation to maintain such prepaid policy for the duration thereof; provided,
however, that the cost of such “tail” policy shall in no event exceed 300% of the amount of the last annual premium
paid by the Company for such existing directors’ and officers’ liability (and fiduciary) insurance. If, but for the proviso
to the immediately preceding sentence, the Surviving Corporation would be required to expend more than 300% of current annual premiums,
the Surviving Corporation will obtain the maximum amount of that insurance obtainable by payment of annual premiums equal to 300% of
current annual premiums.
(c) Nothing
in this Agreement is intended to, shall be construed to or shall release, waive or impair any rights to directors’ and officers’
rights to indemnification, advancement of expenses and exculpation by the Company as provided in the Company Charter Documents for any
of the Company’s directors, officers or other employees, it being understood and agreed that the provisions of this Section 6.05
are not prior to or in substitution for, but rather in addition to, any such existing rights.
The Indemnified Parties shall be third-party beneficiaries
of this covenant, which is intended to be for the benefit of, and shall be enforceable by, such Indemnified Parties and their respective
heirs and legal representatives. The rights to indemnification and advancement and the other rights provided for herein shall not be
deemed exclusive of any other rights to which any Indemnified Parties under this Section 6.05 is entitled, whether pursuant
to Law, contract or otherwise, all of which shall survive consummation of the Merger, continue in full force and effect and are intended
to benefit, and shall be enforceable by, each Indemnified Parties. The obligations of Parent and the Surviving Corporation under this
Section 6.05 shall not be terminated or modified in such a manner as to adversely affect the rights of any Indemnified Parties
without the consent of such Indemnified Parties. Notwithstanding anything herein to the contrary, if any Indemnified Parties notifies
Parent on or prior to the sixth (6th) anniversary of the Effective Time of a matter in respect of which such person may seek indemnification
or insurance pursuant to this Section 6.05, the provisions of this Section 6.05 shall continue in effect with
respect to such matter until the final disposition of all Proceedings relating thereto.
Section 6.06 Public
Announcements. The initial press release with respect to the execution and delivery of
this Agreement, the Merger and the other transactions contemplated hereby shall be a joint press release, the text of which is to be
reasonably agreed upon by Parent and the Company. Thereafter, Parent and the Company shall consult with each other before issuing, and,
to the extent practicable, give each other the reasonable opportunity to review and comment upon, any press release or other public statements,
disclosures, filings or communications (including any filings with the SEC related to the Merger) with respect to the Merger and the
other transactions contemplated hereby, and shall consider in good faith the reasonable comments of the other Party, and shall not issue
any such press release or make any such public statement, disclosure, filing or communication prior to such consultation, except (a) as
may be required by applicable Law (including, in the case of the Company, by the directors’ fiduciary duties, it being expressly
understood that nothing herein shall be construed as a modification or limitation of Section 5.02), court process or by obligations
pursuant to any listing agreement with or rules of any applicable national securities exchange, interdealer quotation service or
trading market, (b) with respect to any Change in Company Board Recommendation made in compliance with Section 5.02(d) of
this Agreement or (c) as otherwise required by this Agreement, in which case the Party required to make the release or announcement
shall use reasonable best efforts to allow the other Party reasonable time to comment on such release or announcement in advance of such
issuance (it being understood that the final determination of the disclosure requirements under applicable Law shall be made by the disclosing
Party after consultation with its outside legal counsel). Notwithstanding the foregoing, Parent and the Company may make public statements
(a) so long as any such statement is substantially consistent with previous public statements, disclosures or communications permitted
by this Section 6.06 and (b) in a legal proceeding where the Company or any of its Affiliates, on the one hand, and
Parent or any of its Affiliates, on the other hand, are adverse parties or reasonably likely to become adverse parties.
Section 6.07 Section 16
Matters. Prior to the Effective Time, the Company and Parent shall take all reasonable
steps as may be required to cause any dispositions of Company equity securities (including derivative securities with respect to Company
Securities and Company Equity Awards) resulting from the transactions contemplated by this Agreement by each individual who is subject
to the reporting requirements of Section 16(a) of the Exchange Act to be exempt under Rule 16b-3 promulgated under the
Exchange Act to the extent permitted by applicable Law.
Section 6.08 Merger
Sub and Surviving Corporation. Parent shall cause Silk USA to, and Parent and Silk USA
shall cause Merger Sub (and, after the Effective Time, the Surviving Corporation) to, take all action necessary to perform their respective
obligations under this Agreement.
Section 6.09 Notification
of Certain Matters. The Company shall give prompt notice to Parent, and Parent shall
give prompt notice to the Company, of: (a) any notice or other communication received by such Party from any Governmental Authority
in connection with the Merger or the other transactions contemplated hereby or from any person alleging that the consent of such person
is or may be required in connection with the Merger, if the subject matter of such communication or the failure of such Party to obtain
such consent would reasonably be expected to be material to the Company, the Surviving Corporation or Parent; (b) any actions commenced
or, to such Party’s Knowledge, threatened against, relating to or involving or otherwise affecting such Party or any of its Subsidiaries
which relate to the Merger or the other transactions contemplated hereby; (c) upon becoming aware of the occurrence or the impending
occurrence of any Effect relating to the Company or any of its Subsidiaries which has had, or would reasonably be expected to have, individually
or in the aggregate, a Company Material Adverse Effect; and (d) upon becoming aware that any representation or warranty made by
the Company in this Agreement has become untrue or inaccurate, or of any failure of the Company to comply with or satisfy any covenant,
condition or agreement to be complied with or satisfied by it under this Agreement, in any such case, to the extent the conditions in
Section 7.02(a) or Section 7.02(b) shall not be satisfied as of such time; provided, however,
that the delivery of any notice pursuant to this Section 6.09 shall not (i) cure any breach of any representation or
warranty requiring disclosure of such matter prior to the date of this Agreement, or any non-compliance with any covenant, obligation
or other provision of this Agreement, or (ii) limit the remedies available to the Party receiving such notice. The Parties agree
and acknowledge that the Company’s, on the one hand, and Parent’s on the other hand, compliance or failure of compliance
with this Section 6.09 shall not be taken into account for purposes of determining whether the conditions referred to in
Article VII shall have been satisfied or whether any Party has any right to terminate this Agreement pursuant to Article VIII.
Section 6.10 Credit
Facility.
(a) Payoff
Letters. The Company shall use commercially reasonable efforts to obtain and deliver to Parent, at least two (2) Business Days
prior to the anticipated Closing Date, an executed payoff letter with respect to the Existing Revolver in customary form which shall
be effective as of the Effective Time (subject only to delivery of funds as arranged by Parent at the Closing), which shall include a
customary release of any Liens on or other security interests in the properties and assets of the Company and its Subsidiaries securing
all obligations under the Existing Revolver; provided that the failure to obtain such payoff letter, in and of itself, shall not
in any case be taken into account as to whether any of the conditions set forth in Article VII have been satisfied.
(b) Payment.
At the Closing, Parent shall, or shall cause Silk USA to, repay, or cause to be repaid, on behalf of the Company and its Subsidiaries,
all Indebtedness outstanding under the Existing Revolver (including, for the avoidance of doubt, any and all prepayment or similar fees),
by wire transfer of immediately available funds as directed by the payoff letter for the Existing Revolver.
Section 6.11 Employee
Matters.
(a) During
the period commencing at the Effective Time and ending on the last day of the calendar year following the Effective Time, Parent shall
cause the Surviving Corporation (or its Subsidiaries, as appropriate) to provide to each employee of the Surviving Corporation and its
Subsidiaries (other than any employee represented by a labor organization or covered by any Collective Bargaining Agreement) as of the
Effective Time (each such an employee, a “Covered Employee”) for so long as such Covered Employee continues to be
employed during such period by Parent, the Surviving Corporation or any of its Subsidiaries (i) a base salary or base wage rate
and target cash bonus opportunities that are, in each case, no less than that provided to such Covered Employee immediately prior to
the Effective Time and (ii) other employee benefits (excluding any compensation or benefits related in any way to equity ownership
of the Company or any of its Subsidiaries) that are substantially comparable in the aggregate to those provided to a Covered Employee
immediately prior to the Effective Time, provided, that none of Parent, the Surviving Corporation or any of their respective Subsidiaries
shall be required to take into account any defined benefit pension plans or equity-related awards in determining whether employee benefits
are substantially comparable in the aggregate.
(b) To
the extent that Parent modifies any coverage or benefit plan in which any employee of the Surviving Corporation and its Subsidiaries
(each such employee, a “Continuing Employee”) participates, Parent or any of its Subsidiaries (including the Company
and any Subsidiaries thereof) shall use commercially reasonable efforts to (i) waive or cause to be waived any pre-existing conditions,
exclusions, limitations, actively-at-work requirements, and eligibility waiting periods under any group health plans of Parent or its
Subsidiaries to be waived with respect to Continuing Employees and their eligible dependents to the extent such conditions were inapplicable
or waived under a comparable Company Benefit Plan or Foreign Benefit Plan, (ii) give each Continuing Employee credit for the plan
year in which the Effective Time occurs towards applicable deductibles and annual out-of-pocket limits for medical expenses incurred
prior to the Effective Time for which payment has been made, to the extent the expense would have been taken into account under a similar
Company employee benefit plan, and (iii) to the extent that it would not result in a duplication of benefits and to the extent that
such service was recognized under a similar Company Benefit Plan or Foreign Benefit Plan, give each Continuing Employee service credit
for such Continuing Employee’s employment with the Company for purposes of eligibility to participate and vesting credit (but excluding
benefit accrual under any defined benefit pension plan) under each applicable Parent benefit plan as if such service had been performed
with Parent.
(c) If
requested in writing by Parent at least five (5) Business Days prior to the Effective Time, as of no later than one (1) day
prior to the Effective Time, the Company shall terminate the eMagin Corporation 401(k) plan (the “Company 401(k) Plan”).
The Company shall provide Parent with evidence that such plan has been terminated in accordance with this Section 6.11(c) pursuant
to resolutions of the Board of Directors of the Company or such Subsidiary, as the case may be, to be delivered to Parent within fifteen
(15) days prior to the Effective Time. The form and substance of such resolutions shall be subject to the reasonable review and approval
of Parent. In the event of such a termination, Parent shall use commercially reasonable efforts to (i) make available a 401(k) plan
of the Parent or its applicable Affiliate (the “Parent 401(k) Plan”) for the benefit of the Continuing Employees
who were eligible to participate in a Company 401(a) Plan immediately prior to the Closing Date, and (ii) allow Continuing
Employees to make eligible rollover contributions to the Parent 401(k) Plan account balances (in cash and in loan notes evidencing
loans to such Continuing Employees as of the date of distributions) from the applicable Company 401(k) Plan, in each case as soon
as practicable following the Closing Date.
(d) The
provisions of this Section 6.11 are for the sole benefit of the Parties and nothing herein, express or implied, is intended
or shall be construed to confer upon or give to any person (including, for the avoidance of doubt, any current, former, or retired employee,
officer, non-employee director, independent contractor, consultant, or other service provider of the Company or any of its Subsidiaries,
Parent or any of its Affiliates, or on or after the Effective Time, the Surviving Corporation or any of its Subsidiaries), other than
the Parties and their respective permitted successors and assigns, any legal or equitable or other rights or remedies (with respect to
the matters provided for in this Section 6.11) under or by reason of any provision of this Agreement, including, without
limitation, any rights to continued employment or service with Parent, the Surviving Corporation or any of their Subsidiaries. Notwithstanding
anything in this Section 6.11 to the contrary, nothing contained herein, whether express or implied, shall be treated as
an amendment or other modification of any Company Benefit Plan or Foreign Benefit Plan maintained by the Company or any of its Subsidiaries,
Parent or any of its Subsidiaries, or on or after the Effective Time, the Surviving Corporation or any of its Subsidiaries, or shall
limit the right of Parent to amend, terminate or otherwise modify any Company Benefit Plan or Foreign Benefit Plan or any employee benefit
plan maintained by Parent, the Surviving Corporation or any of their Subsidiaries following the Effective Time. Nothing contained herein
shall be construed as requiring, and the Company and its Subsidiaries shall take no action that would have the effect of requiring, Parent
or the Surviving Corporation to adopt or continue any specific employee benefit plans or to continue the employment of any specific person.
Section 6.12 Exercise
of Warrants. Prior to the Effective Time, the Company shall request the holders of the
Company Warrants to exercise the Company Warrants as of the Effective Time and shall use its commercially reasonable efforts to seek
such exercise by the holders of the Company Warrants; provided, that the Company shall not be required to pay any fees, other
amounts or give anything of value to any such holder or any other person in connection with seeking any such exercise; provided,
further, that the failure of any such holder to exercise or agree to exercise any Company Warrant, in and of itself, shall not
in any case be taken into account as to whether any of the conditions set forth in Article VII have been satisfied.
Section 6.13 FIRPTA.
At or prior to the Effective Time, the Company shall use its commercially reasonable efforts to deliver to Parent (i) a copy of
the notice filed with the Internal Revenue Service prepared in accordance with the requirements of Treasury Regulation Section 1.897-2(h),
and (ii) a properly executed certificate of the Company complying with the terms of Treasury Regulation Section 1.1445-2(c)(3),
certifying that an interest in the Company does not constitute a U.S. real property interest within the meaning of Section 897 of
the Code and the Treasury Regulations promulgated thereunder, provided, however, that that the sole remedy of Parent for
the Company’s failure to provide such notice and certificate to Parent shall be to withhold, or cause to be withheld, Taxes from
the consideration otherwise payable pursuant to this Agreement in accordance with Section 2.03(h); provided further,
that the Parties agree and acknowledge that the Company’s compliance or failure of compliance with this Section 6.13
shall not be taken into account for purposes of determining whether the conditions referred to in Article VII shall have
been satisfied.
Section 6.14 Proprietary
Information and Inventions Assignment Agreement. At or prior to the Effective Time, the
Company shall use its commercially reasonable efforts to cause (a) each employee of the Company as of the date hereof to enter into
and execute a Confirmatory Assignment Agreement in a form reasonably satisfactory to Parent, and (b) each person who becomes an
employee of the Company after the date hereof and prior to the Effective Time, to enter into and execute a Proprietary Information and
Inventions Assignment Agreement, in a form reasonably satisfactory to Parent, effective as of such employee’s first date of employment
or service, in each case, without exclusions thereto; provided that the failure to obtain any such Confirmatory Assignment Agreements
and/or Proprietary Information and Inventions Assignment Agreements, in and of itself, shall not in any case be taken into account as
to whether any of the conditions set forth in Article VII have been satisfied.
Section 6.15 Termination
of At the Market Offering Agreement. At or prior to the Effective Time, the Company shall
deliver a notice to terminate the At the Market Offering Agreement, dated as of November 18, 2021, by and between the Company and
H.C. Wainwright & Co., LLC, in accordance with Section 8(a) of such agreement, effective as of the Effective Time
and subject to the consummation of the Merger.
Article VII
Conditions
Precedent
Section 7.01 Conditions
to Each Party’s Obligation to Effect the Merger. The respective obligations of
each Party to effect the Merger shall be subject to the satisfaction (or waiver by the Party entitled to the benefit thereof, to the
extent permitted by applicable Law) at or prior to the Effective Time of the following conditions:
(a) Stockholder
Approval. The Company Stockholder Approval shall have been obtained.
(b) Governmental
Approvals.
(i) Any
waiting period (and extensions thereof) applicable to the transactions contemplated by the Agreement (including the Merger) under the
HSR Act shall have expired or been terminated and all applicable waiting periods and Governmental Authorizations required under the Specified
Foreign Merger Control Laws shall have expired or been obtained.
(ii) CFIUS
Clearance shall have been obtained.
(iii) ITAR
Clearance shall have occurred.
(iv) NSIA
Clearance shall have been obtained.
(c) No
Injunctions or Other Restraints. No Governmental Authority of competent jurisdiction shall have enacted, issued, promulgated, enforced
or entered any Law or Order after the date of this Agreement that remains in effect and that makes illegal, enjoins or otherwise prohibits
the consummation of the Merger.
Section 7.02 Conditions
to Obligation of Parent, Silk USA and Merger Sub to Effect the Merger. The obligations
of Parent, Silk USA and Merger Sub to effect the Merger shall be subject to the satisfaction (or waiver by Parent, Silk USA and Merger
Sub, to the extent permitted by applicable Law) at or prior to the Closing of the following additional conditions:
(a) Representations
and Warranties. (i) Each of the representations and warranties of the Company set forth in the first sentence of Section 3.01(a) (Due
Organization and Qualification; Subsidiaries), Section 3.04 (Authority; Binding Nature of Agreement), Section 3.15(o) (Intellectual
Property; Data Security and Data Privacy), Section 3.23 (Brokers and Other Advisors) and Section 3.24 (Opinion
of Financial Advisors) shall be true and correct in all material respects on and as of the date of this Agreement and as of the Closing
Date with the same force and effect as if made on and as of the Closing Date (except those representations and warranties which address
matters only as of a particular date, which shall remain true and correct in all material respects as of such date); (ii) each of
the representations and warranties of the Company set forth in the first two sentences, and the last sentence, of Section 3.03(a) and
the first sentence of Section 3.03(b) (Capital Structure) shall be true and correct in all respects (except for any
inaccuracies in the representations and warranties set forth in the first two sentences, and the last sentence, of Section 3.03(a) and
the first sentence of Section 3.03(b) (Capital Structure) that are de minimis) on and as of the date of this
Agreement and as of the Closing Date with the same force and effect as if made on and as of the Closing Date (except those representations
and warranties which address matters only as of a particular date, which shall remain true and correct (except for any inaccuracies that
are de minimis) as of such date); (iii) the representation and warranty in Section 3.07(b) (Absence of Certain
Changes or Events) is true and correct in all respects on and as of the date of this Agreement and as of the Closing Date with the same
force and effect as if made on and as of the Closing Date, and (iv) each of the other representations and warranties of the Company
set forth in this Agreement shall be true and correct on and as of the date of this Agreement and as of the Closing Date with the same
force and effect as if made on and as of the Closing Date (except those representations and warranties which address matters only as
of a particular date, which shall remain true and correct as of such date), except, solely with respect to this clause (iv), where
the failure of such representations and warranties to be so true and correct (without regard to any qualifications or exceptions as to
“materiality” or “Company Material Adverse Effect” set forth therein), has not had, and would not reasonably
be expected to have, individually or in the aggregate, a Company Material Adverse Effect.
(b) Performance
of Obligations of the Company. The Company shall have performed or complied in all material respects with all of its obligations
and covenants required to be performed or complied with by it under this Agreement at or prior to the Closing.
(c) No
Material Adverse Effect. Since the date of this Agreement through the Closing Date, no Effect shall have occurred that, individually
or in the aggregate, has had, or would reasonably be expected to have, a Company Material Adverse Effect.
(d) Certificate.
Parent shall have received a certificate executed by the principal executive officer or principal financial officer of the Company confirming
that the conditions set forth in Section 7.02(a), Section 7.02(b) and Section 7.02(c) shall
have been duly satisfied.
Section 7.03 Conditions
to Obligation of the Company to Effect the Merger. The obligations of the Company to
effect the Merger shall be subject to the satisfaction (or waiver by the Company, to the extent permitted by applicable Law) at or prior
to the Closing of the following additional conditions:
(a) Representations
and Warranties. (i) Each of the representations and warranties of Parent, Silk USA and Merger Sub set forth in Section 4.01(a) (Organization,
Standing and Corporate Power) and Section 4.02 (Authority; Binding Nature of Agreement) shall be true and correct in all
respects on and as of the date of this Agreement and as of the Closing Date with the same force and effect as if made on and as of the
Closing Date (except those representations and warranties which address matters only as of a particular date, which shall remain true
and correct as of such date), and (ii) each of the other representations and warranties of Parent, Silk USA and Merger Sub set forth
in this Agreement shall be true and correct on and as of the date of this Agreement and as of the Closing Date (except those representations
and warranties which address matters only as of a particular date, which shall remain true and correct as of such date), except, solely
with respect to this clause (ii), where the failure of such representations and warranties to be so true and correct (without regard
to any qualifications or exceptions as to “materiality” or “Parent Material Adverse Effect” set forth therein),
has not had, and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect.
(b) Performance
of Obligations of Parent, Silk USA and Merger Sub. Each of Parent, Silk USA and Merger Sub shall have performed or complied
in all material respects with all of its obligations and covenants required to be performed or complied with by it under this Agreement
at or prior to the Closing.
(c) Certificate.
The Company shall have received a certificate executed by the principal executive officer of Parent confirming that the conditions set
forth in Section 7.03(a) and Section 7.03(b) shall have been duly satisfied.
Section 7.04 Frustration
of Conditions Precedent. Notwithstanding anything herein to the contrary, (a) the
Company may not rely on the failure of any condition set forth in Section 7.01 or Section 7.03 to be satisfied
if such failure was caused by its material breach of its obligations under this Agreement, and (b) none of Parent, Silk USA or Merger
Sub may rely on the failure of any condition set forth in Section 7.01 or Section 7.02 to be satisfied if such
failure was caused by Parent’s, Silk USA’s or Merger Sub’s material breach of any of their respective obligations under
this Agreement.
Article VIII
Termination,
Amendment and Waiver
Section 8.01 Termination.
This Agreement may be terminated at any time prior to the Effective Time, whether before or after receipt of the Company Stockholder
Approval:
(a) by
mutual written consent of Parent and the Company;
(b) by
either Parent or the Company if:
(i) the
Effective Time shall not have occurred on or before the date that is twelve (12) months after the date of this Agreement (the “Outside
Date”); provided that, if on the Outside Date any of the conditions set forth in Section 7.01(b) or
Section 7.01(c) (to the extent relating to the matters set forth in Section 7.01(b)) shall not have been
satisfied but all other conditions set forth in Article VII shall have been satisfied or waived (other than those conditions
that by their terms are to be satisfied at Closing, but provided that such conditions shall then be capable of being satisfied
if the Closing were to take place on such date), then the Outside Date shall be automatically extended one time, and only one time, for
ninety (90) days from the twelve (12) month anniversary of this Agreement and such date shall become the Outside Date for purposes of
this Agreement; and provided further that, the right to terminate this Agreement pursuant to this Section 8.01(b)(i) shall
not be available to any Party if the failure of the Effective Time to occur on or before the Outside Date is primarily caused by a failure
of such Party to perform any of its obligations under this Agreement required to be performed at or prior to the Effective Time and such
action or failure to perform constitutes a breach in any material respect of this Agreement (it being understood that for the purposes
of this Section 8.01(b)(i) any such breach by Merger Sub shall be deemed such a breach by Parent);
(ii) a
Governmental Authority of competent jurisdiction shall have issued a final and non-appealable Order having the effect of permanently
restraining, enjoining or otherwise prohibiting the consummation of the Merger; provided, however, that the right to terminate
this Agreement pursuant to this Section 8.01(b)(ii) shall not be available to a Party if the issuance of such final,
non-appealable Order is primarily caused by a failure of such Party to perform or comply with any of its obligations or covenants under
this Agreement; and provided further that, the Party seeking to terminate this Agreement pursuant to this Section 8.01(b)(ii) shall
have complied with its obligations under Section 6.03 (it being understood that for purposes of this Section 8.01(b)(ii) any
such breach by Merger Sub shall be deemed such a breach by Parent); or
(iii) at
the Stockholders’ Meeting (including any adjournment or postponement thereof) where the Merger is voted upon, the Company Stockholder
Approval shall not have been obtained;
(c) by
Parent, if: (i) there shall be any breach or inaccuracy in any of the Company’s representations or warranties set forth in
this Agreement; or (ii) the Company has failed to perform any of its obligations or covenants set forth in this Agreement, which
inaccuracy, breach or failure to perform: (A) would result in the failure of any condition set forth in Section 7.02(a) or
Section 7.02(b) to be satisfied (other than those conditions that by their terms are to be satisfied by actions taken
at the Closing, each of which is capable of being satisfied at the Closing); and (B) is not capable of being cured by the earlier
of the Outside Date and the date that is thirty (30) Business Days following written notice from Parent to the Company describing such
breach or failure in reasonable detail; provided that Parent shall not have the right to terminate this Agreement pursuant to
this Section 8.01(c) if Parent, Silk USA or Merger Sub is then in material breach of any of its covenants or agreements
contained in this Agreement, which breach would result in a failure of a condition set forth in Section 7.03(a) or Section 7.03(b) as
of such time;
(d) by
the Company, if: (i) there shall be any breach or inaccuracy in any of Parent’s, Silk USA’s or Merger Sub’s representations
or warranties set forth in this Agreement; or (ii) any of Parent, Silk USA or Merger Sub has failed to perform any of its obligations
or covenants set forth in this Agreement, which inaccuracy, breach or failure to perform: (A) would result in the failure of any
condition set forth in Section 7.03(a) or Section 7.03(b) to be satisfied (other than those conditions
that by their terms are to be satisfied by actions taken at the Closing, each of which is capable of being satisfied at the Closing);
and (B) is not capable of being cured by the earlier of the Outside Date and the date that is thirty (30) Business Days following
written notice from the Company to Parent describing such breach or failure in reasonable detail; provided that the Company shall
not have the right to terminate this Agreement pursuant to this Section 8.01(d) if the Company is then in material breach
of any of its covenants or agreements contained in this Agreement, which breach would result in a failure of a condition set forth in
Section 7.02(a) or Section 7.02(b) as of such time;
(e) by
Parent, if a Change in Company Board Recommendation shall have occurred; or
(f) by
the Company, at any time prior to the time the Company Stockholder Approval shall have been obtained, but not after, subject to material
compliance with Section 5.02(e), in order to enter into an Acquisition Agreement providing for a Superior Proposal (it being
understood that the Company shall enter into a definitive Acquisition Agreement with respect to the Superior Proposal concurrently with
the termination of this Agreement); provided that the Company shall not be entitled to terminate this Agreement pursuant to this
Section 8.01(f) if such Superior Proposal resulted from a material breach by the Company of Section 5.02;
and provided, further, that the Company Termination Fee pursuant to Section 8.03(b) is paid prior to or
concurrently with the termination of this Agreement by the Company pursuant to this Section 8.01(f).
Section 8.02 Effect
of Termination. Any Party terminating this Agreement pursuant to Section 8.01
shall give written notice of such termination to each other Party in accordance with this Agreement specifying the provision or provisions
hereof pursuant to which such termination is being effected. In the event of termination of this Agreement as provided in Section 8.01,
this Agreement shall forthwith become null and void and of no effect without any liability or obligation on the part of any Party to
this Agreement (or any Parent Related Party or Company Related Party); provided, however, that the provisions of the last
sentence of Section 6.02, this Article VIII, Article IX, and Article X shall survive
such termination. Notwithstanding anything herein to the contrary, no termination of this Agreement pursuant to Section 8.01
shall relieve any Party from any liability or damages resulting from fraud as determined by a court of competent jurisdiction pursuant
to a final and non-appealable judgment, or Willful Breach prior to such termination by any Party hereto. In addition to the foregoing,
no termination of this Agreement will affect the rights or obligations of any Party pursuant to the Confidentiality Agreement, which
rights, obligations and agreements will survive the termination of this Agreement in accordance with their respective terms. Nothing
shall limit or prevent any party from exercising any rights or remedies it may have under Section 10.09 in lieu of terminating
this Agreement pursuant to Section 8.01.
Section 8.03 Termination
Fees and Expenses.
(a) If
this Agreement is terminated: (i) by Parent pursuant to Section 8.01(e); or (ii) by Parent or the Company
pursuant to Section 8.01(b)(iii) following any time at which Parent was entitled to terminate this Agreement pursuant
to Section 8.01(e), then, in each case, the Company shall pay (or cause to be paid) to Parent the Company Termination Fee,
by wire transfer (to an account designated by Parent) of immediately available funds within two (2) Business Days following
the date of any such termination by Parent and prior to or concurrently with any such termination in the case of termination by the Company.
(b) If
the Company terminates this Agreement pursuant to Section 8.01(f), the Company shall pay (or cause to be paid) to Parent
the Company Termination Fee, by wire transfer (to an account designated by Parent) in immediately available funds, immediately before
or concurrently with such termination.
(c) If:
(i) this Agreement is terminated (A) by Parent or the Company pursuant to Section 8.01(b)(i) or Section 8.01(b)(iii),
or (B) by Parent pursuant to Section 8.01(c); and (ii) (A) at any time after the date of this Agreement and
prior to such termination (or, in the case of a termination pursuant to Section 8.01(b)(iii), prior to the date of such Company
Stockholders’ Meeting), an Acquisition Proposal shall have been publicly announced or publicly made known to the stockholders of
the Company and not publicly withdrawn, and (B) within twelve (12) months after such termination, the Company shall have entered
into a definitive agreement with respect to any Acquisition Proposal which is thereafter consummated or any Acquisition Proposal shall
have been consummated (in each case, whether or not such Acquisition Proposal (or the person making such Acquisition Proposal) is the
same as the original Acquisition Proposal made (or person making the original Acquisition Proposal), publicly made known or publicly
announced), then, in any such event, the Company shall pay (or cause to be paid) to Parent the Company Termination Fee by wire transfer
(to an account designated by Parent) of immediately available funds prior to or on the date the Company consummates such Acquisition
Proposal; provided that for purposes of this clause (B) the references to “15%” in the definition of “Acquisition
Proposal” shall be deemed to be references to “50%”.
(d) Each
of Parent and the Company acknowledges and agrees that the agreements contained in this Section 8.03 are an integral part
of the transactions contemplated by this Agreement, and that, without these agreements, neither the Company nor Parent would have entered
into this Agreement; accordingly, if the Company fails timely to pay (or cause to be paid) the fee due pursuant to this Section 8.03,
and, in order to obtain such payment, Parent makes a claim against the Company that results in a judgment against the Company, the Company
shall pay (or cause to be paid) to Parent its costs and expenses (including attorneys’ fees and expenses) in connection with such
claim, together with interest on the amount of the applicable fee from the date such payment was required to be made until the date of
payment at the prime lending rate as published in The Wall Street Journal in effect on the date such payment was required to be
made.
(e) The
Parties agree that in no event shall the Company be required to pay or (cause to be paid) the Company Termination Fee on more than one
occasion.
(f) Notwithstanding
anything to the contrary set forth in this Agreement, in any circumstance in which Parent receives payment of the Company Termination
Fee pursuant to Section 8.03(a), Section 8.03(b), or Section 8.03(c), the Company Termination Fee
shall, subject to Section 8.02 and Section 10.09, and except for fraud or Willful Breach, constitute the sole
and exclusive remedy of Parent, Silk USA and Merger Sub against the Company, any of its Subsidiaries and any Company Related Party for
all losses and damages suffered as a result of this Agreement the failure of the transactions contemplated by this Agreement to be consummated
or for a breach or failure to perform hereunder or otherwise, and upon payment of such amount, neither the Company nor any of its Subsidiaries
or any Company Related Party shall have any further liability or obligation to Parent, Silk USA, Merger Sub or any Parent Related Party
relating to or arising out of this Agreement, the transactions contemplated hereby or in respect of any other document, theory of law
or equity or oral representations made or alleged to be made in connection herewith or therewith, in contract, in tort or otherwise.
Section 8.04 Amendment.
This Agreement may be amended by the Parties at any time prior to the Effective Time, whether before or after the Company Stockholder
Approval shall have been obtained; provided, however, that after the Company Stockholder Approval has been obtained, there
shall be made no amendment that by applicable Law requires further approval by the stockholders of the Company without such approval
having been obtained. This Agreement may not be amended except by an instrument in writing signed on behalf of each of the Parties.
Section 8.05 Extension;
Waiver. At any time prior to the Effective Time, the Parties may: (a) extend the
time for the performance of any of the obligations or other acts of the other Parties; (b) to the extent permitted by applicable
Law, waive any inaccuracies in the representations and warranties contained herein or in any document delivered pursuant hereto; or (c) subject
to the proviso to the first sentence of Section 8.04 and only to the extent permitted by applicable Law, waive compliance
with any of the agreements or conditions contained herein. Any agreement on the part of a Party to any such extension or waiver shall
be valid only if set forth in an instrument in writing signed on behalf of such Party. No failure or delay by any Party in exercising
any right, power or privilege hereunder shall operate as a waiver thereof, nor shall any single or partial exercise thereof preclude
any other or further exercise thereof or the exercise of any other right, power or privilege. The rights and remedies herein provided
shall be cumulative and not exclusive of any rights or remedies provided by applicable Law.
Article IX
Definitions
Section 9.01 Certain
Definitions. For purposes of this Agreement:
“Acceptable Confidentiality Agreement”
means a confidentiality agreement (a) with terms no less favorable in the aggregate to the Company than those contained in the Confidentiality
Agreement; provided, that it need not include a “standstill” or similar provision, (b) that does not contain
any provision requiring the Company or its Subsidiaries to pay or reimburse the counter-party’s fees, costs or expenses of any
nature, and (c) that does not prohibit the Company’s compliance with the provisions of this Agreement.
“Acquisition Agreement” means
any letter of intent, memorandum of understanding, agreement in principle, option agreement, merger agreement, acquisition agreement,
joint venture agreement, partnership agreement or other similar definitive agreement related to any Acquisition Proposal (other than
any Acceptable Confidentiality Agreement).
“Acquisition Proposal” means
any inquiry, bid, proposal or offer from any person or “group” (as defined in the Exchange Act and the rules promulgated
thereunder) (other than from Parent or any of its Affiliates) to purchase or otherwise acquire, directly or indirectly, in a single transaction
or a series of related transactions, (a) assets of the Company or any of its Subsidiaries (including capital stock of Subsidiaries
of the Company) whether by asset acquisition, joint venture or otherwise that account for 15% (based on the fair market value) or more
of the consolidated assets (including capital stock of the Subsidiaries of the Company) of the Company and its Subsidiaries, taken as
a whole, or from which 15% or more of the consolidated revenues or earnings of the Company and its Subsidiaries are derived, (b) 15%
or more of the outstanding Company Capital Stock on an as-converted basis (or 15% or more of the respective voting power thereof on an
as-converted basis) or the capital stock or voting power of the surviving entity or the resulting direct or indirect parent of the Company
or such surviving entity (including if such ownership is through the equity holders of any such parent) pursuant to a merger, consolidation
or other business combination, tender offer, exchange offer, binding share exchange, purchase or sale of capital stock, liquidation,
dissolution, recapitalization or similar transaction, or (c) any combination of the foregoing.
“Affiliate” of any person means
another person that directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control
with, such first person. For purposes of the immediately preceding sentence, the term “control” (including, with correlative
meanings, the terms “controlling,” “controlled by” and “under common control with”), as used with
respect to any person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management
and policies of such person, whether through ownership of voting securities, by contract or otherwise.
“Agreement” has the meaning
set forth in the Preamble.
“Anti-Corruption Laws” has
the meaning set forth in Section 3.21.
“Antitrust Law” means the Sherman
Act, as amended, the Clayton Act, as amended, the HSR Act, the Federal Trade Commission Act, as amended, any Foreign Merger Control Law
and all other federal, state and foreign, if any, statutes, rules, regulations, orders, decrees, administrative and judicial doctrines
and other laws that are designed or intended to prohibit, restrict or regulate actions having the purpose or effect of monopolization
or restraint of trade or lessening of competition through merger or acquisition (it being understood that “Antitrust Law”
specifically excludes any laws related to CFIUS).
“Bankruptcy and Equity Exception”
has the meaning set forth in Section 3.04(b).
“Book Entry Shares” has the
meaning set forth in Section 2.03(b).
“Burdensome Condition” has
the meaning set forth in Section 6.03(d).
“Business Day” means any day
except a Saturday, a Sunday or any other day on which commercial banks are required or authorized to close in the City of New York.
“Capitalization Date” has the
meaning set forth in Section 3.03(a).
“CARES Act” means the Coronavirus
Aid, Relief and Economic Security Act.
“Certificate of Merger” has
the meaning set forth in Section 1.03.
“CFIUS” means the Committee
on Foreign Investment in the United States, and each member agency thereof acting on its behalf.
“CFIUS Clearance” means (i) written
notice from CFIUS to the effect that either (A) the Merger and the other transactions contemplated by this Agreement are not subject
to the DPA, or (B) CFIUS has determined that there are no unresolved national security concerns with respect to the Merger and the
other transactions contemplated by this Agreement and has concluded all action under the DPA; or (ii) if CFIUS has sent a report
to the President of the United States of America requesting the President’s decision with respect to the Merger and the other transactions
contemplated by this Agreement, the President of the United States of America has announced a decision not to suspend or prohibit such
transactions pursuant to his authorities under the DPA.
“CFIUS Notice” means a joint
notice with respect to the Merger and the other transactions contemplated by this Agreement prepared by the parties and submitted to
CFIUS in accordance with the requirements of the DPA.
“Change in Company Board Recommendation”
has the meaning set forth in Section 5.02(d).
“Closing” has the meaning set
forth in Section 1.02.
“Closing Date” has the meaning
set forth in Section 1.02.
“COBRA” has the meaning set
forth in Section 3.12(a).
“Code” means Internal Revenue
Code of 1986, as amended from time to time.
“Collective Bargaining Agreement”
has the meaning set forth in Section 3.09(b)(ii).
“Company” has the meaning set
forth in the Preamble.
“Company 401(k) Plan”
has the meaning set forth in Section 6.11(c).
“Company
Balance Sheet” means the consolidated balance sheet of the Company and its consolidated Subsidiaries as of December 31,
2022 set forth in the Company’s annual report on Form 10-K filed with the SEC on March 10, 2023.
“Company
Balance Sheet Date” means December 31, 2022.
“Company Benefit Plans” has
the meaning set forth in Section 3.12(a).
“Company Board” has the meaning
set forth in the Recitals.
“Company Board Recommendation”
has the meaning set forth in Section 3.04(a).
“Company Bylaws” has the meaning
set forth in Section 1.05(b).
“Company Capital Stock” means,
collectively, Company Common Stock and Company Preferred Stock, including Company Series B Convertible Preferred Stock.
“Company Certificate of Incorporation”
has the meaning set forth in Section 1.05(a).
“Company Charter Documents”
has the meaning set forth in Section 3.02.
“Company Common Stock” means
the common stock, par value $0.001 per share, of the Company.
“Company Contract” means any
Contract: (a) to which the Company or any of its Subsidiaries is a party; (b) by which the Company or any of its Subsidiaries
or any asset of any of the Company or its Subsidiaries is bound or under which the Company or any of its Subsidiaries has, or may become
subject to, any obligation.
“Company Equity Awards” means,
collectively, all Company Stock Options and Company RSUs granted under any Company Stock Plan.
“Company Intellectual Property”
means all Owned Intellectual Property and all Licensed Intellectual Property.
“Company Leases” has the meaning
set forth in Section 3.14(b).
“Company Material Adverse Effect”
means any Effect that, individually or in the aggregate with all other Effects: (a) prevents or materially interferes with the consummation
by the Company of the Merger by the Outside Date in accordance with the terms hereof or applicable Law; or (b) has had a material
adverse effect on the business, financial condition or results of operations of the Company and its Subsidiaries, taken as a whole; provided,
however, that in the case of clause (b) above, no Effect resulting from, arising out of or relating to any of the following
shall be deemed to constitute or contribute to, alone or in combination, or taken into account in determining whether there has occurred,
a Company Material Adverse Effect: (i) general economic, securities, currency, credit, capital, commodities or financial markets
(including changes in the prices of commodities) or general economic, political, geopolitical, or regulatory conditions in the United
States or elsewhere in the world, including with respect to interest rates or currency exchange rates; (ii) general changes, developments
or conditions in the industries in which the Company or its Subsidiaries operate or the industries to which the Company and its Subsidiaries
sell their products, solutions and services, including, but not limited to, changes in Governmental Authority funding level or program
changes; (iii) (A) any hurricane, tornado, earthquake, flood, fire, explosion, weather-related event, natural or man-made disaster,
act of God or other force majeure events or occurrences, (B) epidemics, pandemics or disease outbreaks (including COVID-19) or the
worsening thereof or applicable Laws (or the interpretation thereof) adopted in response thereto, including any COVID-19 Measures, or
(C) (1) any outbreak or escalation or worsening of hostilities, acts of war (whether or not declared), military actions, cyber-attacks,
data breaches, acts of insurrection, political unrest, riots or any act of sabotage or terrorism (foreign or domestic) or (2) the
geopolitical dispute between the Russian Federation and Ukraine and any evolution or worsening thereof, including, in all cases of this
clause (iii), the response of any Governmental Authorities thereto; (iv) (A) any change in applicable Law or GAAP (or the interpretation
thereof) or (B) any change in the regulatory accounting requirements applicable to the industries in which the Company or its Subsidiaries
operate or to which the Company or its Subsidiaries sell their respective products, solutions and services (or the interpretation thereof),
including, in the case of both (A) and (B), any actions taken to comply with any such changes; (v) a change in the market price
or trading volume of the Company’s Common Stock; (vi) any failure by the Company and its Subsidiaries to meet internal or
published budgets or internal or analysts’ projections, predictions or forecasts for any period or any change in the Company’s
credit rating; (vii) (A) any action taken (or omitted to be taken) by Parent or its Affiliates or (B) any action taken
(or omitted to be taken) by the Company or its Subsidiaries, if included in Part 5.01(a) of the Disclosure Letter, or
if taken at Parent’s written request or with the consent of Parent or its Affiliates or which action or omission is required by
Law; (viii) the announcement, pendency, or consummation of the Merger or the other transactions contemplated by this Agreement or
the identity of Parent or its Affiliates, or any facts or circumstances relating to Parent, including the effect of any of the foregoing
on the relationships, contractual or otherwise, of the Company or its Subsidiaries with clients, customers, resellers, employees (including
the departure or termination of any officer, director, employee or independent contractor of the Company or its Subsidiaries), suppliers,
vendors, service providers, counterparties or Governmental Authorities; (ix) any litigation or other Proceeding brought in connection
with this Agreement or any of the transactions contemplated hereby, including breach of fiduciary duty or inadequate disclosure claims,
or (x) any of the matters set forth in Part 9.01(c) of the Disclosure Letter under the heading “Company Material
Adverse Effect”; provided that, in the cases of clauses (i), (ii), (iii) or (iv), such Effect that is not otherwise
excluded from this definition may be taken into account if and to the extent (but only to the extent), individually or in the aggregate
with any other Effect, it materially and disproportionately adversely affects the Company and its Subsidiaries, taken as a whole, as
compared with other participants in the industries in which the Company and its Subsidiaries primarily operate (in which case the incremental
materially disproportionate impact or impacts may be taken into account in determining whether there has been, or is reasonably expected
to be, a Company Material Adverse Effect); and provided, further, with respect to clauses (v) and (vi), the underlying
cause of such change or failure that is not otherwise excluded from this definition may be taken into account in determining whether
a Company Material Adverse Effect has occurred.
“Company Preferred Stock” has
the meaning set forth in Section 3.03(a).
“Company Products” means all
products that have been made commercially available by or on behalf of the Company or any of its Subsidiaries, or are under development
and the Company or any of its Subsidiaries intends to make commercially available within twenty-four (24) months after the date of this
Agreement.
“Company Registered IP” has
the meaning set forth in Section 3.15(a).
“Company Related Party” means
the respective, direct or indirect, former, current or future, officers, directors, partners, stockholders, managers, members or Affiliates
of each of the Company and any of its Subsidiaries.
“Company RSUs” has the meaning
set forth in Section 2.04(b).
“Company SEC Documents” has
the meaning set forth in Section 3.06(a).
“Company Securities” has the
meaning set forth in Section 3.03(b).
“Company Series B Convertible Preferred
Stock” means the preferred stock, par value $0.001 per share, of the Company designated as “Series B Convertible
Preferred Stock”.
“Company Software” has the
meaning set forth in Section 3.15(l).
“Company Stock Certificate”
has the meaning set forth in Section 2.03(b).
“Company Stock Options” has
the meaning set forth in Section 3.03(a).
“Company Stock Plans” means
the Company’s 2008 Incentive Stock Plan, 2011 Incentive Stock Plan, 2013 Incentive Stock Plan, 2017 Stock Option and Incentive
Plan, 2019 Employee and Consultant Stock Option and Incentive Plan and 2019 Non-Employee Director Stock Option and Incentive Plan, each
as amended, and any applicable award agreements thereunder (including any RSU Agreement).
“Company Stockholder Approval”
has the meaning set forth in Section 3.04(a).
“Company Technology” means
all Owned Technology and all Licensed Technology.
“Company Termination Fee” shall
mean an amount equal to $9,000,000.
“Company Warrant Shares” means
the shares of Company Capital Stock issued in connection with the deemed exercise of the Company Warrants immediately prior to the Closing
pursuant to the Company Warrants.
“Company Warrants” means the
warrants to purchase shares of Company Capital Stock, including the warrants set forth on Part 3.03(a) of the Disclosure
Letter.
“Confidentiality Agreement”
has the meaning set forth in Section 6.02.
“Continuing Employee” has the
meaning set forth in Section 6.11(b).
“Contract” means any contract,
subcontract, lease, permit, authorization, indenture, note, bond, mortgage, license, sublicense, franchise or other agreement or instrument,
commitment, obligation or binding arrangement with respect to which there are continuing rights, liabilities or obligations, whether
oral or in writing.
“Copyrights” has the meaning
set forth in the definition of “Intellectual Property.”
“Covered Employee” has the
meaning set forth in Section 6.11(a).
“COVID-19” means SARS-CoV-2
or COVID-19, and any evolutions thereof or related or associate epidemics, pandemic or disease outbreaks.
“COVID-19 Measures” means any
quarantine, “shelter in place,” “stay at home,” workforce reduction, social distancing, shut down, closure, sequester,
safety or similar Law, guideline or recommendation by any Governmental Authority, including, but not limited to, the Centers for Disease
Control and Prevention and the World Health Organization, in each case, in connection with or in response to COVID-19, including the
CARES Act and Families First Coronavirus Response Act (Pub. L. 116-127).
“DDTC” means the Directorate
of Defense Trade Controls, U.S. Department of State.
“Delaware Secretary” has the
meaning set forth in Section 1.03.
“DGCL” has the meaning set
forth in the Recitals.
“Disclosure Letter” means the
disclosure letter delivered by the Company to Parent, Silk USA and Merger Sub on the date of this Agreement.
“Dissenting Shares” has the
meaning set forth in Section 2.05(a).
“DOJ” has the meaning set forth
in Section 6.03(b).
“DPA” means Section 721
of the Defense Production Act of 1950, as amended (50 U.S.C. § 4565), and all interim or final rules and regulations issued
and effective thereunder.
“Draft CFIUS Notice” has the
meaning set forth in Section 6.03(c).
“EAR” has the meaning set forth
in Section 3.19.
“Effect” means any change,
effect, event, fact, development, occurrence or circumstance.
“Effective Time” has the meaning
set forth in Section 1.03.
“Environmental Claims” means
any administrative or judicial actions, suits, claims, Proceedings or written notices of noncompliance before, by or from any Governmental
Authority alleging liability arising out of the Release of any Hazardous Material or the failure to comply with any applicable Environmental
Law or any Governmental Authorization issued thereunder.
“Environmental Law” means any
applicable Law relating to pollution or protection of the environment or natural resources or human exposure to Hazardous Materials.
“Equity Award Amounts” means,
collectively, all amounts payable pursuant to Section 2.04.
“ERISA” means the Employee
Retirement Income Security Act of 1974, as amended, and the rules and regulations issued thereunder.
“ERISA Affiliate” means
all entities (whether or not incorporated) that would be treated together with any other entity as a “single employer” within
the meaning of Section 414(b), (c), (m) or (o) of the Code.
“Exchange Act” means the Securities
Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.
“Exchange Fund” has the meaning
set forth in Section 2.03(a).
“Existing Revolver” means the
Financing Agreement, dated as of December 29, 2016, by and between Rosenthal & Rosenthal, Inc. and the Company, as
amended.
“Exploit” means to research,
design, develop, implement, use, reproduce, modify and otherwise create improvements or derivative works based upon, make, have made,
assemble, test, support, display, perform (whether publicly or otherwise), publish, transmit, broadcast, sell, offer to sell, import,
distribute and otherwise dispose of, commercialize or exploit, or authorize any person to do any of the foregoing.
“Fairness Opinion” has the
meaning set forth in Section 3.24.
“Filed Company Contract” has
the meaning set forth in Section 3.09(a).
“Final Order” has the meaning
set forth in the definition of “NSIA Clearance”.
“Foreign Benefit Plan” means
each agreement, plan or arrangement that would, if maintained primarily for the benefit of individuals regularly employed inside the
United States, constitute a Company Benefit Plan, that is instead maintained for the benefit of individuals regularly employed outside
of the United States.
“Foreign Merger Control Laws”
has the meaning set forth in Section 3.05(b).
“FTC” has the meaning set forth
in Section 6.03(b).
“GAAP” means generally accepted
accounting principles in effect in the United States, applied on a consistent basis.
“GDPR” has the meaning set
forth in the definition of “Privacy Laws”.
“Government Contract” means
(a) any Contract for the provision of goods or services, between the Company and a Governmental Authority, in which the Company
is providing the goods or services, (b) any Contract between the Company and another Company, in the role of a higher-tier contractor,
supporting a Governmental Authority end user, which flows down Federal Acquisition Regulation (FAR), Defense FAR Supplement, or other
procurement-related compliance requirements from the higher-tier contractor’s Contract with a Governmental Authority; and (c) any
Government Grant or Other Transaction Authority Agreement issued to the Company by a Governmental Authority.
“Government Grant” means any
Contract between the Company, on the one hand, and a Governmental Authority, on the other, that either meets the definition of a “federal
award” under Section 200.1, Title 2, Code of Federal Regulations, or that otherwise qualifies as a “grant” or
“cooperative agreement” under Part 22, Title 32, Code of Federal Regulations.
“Governmental Authority” means
any: (a) country, nation, state, commonwealth, province, territory, county, municipality, district or other jurisdiction of any
nature; (b) federal, state, local, municipal, multinational, foreign or other government; or (c) governmental or quasi-governmental
authority of any nature (including any governmental division, department, agency, commission, instrumentality, official, organization,
unit, body or entity and any court, arbitrator or other tribunal).
“Governmental Authorization”
means any: (a) consent, approval, permit, license, certificate, franchise, permission, variance, waiver, clearance, registration,
qualification or authorization issued, granted given or otherwise made available by or under the authority of any Governmental Authority
or pursuant to any Law; or (b) right under any Contract with any Governmental Authority.
“Hazardous Materials” means
any materials or wastes that are listed or defined in relevant form, quantity, concentration or condition as hazardous substances, hazardous
wastes, hazardous materials, extremely hazardous substances, toxic substances, pollutants, contaminants or terms of similar import under
any applicable Environmental Law.
“HSR Act” means the Hart-Scott-Rodino
Antitrust Improvements Act of 1976, as amended, and the regulations promulgated thereunder.
“Inbound Intellectual Property Contracts”
mean any Contracts pursuant to which the Company or any of its Subsidiaries has been granted a license or the right to Exploit any Licensed
Intellectual Property or Licensed Technology of a third party, including all modifications, amendments and supplements thereto and waivers
thereunder, other than Contracts providing for (a) the non-exclusive license to the Company or any of its Subsidiaries of commercially
available software products licensed in object code form only on the licensor’s non-negotiated standard terms, (such as “click-wrap”
or “shrink-wrap” software licenses), (b) the license to the Company or any of its Subsidiaries of any Open Source Software
under the terms of a publicly available Open Source Software license, (c) the non-exclusive license to the Company or any of its
Subsidiaries of any Intellectual Property or Technology that is incidental to such agreement, such as licenses to use feedback and suggestions
and licenses authorizing the use of brand materials for marketing purposes, (d) the license of any Intellectual Property or Technology
to the Company or any of its Subsidiaries from any employee, contractor, subcontractor, or consultant of the Company or any of its Subsidiaries,
and (e) nondisclosure agreements entered into in the Ordinary Course of Business.
“Indebtedness” of any person
means, without duplication: (a) all obligations of such person for borrowed money and all obligations of such person evidenced by
a note, bond, debenture, mortgage, debt security or similar instrument; (b) all obligations, contingent or otherwise, relative to
the face amount of all letters of credit, bonds (including surety bonds) and similar obligations, whether or not drawn, and banker’s
acceptances issued for the account of such person; (c) all obligations of such person as lessee under leases which are required
to be, in accordance with GAAP, recorded as capitalized lease liabilities; (d) all obligations of such person in the nature of overdrafts;
(e) net liabilities of such person under all hedging obligations; (f) whether or not so included as liabilities in accordance
with GAAP, all obligations of such person to pay the deferred purchase price of property or services (excluding open accounts extended
by suppliers in connection with purchases of goods and services); (g) all obligations of such person to purchase, redeem, retire,
defease or otherwise acquire for value any capital stock of such person or any warrants, rights or options to acquire such capital stock;
(h) indebtedness (excluding prepaid interest thereon) secured by any Liens on any property owned by such person even though such
person has not assumed or otherwise become liable for the payment thereof; (i) all obligations of such person under interest rate,
currency or commodity derivatives; (j) solely with respect to the Company, all obligations under the Existing Revolver; and (k) direct
or indirect guarantees or other contingent liabilities with respect to any indebtedness, obligation, claim or liability of any other
person of a type described in clauses (a) through (j) above, and with respect to any indebtedness, obligation, claim or liability
of a type described in clauses (a) through (k) above, all accrued and unpaid interest, premiums, penalties, breakage costs,
unwind costs, fees, termination costs, redemption costs, and other charges with respect thereto.
“Indemnified Parties” has the
meaning set forth in Section 6.05(a).
“Intellectual Property” means
all intellectual property and other similar proprietary rights in any jurisdiction, whether registered or not, including such rights
in and to: (a) any patent (including all reissues, divisions, provisionals, continuations, continuations-in-part, re-examinations,
renewals, substitutions and extensions thereof), patent application, patent disclosure and other patent rights and any other Governmental
Authority-issued indicia of invention ownership (collectively, “Patents”); (b) any trademark, service mark, trade
name, business name, brand name, slogan, logo, trade dress and all other indicia of origin together with all goodwill associated therewith,
and all registrations, applications for registration, and renewals for any of the foregoing (collectively, “Marks”);
(c) any copyright, work of authorship (whether or not copyrightable), design, design registration, database rights, and all registrations,
applications for registration, and renewals for any of the foregoing (and including in all website content and software) (collectively,
“Copyrights”); (d) any Internet domain names; and (e) any trade secrets and trade secret rights arising
under common law, state law, federal law or laws of foreign countries, in each case to the extent any of the foregoing derives economic
value (actual or potential) from not being generally known to other persons who can obtain economic value from its disclosure or use
(collectively, “Trade Secrets”).
“Intellectual Property Contracts”
means the Inbound Intellectual Property Contracts and the Outbound Intellectual Property Contracts.
“Intervening Event” means any
material Effect on the business, assets, financial condition or results of operations of the Company and its Subsidiaries, taken as a
whole, that (a) is not known to, or reasonably foreseeable by, the Company Board as of the date of this Agreement (or if known to
the Company Board as of the date hereof, the consequences of which were not known or reasonably foreseeable to the Company Board as of
the date hereof), (b) did not result from a breach of this Agreement by the Company or its Subsidiaries or any of their respective
Representatives and (c) which Effect becomes known to or by the Company Board prior to obtaining the Company Stockholder Approval;
provided, however, that none of the following shall constitute or be deemed to contribute to whether there has been an
Intervening Event: (i) any changes in the market price or trading volume of the Company Common Stock (provided, however that the
underlying cause of any such change may be taken into account in any such determination), (ii) the fact that the Company exceeds
internal or published budgets, projections or forecasts for any period, or (iii) the receipt, existence of or terms of an Acquisition
Proposal or Superior Proposal, or any inquiry, offer or proposal that constitutes or would reasonably be expected to lead to an Acquisition
Proposal or a Superior Proposal, or any inquiry related thereto or the consequences thereof.
“In-the-Money Option” means
each Company Stock Option which has a per share exercise price that is less than the Per Share Merger Price.
“IRS” has the meaning set forth
in Section 3.12(b).
“IT Systems” means all computer
systems, servers, network equipment and other computer hardware owned, leased, licensed or otherwise used by the Company and its Subsidiaries.
“ITAR” means the International
Traffic in Arms Regulations (22 C.F.R. Parts 120-130).
“ITAR Clearance” means sixty
(60) days shall have elapsed following the submission of the ITAR Notice to the DDTC, or if such period has not elapsed, that DDTC has
otherwise confirmed to the Company its non-objection to the consummation of the Merger and other transactions contemplated by this Agreement.
“ITAR Notice” means written
notice to the DDTC by the Company pursuant to §122.4(b) of the ITAR of the change in “foreign ownership” of the
Company, as that term is defined in the ITAR.
“Knowledge” means: (a) with
respect to the Company, the actual knowledge of the individuals set forth in Part 9.01(a) of the Disclosure Letter;
and (b) with respect to Parent, Silk USA or Merger Sub, the actual knowledge of the individuals set forth in Part 9.01(b) of
the Parent Disclosure Letter.
“Law” means any federal, state,
local, municipal, foreign, international or other law (including common law), statute, constitution, resolution, ordinance, code, edict,
consent order, consent decree, decree, Order, judgment, rule, regulation, ruling or requirement issued, enacted, adopted, promulgated,
implemented or otherwise put into effect by or under the authority of any Governmental Authority.
“Leased Real Property” has
the meaning set forth in Section 3.14(b).
“Licensed Intellectual Property”
means any and all Intellectual Property that is licensed or sublicensed to the Company or any of its Subsidiaries.
“Licensed Technology” means
any and all Technology that is licensed or sublicensed to the Company or any of its Subsidiaries.
“Liens” means, with respect
to any property or asset, any lien, pledge, hypothecation, charge, mortgage, security interest, claim, option, right of first refusal,
preemptive right, or community property interest or any restriction on the voting of any security, the transfer of any security or asset,
or the possession, exercise or transfer of any other attribute of ownership of any asset.
“Loan and Security Agreement”
has the meaning set forth in the Recitals.
“Major Customer” has the meaning
set forth in Section 3.16(a).
“Major Supplier” has the meaning
set forth in Section 3.16(b).
“Marks” has the meaning set
forth in the definition of “Intellectual Property.”
“Material Contract” has the
meaning set forth in Section 3.09(b).
“Merger” has the meaning set
forth in the Recitals.
“Merger Consideration” means,
with respect to a holder of shares of Company Common Stock or Company Series B Convertible Preferred Stock, the cash consideration
that such holder is entitled to receive in exchange for such shares of Company Common Stock or Company Series B Convertible Preferred
Stock pursuant to Section 2.01(c) or Section 2.01(d), as applicable.
“Merger Sub” has the meaning
set forth in the Preamble.
“Multiemployer Plan” means
a multiemployer plan as defined in Section 3(37) of ERISA.
“Nomura” has the meaning set
forth in Section 3.23.
“NSIA” means the National Security
and Investment Act 2021 of the United Kingdom.
“NSIA Authority” means the
Secretary of State in the Cabinet Office of the United Kingdom.
“NSIA Clearance” means, in
respect of the Merger and other transactions contemplated by this Agreement, receipt from the NSIA Authority of (i) a notification
under section 14(8)(b)(ii) of the NSIA; or (ii) in the event that a call-in notice, as contemplated by section 14(8)(b)(i) of
the NSIA is issued, of either (A) a final order under section 26(1)(a) of the NSIA (“Final Order”), provided
that (x) the Final Order allows the Merger subject to certain provisions set out in the Final Order (“NSIA Provisions”),
and (y) the NSIA Provisions do not contain a Burdensome Condition (or if they do contain a Burdensome Condition, such Burdensome
Condition is acceptable to Parent in its sole discretion), or (B) a final notification under section 26(1)(b) of the NSIA.
“NSIA Provisions” has the meaning
set forth in the definition of “NSIA Clearance”.
“NYSE American” means the New
York Stock Exchange American.
“OFAC” has the meaning set
forth in Section 3.19.
“Open Source Software” means
any software that is subject to a license or other agreement commonly referred to as “free software” or as “open source
software” or under any licensing or distribution models similar to open source, including (a) software licensed or distributed
under any of the following licenses or distribution models, or licenses or distribution models similar to the following: the Artistic
License, the BSD License, the Apache License, the Mozilla Public License, the GNU General Public License (GPL) or Lesser/Library GPL,
or the Sun Community Source License or (b) any other similar “open source”, “free software” or “sharealike”
license.
“Order” means any order, writ,
assessment, decision, injunction, decree, judgment, ruling, award, settlement or stipulation issued, promulgated or entered into by or
with any Governmental Authority.
“Ordinary Course of Business”
means the ordinary course of business.
“Other Transaction Authority Agreement”
means any Contract between the Company, on the one hand, and a Governmental Authority, on the other, awarded under the authority of Sections
4021 or 4022, Title 10, U.S. Code.
“Outbound
Intellectual Property Contracts” means any Contracts pursuant to which any person (other than the Company or its Subsidiaries)
is granted rights by the Company or its Subsidiaries to Exploit any Company Intellectual Property or Company Technology, or pursuant
to which the Company or any of its Subsidiaries otherwise grant any rights under or with respect to any Intellectual Property or Technology
to any third person, including all modifications, amendments and supplements thereto and waivers thereunder, other than Contracts entered
into in the Ordinary Course of Business providing for (a) the non-exclusive license granted by the Company or its Subsidiaries
of any Intellectual Property or Technology that is incidental to the purpose of such agreement, such as licenses to use feedback and
suggestions and licenses authorizing the use of brand materials for marketing purposes, and no other license grants by the Company or
its Subsidiaries, (b) the license of any Intellectual Property or Technology to any employee, contractor, subcontractor, or consultant
of the Company or any of its Subsidiaries solely for the purpose of the performance of services for the benefit of the Company or its
Subsidiaries, and no other license grants by the Company or its Subsidiaries, and (c) nondisclosure agreements.
“Outside Date” has the meaning
set forth in Section 8.01(b)(i).
“Out-of-the-Money Option” means
each Company Stock Option which has a per share exercise price that is equal to or greater than the Per Share Merger Price.
“Owned Intellectual Property”
means any and all Intellectual Property owned or purported to be owned by the Company or any of its Subsidiaries.
“Owned Technology” means any
and all Technology owned or purported to be owned by the Company or any of its Subsidiaries.
“Parent” has the meaning set
forth in the Preamble.
“Parent 401(k) Plan” has
the meaning set forth in Section 6.11(c).
“Parent Disclosure Letter”
means the disclosure letter delivered by the Parent, Silk USA and Merger Sub to the Company on the date of this Agreement.
“Parent Material Adverse Effect”
means any Effect that, individually or in the aggregate, with all other Effects, prevents or materially interferes with, or would reasonably
be expected to prevent or materially interfere with, the consummation by Parent, Silk USA or Merger Sub of the Merger by the Outside
Date in accordance with the terms hereof or applicable Law.
“Parent Related Party” means
the respective, direct or indirect, former, current or future, officers, directors, partners, stockholders, managers, members or Affiliates
of each of Parent, Silk USA and Merger Sub.
“Patents” has the meaning set
forth in the definition of “Intellectual Property.”
“Party” or “Parties”
has the meaning set forth in the Preamble.
“Paying Agent” has the meaning
set forth in Section 2.03(a).
“PDF” shall mean portable document
format.
“Per Share Merger Price” has
the meaning set forth in Section 2.01(c).
“Permitted
Liens” mean: (a) mechanics’, carriers’, workmen’s, warehousemen’s, repairmen’s or other
similar Liens arising or incurred in the Ordinary Course of Business or by operation of Law; (b) any Lien for current Taxes, assessments
and other governmental charges or levies not yet due and payable, or being contested in good faith by appropriate Proceedings and for
which adequate reserves have been established in accordance with GAAP; (c) all Liens created or incurred by any owner, landlord,
sublandlord or other person in title; (d) all licenses and covenants not to assert granted with respect to Owned Intellectual Property
to any person in the Ordinary Course of Business; (e) pledges and deposits to secure the performance of bids, trade Contracts, leases,
surety and appeal bonds, performance bonds and other obligations of a similar nature, in each case in the Ordinary Course of Business;
(f) easements, encroachments, declarations, covenants, conditions, reservations, limitations and rights of way (unrecorded and of
record) and other similar restrictions or encumbrances of record, zoning, building and other similar ordinances, regulations, variances
and restrictions, and all defects or irregularities in title, including any condition or other matter, if any, that may be shown or disclosed
by a survey or physical inspection; (g) with respect to any Leased Real Property (i) the interests and rights of the
respective lessors with respect thereto, including any statutory landlord liens and any Lien on the lessor’s interest therein,
and (ii) any Liens encumbering the underlying fee title of the real property of which the Leased Real Property is a part; and (h) reversionary
rights in favor of landlords under any real property leases.
“person” means an individual,
corporation (including not-for-profit corporation), general or limited partnership, limited liability company, joint venture, association,
trust, estate, association, Governmental Authority, unincorporated organization or other entity or group.
“Personal Information” means
any information (a) relating to an identified or identifiable natural person individual, which includes, without limitation, name,
address, telephone number, email address, financial account number, health related information, government-issued identifier, and any
other data used or intended to be used to identify, contact or locate a person; or (b) defined as “personal information”,
“personal data”, “personally identifiable information” or any similar term under applicable Laws.
“Pre-Closing Period” has the
meaning set forth in Section 5.01.
“Privacy Commitments” has the
meaning set forth in Section 3.15(n).
“Privacy Laws” means any applicable
Law that governs the Processing of Personal Information or that relates to privacy, data security, data or security breach notification,
Processing and security of payment card information, and email, text message, or telephone communications, any penalties and compliance
with any order, including, without limitation, the Gramm-Leach-Bliley Act, the Telephone Consumer Privacy Act, the Fair Credit Reporting
Act, the Controlling the Assault of Non-Solicited Pornography and Marketing Act, the Health Insurance Portability and Accountability
Act, the Federal Trade Commission Act, the California Consumer Privacy Act, the California Privacy Rights Act, the California Online
Privacy Protection Act and other United States state laws concerning privacy that may apply from time to time, the UK Data Protection
Act 2018, the Information Technology Act, 2000, the Personal Information Protection Act of the Republic of Korea, Information Technology
(Reasonable security practices and procedures and sensitive personal data or information) Rules, 2011, and other laws of the Republic
of India concerning privacy, the China Personal Information Protection Law, the European General Data Protection Regulation (the “GDPR”),
EU Directive 95/46/EC, EU Directive 2002/58/EC and any Laws or regulations implementing either or both of the GDPR, EU Directive 95/46/EC
and EU Directive 002/58/EC.
“Proceeding” means any action,
suit, claim (or counterclaim), charge, complaint, litigation, arbitration, mediation, grievance, proceeding (including any civil, criminal,
administrative, investigative or appellate proceeding), hearing, inquiry, audit, examination or investigation commenced, brought, conducted
or heard by or before, any court or other Governmental Authority or any arbitrator or arbitration or mediation panel.
“Process” or “Processing”
means any operation or set of operations which is performed on Personal Information, such as the use, collection, processing, storage,
recording, organization, adaption, alteration, transfer, retrieval, consultation, disclosure, dissemination or combination of such Personal
Information.
“Proxy Statement” has the meaning
set forth in Section 6.01(a).
“Public Official” means (a) any
director, officer, employee or representative of any Governmental Authority; (b) any director, officer, employee or representative
of any commercial enterprise that is owned or controlled by a Governmental Authority; (c) any director, officer, employee or representative
of any public international organization, such as the International Monetary Fund, the United Nations or the World Bank; (d) any
person acting in an official capacity for any Governmental Authority, enterprise, or organization identified above; and (e) any
political party, party official or candidate for political office.
“Qualifying Subsidiary” has
the meaning set forth in Section 10.06.
“Release” means any release,
spill, emission, leaking, pumping, discharging, injecting, escaping, leaching, dumping or disposing into or through the environment.
“Representative” means, with
respect to any person, any Subsidiary of such person and such person’s and each of its respective Subsidiaries’ directors,
officers, employees, investment bankers, financial advisors, attorneys, accountants or other advisors, agents or representatives.
“RSU Agreement” has the meaning
set forth in Section 2.04(b).
“Sanctions” has the meaning
set forth in Section 3.19.
“Sarbanes-Oxley Act” means
the Sarbanes-Oxley Act of 2002.
“SEC” has the meaning set forth
in Section 3.05(b).
“Security Incident” shall mean
any accidental or unauthorized access, use, loss, disclosure, alteration, destruction, compromise or other unauthorized Processing of
any data or Personal Information owned by the Company or provided by the Company’s customers.
“Securities Act” shall mean
the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.
“Series B Charter Amendment”
means that certain Certificate of Amendment to the Certificate of Designations of the Series B Convertible Preferred Stock of the
Company in the form attached hereto as Exhibit B.
“Silk USA” has the meaning
set forth in the Preamble.
“Specified Foreign Merger Control Laws”
has the meaning set forth in Section 6.03(a).
“Standards Organizations” has
the meaning set forth in Section 3.15(e).
“Stillwater” has the meaning
set forth in the Recitals.
“Stillwater Stockholders” has
the meaning set forth in the Recitals.
“Stockholders’ Meeting”
has the meaning set forth in Section 6.01(c).
“Subsidiary” means, with respect
to any person, any corporation, partnership, limited liability company or other entity in which such person owns an amount of the voting
securities, other voting rights or voting partnership interests of which is sufficient to elect at least a majority of its board of directors
or other governing body (or, if there are no such voting interests, directly or indirectly, owns or controls more than 50% of the equity
interests).
“Subsidiary Charter Documents”
has the meaning set forth in Section 3.02.
“Superior Proposal” means a
bona fide written Acquisition Proposal not solicited in breach of Section 5.02 (except that, for purposes of this
definition, the references in the definition of “Acquisition Proposal” to “15%” shall be replaced by “50%”)
made by a Third Party on terms that the Company Board determines in good faith, after consultation with the Company’s outside legal
counsel and financial advisor, to be more favorable, from a financial point of view, to the holders of Company Capital Stock than the
Merger, taking into account the relevant terms and conditions contained therein, the person making the Acquisition Proposal, the likelihood
of the consummation of the Acquisition Proposal.
“Support Agreement” has the
meaning set forth in the Recitals.
“Surviving Corporation” has
the meaning set forth in Section 1.01.
“Takeover Law” means any “fair
price,” “moratorium,” “control share acquisition,” “interested stockholder,” “business
combination” or other form of anti-takeover statute or regulation.
“Tax” or “Taxes”
means all: (a) taxes, charges, withholdings, fees, levies, imposts, duties and governmental fees or other like assessments or charges
of any kind whatsoever in the nature of taxes imposed by any United States federal, state, local or foreign or other taxing authority
(including those related to income, net income, gross income, receipts, capital, windfall profit, severance, property (real and personal),
sales, goods and services, use, business and occupation, license, excise, registration, franchise, employment, payroll (including social
security contributions), withholding, alternative or add-on minimum, intangibles, ad valorem, transfer, gains, stamp, customs, duties,
estimated, transaction, title, capital, paid-up capital, profits, premium, value added or recording tax); and (b) interest, penalties,
fines, additions to tax or additional amounts imposed by any Governmental Authority in connection with any item described in clause (a).
“Tax Return” means any return
(including any information return), report, statement, declaration, estimate, schedule, form, election, certificate or other document
(including any amendment thereto) filed with or submitted to, or required to be filed with or submitted to, any Governmental Authority
in connection with the determination, assessment, collection, deposit, remittance, withholding or payment of any Tax or in connection
with the administration, implementation or enforcement of or compliance with any applicable Law relating to any Tax.
“Technology” means, collectively,
any technology, information, or embodiments of any Intellectual Property, in electronic, written or any other form, including designs,
formulae, specifications, research and development information, technical information, design and manufacturing schematics, manufacturing
and other processes, procedures, algorithms, data, databases, methods, techniques, ideas, know-how, concepts, inventions, invention disclosures,
discoveries, developments, creations, works of authorship, improvements, derivative works, products, hardware, and software and other
similar materials (including firmware or software in the form of source code, object code, byte code or other format and any bug fixes,
patches, updates, upgrades or modifications thereto).
“Third Party” means any Person,
including any “group” (as defined in Section 13(d) of the Exchange Act and the rules promulgated thereunder),
other than Parent, Silk USA and Merger Sub.
“Trade Compliance Laws” has
the meaning set forth in Section 3.19.
“Trade Secret” has the meaning
set forth in the definition of “Intellectual Property.”
“Transaction Litigation” means
any Proceeding commenced or threatened in writing against any Party or any of its Affiliates (including any members of the Board of Directors
of the Company) by or on behalf of any holder of Company Capital Stock relating to, arising out of or involving this Agreement, the Merger
or any of the other transactions contemplated hereby or that would otherwise prevent or materially impede, interfere with, hinder or
delay the consummation of the Merger and the other transactions contemplated by this Agreement.
“WARN Act” means the Worker
Adjustment and Retraining Notification Act of 1988, as amended, and any similar state, local or foreign Law or regulation requiring advance
notification of a mass layoff or plant closing or other similar event requiring advance notice or pay in lieu thereof to any employee
or former employee of the Company, employee representative or Governmental Authority.
“Warrants” has the meaning
set forth in Section 2.06.
“Willful Breach” means with
respect to any breaches or failures to perform any of the covenants or other agreements contained in this Agreement, a material breach
that is a consequence of a deliberate act or a deliberate failure to act undertaken by the breaching Party with actual knowledge that
such Party’s act or failure to act would result in or constitute a material breach of this Agreement.
Section 9.02 Interpretation.
(a) When
a reference is made in this Agreement to an Article, a Section, Annex or Exhibit, such reference shall be to an Article or a Section of,
or an Annex or an Exhibit to, this Agreement unless otherwise indicated. References to clauses without a cross-reference to a Section or
subsection are references to clauses within the same Section or subsection. All Exhibits, Annexes and Schedules annexed hereto or
referred to herein are hereby incorporated in and made a part of this Agreement as if set forth in full herein. Any capitalized terms
used in any Exhibit, Annex or Schedule but not otherwise defined therein shall have the meaning as defined in this Agreement.
(b) The
table of contents, headings, captions and index of defined terms contained in this Agreement are for reference purposes only and shall
not affect in any way the meaning or interpretation of this Agreement.
(c) Whenever
the words “include,” “includes” or “including” are used in this Agreement, they shall be deemed to
be followed by the words “without limitation,” whether or not they are in fact followed by those words or words of like import.
The word “will” shall be construed to have the same meaning and effect of the word “shall.” The words “hereof,”
“herein”, “hereto” and “hereunder” and words of similar import when used in this Agreement shall
refer to this Agreement as a whole and not to any particular provision of this Agreement. The word “extent” in the phrase
“to the extent” shall mean the degree to which a subject or other thing extends, and such phrase shall not mean simply “if.”
When used in this Agreement, references to (i) “dollars” and “$” shall refer to U.S. dollars and (ii) to
“days” shall be to calendar days unless otherwise indicated. Unless the context otherwise requires, the terms “neither,”
“nor,” “any,” “either” and “or” are not exclusive. “Writing,” “written”
and comparable terms refer to printing, typing and other means of reproducing words (including electronic media) in a visible form. References
to “from” or “through” any date mean, unless otherwise specified, from and including or through and including
such date, respectively. No summary of this Agreement or any Exhibit, Annex, Schedule or other document delivered herewith prepared by
or on behalf of any party will affect the meaning or interpretation of this Agreement or such Exhibit, Annex or Schedule.
(d) Any
reference in this Agreement to a date or time shall be deemed to be such date or time in New York, New York, U.S.A., unless otherwise
specified.
(e) The
Parties have participated jointly in negotiating and drafting this Agreement. In the event that an ambiguity or a question of intent
or interpretation arises, this Agreement shall be construed without regard to any presumption or rule requiring construction or
interpretation against the Party drafting or causing any instrument to be drafted.
(f) References
to a person are also to its permitted successors and assigns. All terms defined in this Agreement shall have the defined meanings when
used in any certificate or other document made or delivered pursuant hereto unless otherwise defined therein.
(g) Any
term contained in this Agreement are applicable to the singular as well as the plural forms of such terms and to the masculine as well
as to the feminine and neuter genders of such term.
(h) Any
agreement, instrument or statute defined or referred to herein or in any agreement or instrument that is referred to herein means such
agreement, instrument or statute as from time to time amended, modified or supplemented (provided that for purposes of any representations
and warranties contained in this Agreement that are made as of a specific date or dates, references to (x) any Contract, instrument
or statute shall be deemed to refer to such Contract, instrument or statute, as amended, as of such date, and (y) any rules or
regulations promulgated under any such statute, in each case, as of such date).
(i) When
calculating the period of time before which, within which, or following which any act is to be done or step taken pursuant to this Agreement,
(i) the date that is the reference date in calculating such period shall be excluded and (ii) if the last day of such period
is not a Business Day, the period in question shall end on the next succeeding Business Day.
(j) Whenever
this Agreement requires a Subsidiary of the Company to take any action, such requirement shall be deemed to include an undertaking on
the part of the Company to cause such Subsidiary to take such action and, after the Effective Time, on the part of Parent and the Surviving
Corporation to cause such Subsidiary to take such action. Whenever this Agreement requires Merger Sub to take any action, such requirement
shall be deemed to include an undertaking on the part of Parent to cause Merger Sub to take such action.
(k) Any
statement in this Agreement to the effect that any information, document or other material has been “furnished,” “delivered”
or “made available” to Parent or any of its Representatives shall, in the case of information, documents, or materials subject
to ITAR, be satisfied by the Company or its Representatives making such information, documents or materials available for review by “U.S.
persons” only (as the term “U.S. person” is defined by the ITAR) at Parent or Parent’s counsel.
Article X
General
Provisions
Section 10.01 Nonsurvival
of Representations and Warranties. None of the representations, warranties, covenants
or agreements in this Agreement or in any certificate, exhibit, schedule or instrument delivered pursuant to this Agreement, including
any rights arising out of any breach of such representations, warranties, covenants or agreements, shall survive beyond the Effective
Time, except for those covenants and agreements contained herein and therein that by their terms apply or are to be performed in whole
or in part after the Effective Time (including the covenants and agreements in Section 6.05, Section 6.11,
and this Article X).
Section 10.02 Expenses.
Except as otherwise provided in this Agreement, including Section 8.03, all fees and expenses incurred in connection with
this Agreement, the Merger and the other transactions contemplated by this Agreement shall be paid by the Party incurring such fees or
expenses, whether or not the Merger or any of the other transactions contemplated by this Agreement are consummated.
Section 10.03 Notices.
All notices and other communications hereunder shall be in writing in one of the following formats and shall be deemed given upon the
earlier of actual receipt or (a) upon delivery if personally delivered by hand providing proof of delivery; (b) on the
date sent by email or facsimile (provided that no “bounce back” or similar message of non-delivery is received with
respect thereto); or (c) when delivered if sent by a courier (with confirmation of delivery) if received prior to 5 p.m.
New York City time on a Business Day in New York City, otherwise such notice or communication shall be deemed not to have been received
until the next succeeding Business Day in New York City; in each case to the Party to be notified at the following address:
If to Parent, Silk USA or Merger Sub, to:
Samsung Display Co., Ltd.
1 Samsung-Ro, Giheung-Gu
Yong-In City, Gyeonggi-Do, Korea 17113
Attention:
Email:
with copies (which shall not constitute notice) to:
O’Melveny & Myers LLP
23F Meritz Tower
382 Gangnam-daero
Gangnam-gu, Seoul, Korea 06232
Attention: Daniel Kim
Email: dkim@omm.com
and
O’Melveny & Myers LLP
2765 Sand Hill Road
Menlo Park, CA 94025
Attention: Brad Finkelstein; Noah
Kornblith
Email: bfinkelstein@omm.com; nkornblith@omm.com
if to the Company, to:
eMagin Corporation
700 South Drive, Suite 201
Hopewell Junction, NY 12533
Attention:
Email:
with copies (which shall not constitute notice)
to:
White & Case LLP
1221 Avenue of the Americas
New York, New York 10020
Attention: John Reiss; Ross Sturman
Email: jreiss@whitecase.com; ross.sturman@whitecase.com
Section 10.04 Entire
Agreement. This Agreement (including the Exhibits hereto, the Parent Disclosure Letter
and the Disclosure Letter), together with the Confidentiality Agreement, constitutes the entire agreement, and supersede all prior agreements
and understandings, both written and oral, among the Parties with respect to the subject matter of this Agreement and the Confidentiality
Agreement. In the event of any inconsistency between the statements in the body of this Agreement, the Confidentiality Agreement, the
Parent Disclosure Letter, and the Disclosure Letter (other than an exception expressly set forth as such in the Parent Disclosure Letter
or Disclosure Letter), the statements in the body of this Agreement will control.
Section 10.05 No
Third-Party Beneficiaries. Except (i) for the provisions of Section 6.05,
and (ii) the right of the Company, on behalf of its stockholders, to pursue damages in the event of Parent’s, Silk USA’s
or Merger Sub’s fraud or Willful Breach of this Agreement, which shall be deemed in such event to be damages of the Company, and
(iii) following the Effective Time, the rights of the Company’s stockholders and holders of Company Equity Awards to receive
the Merger Consideration and other payments pursuant to Article II, neither this Agreement nor any other agreement contemplated
hereby is intended to or shall confer upon any person (including any Company Related Party or Parent Related Party) other than the Parties
hereto and thereto any benefits, obligations, liabilities, or legal or equitable rights or remedies. The representations and warranties
in this Agreement are the product of negotiations among the Parties and are for the sole benefit of the Parties. Any inaccuracies in
such representations and warranties are subject to waiver by the Parties in accordance with Section 8.05 without notice or
liability to any other person. The representations and warranties in this Agreement may represent an allocation among the Parties of
risks associated with particular matters.
Section 10.06 Assignment.
Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned, in whole or in part, by operation
of law or otherwise by any of the Parties without the prior written consent of each of the other Parties, and any assignment without
such consent shall be null and void; provided, however, that, prior to the Closing, (i) Parent, Silk USA and Merger
Sub may assign this Agreement (in whole but not in part) to any of Parent’s direct or indirect wholly owned Subsidiaries (only
to the extent any such subsidiary (each a “Qualifying Subsidiary”) (A) remains a direct or indirect wholly owned
Subsidiary of Parent and (B) is organized and tax resident in either the Republic of Korea or the United States), and (ii) Silk
USA may transfer to Parent, or any of its or Parent’s Qualifying Subsidiaries (so long as such Subsidiary remains a Qualifying
Subsidiary) the beneficial ownership of capital stock of Merger Sub, in each case after providing written notice thereof to the Company
at least five (5) Business Days prior to such assignment or transfer; provided, that (i) no such assignment or transfer
by any Party shall be permitted if such assignment would, or would reasonably be expected to, prevent or materially delay such Party
from performing their respective obligations under this Agreement and (ii) no such assignment or transfer shall relieve such Party
of any of its obligations hereunder. Subject to the immediately preceding sentences, this Agreement will be binding upon, inure to the
benefit of, and be enforceable by, the Parties and their respective successors and assigns.
Section 10.07 Consent
to Jurisdiction; Venue; Governing Law. This Agreement and all claims or causes of action
(whether in tort, contract or otherwise) that may be based upon, arise out of or relate to this Agreement or the negotiation, execution
or performance of this Agreement (including any claim or cause of action based upon, arising out of or related to any representation
or warranty made in or in connection with this Agreement) shall be governed by and construed in accordance with the Laws of the State
of Delaware, without giving effect to any choice or conflict of law provision or rule (whether of the State of Delaware or any other
jurisdiction) that would cause the application of the Laws of any jurisdiction other than the State of Delaware. Each of the Parties
hereto irrevocably agrees that any legal action or Proceeding with respect to this Agreement and the rights and obligations arising hereunder,
or for recognition and enforcement of any judgment in respect of this Agreement and the rights and obligations arising hereunder brought
by the other Party hereto or its successors or assigns, shall be brought and determined exclusively in the Delaware Court of Chancery,
or, if the Delaware Court of Chancery declines to accept jurisdiction over a particular matter, any federal court within the State of
Delaware, or, if both the Delaware Court of Chancery and the federal courts within the State of Delaware decline to accept jurisdiction
over a particular matter, any other state court within the State of Delaware, and, in each case, any appellate court therefrom. Each
of the Parties hereto hereby irrevocably submits with regard to any such legal action or Proceeding for itself and in respect of its
property, generally and unconditionally, to the personal jurisdiction of the aforesaid courts and agrees that it will not bring any action
relating to this Agreement or any of the transactions contemplated by this Agreement in any court other than the aforesaid courts. Each
of the Parties hereto hereby irrevocably waives, and agrees not to assert as a defense, counterclaim or otherwise, in any action or Proceeding
with respect to this Agreement: (a) any claim that it is not personally subject to the jurisdiction of the above named courts for
any reason other than the failure to serve in accordance with this Section 10.07; (b) any claim that it or its property
is exempt or immune from the jurisdiction of any such court or from any legal process commenced in such courts (whether through service
of notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment or otherwise); and (c) to
the fullest extent permitted by the applicable Law, any claim that (i) the suit, action or Proceeding in such court is brought in
an inconvenient forum, (ii) the venue of such suit, action or Proceeding is improper, (iii) a Party has objections or immunities
to jurisdiction to which it may otherwise be entitled or become entitled (including sovereign immunity, immunity to pre-judgement attachment,
post-judgement attachment or execution) or (iv) this Agreement, or the subject matter hereof, may not be enforced in or by such
courts. Each of the Parties hereto agrees that service of process upon such Party in any such action or Proceeding shall be effective
if such process is given as a notice in accordance with Section 10.03. Parent agrees that if the Company obtains a judgment
against Parent, Silk USA and/or Merger Sub in any Delaware Court arising out of or relating to this Agreement or the transactions contemplated
hereby, the Company may bring any Proceeding with respect to the recognition and enforcement thereof in a court in the Republic of Korea,
and Parent hereby irrevocably waives, and agrees not to assert, by way of motion, as a defense, counterclaim or otherwise, any contention
that such judgment of any of the Delaware Courts may not be recognized and/or enforced in whole or in part.
Section 10.08 Waiver
of Jury Trial. Each Party acknowledges and agrees that any controversy which may arise
under this Agreement is likely to involve complicated and difficult issues, and therefore each such Party hereby irrevocably and unconditionally
waives any right such Party may have to a trial by jury in any Proceeding directly or indirectly based upon, relating to or arising out
of this Agreement or any transaction contemplated hereby or the negotiation, execution or performance hereof or thereof. Each Party certifies
and acknowledges that (a) no Representative, agent or attorney of any other Party has represented, expressly or otherwise, that
such other Party would not, in the event of any Proceeding, seek to enforce the foregoing waiver, (b) each Party understands and
has considered the implication of this waiver, (c) each Party makes this waiver voluntarily, and (d) each Party has been induced
to enter into this Agreement by, among other things, the mutual waivers and certifications in this Section 10.08.
Section 10.09 Specific
Performance; Remedies. The Parties agree that irreparable injury for which monetary damages,
even if available, would not be an adequate remedy, would occur in the event that the Parties hereto do not perform any of the provisions
of this Agreement (including failing to take such actions as are required of it hereunder to consummate this Agreement) in accordance
with its specified terms or otherwise breach such provisions. Accordingly, the Parties acknowledge and agree that the Parties shall be
entitled to an injunction, specific performance and other equitable relief to prevent or restrain breaches or threatened breaches of
this Agreement and to enforce specifically the terms and provisions hereof and thereof, in addition to any other remedy to which they
are entitled at law or in equity. Each of the Parties agrees that it will not oppose the granting of an injunction, specific performance
and other equitable relief on the basis that any other Party has an adequate remedy at law or that any award of specific performance
is not an appropriate remedy for any reason at law or in equity. Any Party seeking an injunction to prevent breaches of this Agreement
and to enforce specifically the terms and provisions of this Agreement in any court having jurisdiction related to this Agreement as
provided in Section 10.07 may seek such an injunction without the necessity of demonstrating damages or posting a bond or
other security in connection with any such injunction. To the extent any Party brings a Proceeding to enforce specifically the performance
of the terms and provisions of this Agreement (other than an action to specifically enforce only provisions that expressly survive the
termination of this Agreement) when available to such Party pursuant this Section 10.09, the Outside Date shall automatically
be extended to the later of: (i) the thirtieth (30th) Business Day following the resolution of such Proceeding, or (ii) such
other time period established by the court presiding over such Proceeding.
Section 10.10 Severability.
If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by any rule of law or public
policy, all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long as the economic
or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to any Party. Upon such determination
that any term or other provision is invalid, illegal or incapable of being enforced, the Parties shall negotiate in good faith to modify
this Agreement so as to effect the original intent of the Parties as closely as possible to the fullest extent permitted by applicable
Law in a mutually acceptable manner to the end that the transactions contemplated hereby are fulfilled to the fullest extent possible.
Section 10.11 Counterparts;
Facsimile and Electronic Signatures. This Agreement may be executed in one or more counterparts,
all of which shall be considered one and the same agreement and shall become effective when one or more counterparts have been signed
by each of the Parties and delivered to the other Parties. This Agreement or any counterpart may be executed and delivered by facsimile
copies or delivered by electronic communications by PDF, each of which shall be deemed an original.
{Remainder of page intentionally left
blank.}
IN WITNESS WHEREOF, Parent, Silk USA, Merger Sub
and the Company have caused this Agreement to be signed by their respective officers thereunto duly authorized, all as of the date first
written above.
|
SAMSUNG DISPLAY CO., LTD. |
|
|
|
By: |
/s/ Kwonyoung Choi |
|
|
Name: |
Kwonyoung Choi |
|
|
Title: |
Executive Vice President and Chief Strategy Officer |
|
|
|
EMERALD INTERMEDIATE, INC. |
|
|
|
By: |
/s/ Seo Young Son |
|
|
Name: |
Seo Young Son |
|
|
Title: |
President and Chief Executive Officer |
|
|
|
EMERALD MERGER SUB, INC. |
|
|
|
By: |
/s/ Seo Young Son |
|
|
Name: |
Seo Young Son |
|
|
Title: |
President and Chief Executive Officer |
|
|
|
EMAGIN CORPORATION |
|
|
|
By: |
/s/ Andrew G. Sculley |
|
|
Name: |
Andrew G. Sculley |
|
|
Title: |
Chief Executive Officer |
[Signature Page to the Merger Agreement]
Schedule A
List of Stillwater Entities
(see attachment)
Exhibit A
Amended and Restated Certificate of Incorporation
(see attachment)
Exhibit B
Form of Series B Charter Amendment
(see attachment)
Exhibit C
Form of Loan and Security Agreement
(see attachment)
Exhibit 3.1
CERTIFICATE OF AMENDMENT
TO THE
CERTIFICATE OF DESIGNATIONS OF
SERIES B CONVERTIBLE PREFERRED STOCK
OF
EMAGIN CORPORATION
PURSUANT TO SECTION 242 OF THE
DELAWARE GENERAL CORPORATION LAW
eMagin Corporation (the “Corporation”)
does hereby certify that:
FIRST: That the name
of the corporation is eMagin Corporation, a Delaware corporation.
SECOND: That the initial
Certificate of Designations of Series B Convertible Preferred Stock of the Corporation (the “Initial Certificate”)
was filed with the Secretary of State of the State of Delaware on December 18, 2008.
THIRD: That the Corporation
filed a Certificate of Amendment to the Initial Certificate with the Secretary of State of the State of Delaware on December 16,
2016 (together with the Initial Certificate, the “Amended Certificate”).
FOURTH: That this Certificate
of Amendment to the Amended Certificate amends certain provisions of Section 10 of the Amended Certificate as set forth below, which
amendment was duly adopted by the Board of Directors of the Corporation in accordance with the provisions of Section 242 of the General
Corporation Law of the State of Delaware and duly approved by the holders of at least a majority of the outstanding shares of Series B
Convertible Preferred Stock of the Corporation.
FIFTH: Section 10(d) of
the Amended Certificate is hereby amended by adding the following after clause (3) thereof:
(4) Reference is
made to that certain Agreement and Plan of Merger, dated as of May 17, 2023, by and among the Corporation and the other parties
thereto (the “Merger Agreement”). Notwithstanding any other provision in this Certificate of Designations (as
amended), including but not limited to this Section 10(d), contingent upon the Closing (as defined in the Merger Agreement), at
the Effective Time (as defined in the Merger Agreement), each share of the Series B Convertible Preferred Stock issued and
outstanding immediately prior to the Effective Time (excluding (a) any Dissenting Shares (as defined in the Merger Agreement)
and (b) Company Held Shares (as defined below)), shall be converted into cash, without interest, in an amount equal to
(i) the total number of shares of Common Stock issuable upon conversion of such share of Company Series B Convertible
Preferred Stock in accordance with the Company Charter Documents (as defined in the Merger Agreement) immediately prior to the
Effective Time, multiplied by (ii) the Per Share Merger Price (as defined in the Merger Agreement), subject to the surrender of
such shares of Series B Convertible Preferred Stock in the manner described in the Merger Agreement (the “Share
Conversion”). As of and after the Effective Time, no shares of Series B Convertible Preferred Stock shall be
outstanding and all shares of Series B Convertible Preferred Stock shall be automatically cancelled and cease to exist as of
the Effective Time, and the holders thereof shall only have the right to receive the consideration contemplated hereby. As of the
Effective Time, the other provisions of Section 10(d) of this Certificate of Designations (as amended) shall cease to
apply. In addition, contingent upon the Closing, at the Effective Time all shares of Series B Convertible Preferred Stock held
immediately prior to the Effective Time by (A) the Corporation, or any wholly owned subsidiary of the Corporation,
(B) Parent (as defined in the Merger Agreement) or (C) Merger Sub (as defined in the Merger Agreement) (collectively,
“Company Held Shares”), shall no longer be outstanding and shall be automatically cancelled, and cease to exist
without consideration.
[Remainder of page intentionally left blank]
IN WITNESS WHEREOF, the undersigned, being the
duly elected Chief Executive Officer of the Corporation, does make and file this Amendment to the Certificate of Designations of Series B
Convertible Stock on behalf of the Corporation, hereby declaring and certifying, under penalties of perjury, that this is the act and
deed of the Corporation and that the facts herein stated are true, and accordingly has hereunto set my hand as of this 17th day of May,
2023.
|
EMAGIN CORPORATION |
|
|
|
/s/ Andrew G. Sculley |
|
Name: |
Andrew G. Sculley |
|
Title: |
Chief Executive Officer |
Exhibit 10.1
SUPPORT AGREEMENT
SUPPORT AGREEMENT, dated as of May 17, 2023
(this “Support Agreement”), among Samsung Display Co., Ltd., a Korean corporation (“Parent”),
and the undersigned stockholders of eMagin Corporation, a Delaware corporation (the “Company”), listed on the signature
pages hereto (each, a “Stockholder” and, collectively, the “Stockholders”).
W I T N E S S E T H:
WHEREAS, Parent, Emerald Intermediate, Inc.,
a Delaware corporation and wholly-owned subsidiary of Parent (“Silk USA”), and Emerald Merger Sub, Inc., a Delaware
corporation and wholly-owned subsidiary of Silk USA (“Merger Sub”), and the Company propose to enter into an Agreement
and Plan of Merger dated as of the date hereof (as the same may be amended or supplemented, the “Merger Agreement”;
capitalized terms used but not defined herein shall have the meanings set forth in the Merger Agreement) providing for the merger of Merger
Sub with and into the Company, with the Company surviving the Merger and becoming a wholly-owned subsidiary of Silk USA;
WHEREAS, the Stockholders own the number of shares
of Company Capital Stock set forth on Schedule A hereto (collectively, the “Subject Shares”);
WHEREAS, as a condition and an inducement to Parent’s
willingness to enter into the Merger Agreement, Parent has requested that the Stockholders agree, and the Stockholders have agreed, to
enter into this Support Agreement in connection with the Merger Agreement; and
WHEREAS, concurrently with the execution and delivery
of this Support Agreement, the Stockholders, constituting holders of a majority of the outstanding shares of Company Series B Convertible
Preferred Stock, have approved the Merger Agreement and the Merger;
WHEREAS, concurrently with the execution and delivery
of this Support Agreement, the Stockholders, constituting holders of a majority of the outstanding shares of Company Series B Convertible
Preferred Stock, have approved the Series B Charter Amendment (in the form attached hereto as Exhibit A) and the Company
has validly filed the Series B Charter Amendment with the Secretary of State of the State of Delaware such that the Series B
Charter Amendment is effective;
WHEREAS, in consideration of the execution of the
Merger Agreement by Parent, each Stockholder is hereby agreeing to enter into this Support Agreement and to vote the Subject Shares in
accordance with the terms and conditions set forth herein.
NOW, THEREFORE, in consideration of the foregoing
and the respective representations, warranties, covenants and agreements set forth below and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, do hereby agree as follows:
Section 1. Representations and Warranties
of the Stockholders. Each Stockholder hereby represents and warrants as to only itself, himself or herself (severally and not jointly)
to Parent as follows:
(a) Authority.
The Stockholder has all requisite corporate power and authority to execute and deliver this Support Agreement, to perform the Stockholder’s
obligations hereunder (including, without limitation, Section 3(c)) and to consummate the transactions contemplated hereby. The
execution, delivery and performance by the Stockholder of this Support Agreement, the performance by the Stockholder of Stockholder’s
obligations hereunder (including, without limitation, Section 3(c)) and the consummation of the transactions contemplated hereby
have been duly and validly authorized by all necessary action on the part of such Stockholder, and no other actions or proceedings on
the part of the Stockholder are necessary to authorize the execution and delivery by the Stockholder of this Support Agreement, the performance
by the Stockholder of such Stockholder’s obligations hereunder (including, without limitation, Section 3(c)) and the consummation
of the transactions contemplated hereby.
(b) Execution;
Delivery; Enforceability. The Stockholder has duly executed and delivered this Support Agreement, and this Support Agreement constitutes
the valid and binding obligation of such Stockholder, enforceable against such Stockholder in accordance with its terms, except that such
enforceability (i) may be limited by bankruptcy, insolvency, moratorium or other similar laws affecting or relating to the enforcement
of creditors’ rights generally and (ii) is subject to general principles of equity. No consent, approval, order or authorization
of, or registration, declaration or filing with, any Governmental Authority or any other person is required to be obtained or made by
or with respect to such Stockholder in connection with the execution and delivery of this Support Agreement, the performance by the Stockholder
of such Stockholder’s obligations hereunder (including, without limitation, Section 3(c)) or the consummation of the transactions
contemplated hereby, other than such reports, schedules or statements under Sections 13(d) and 16 of the 1934 Act as may be required
in connection with this Support Agreement and the transactions contemplated hereby.
(c) No
Conflict. The execution and delivery of this Support Agreement by the Stockholder do not, and the consummation of the transactions
contemplated hereby and compliance with the provisions hereof by the Stockholder will not, conflict with, result in a breach or violation
of or default (with or without notice or lapse of time or both) under, give to others any rights of termination, amendment, acceleration
or cancellation of, or result in the creation of a Lien on any of the shares of Company Capital Stock beneficially owned by such Stockholder
pursuant to, any note, bond, mortgage, indenture, contract, agreement, lease, license, permit, franchise or other instrument or obligation
to which the Stockholder is a party or by which such Stockholder is bound, or any law, rule, regulation, judgment, order or decree by
which the Stockholder is bound, except for such conflicts, breaches, violations or defaults that would not, individually or in the aggregate,
materially prevent or delay consummation of the Merger and the transactions contemplated by the Merger Agreement and this Support Agreement
or otherwise prevent or materially delay the Stockholder from performing its obligations under this Support Agreement.
(d) The
Subject Shares. The Stockholder is the beneficial owner of the Subject Shares listed on Schedule A hereto across from his,
her or its name, free and clear of any Lien (other than any restrictions or rights created by this Support Agreement, under applicable
federal or state securities laws or pursuant to any written policies of the Company with respect to the trading of securities in connection
with insider trading restrictions, applicable securities laws and similar consideration). The Subject Shares constitute the Stockholder’s
entire interest in the outstanding shares of capital stock of the Company. The Stockholder has or will have sole voting power, sole power
of disposition, sole power to issue instructions with respect to the matters set forth herein, and sole power to agree to all of the matters
set forth in this Support Agreement, in each case with respect to all of the Subject Shares, with no limitations, qualifications or restrictions
on such rights (other than any restrictions or rights created by this Support Agreement). None of the Subject Shares owned by such Stockholder
are subject to any stockholders’ agreement, proxy, voting trust or other agreement or arrangement with respect to the voting of
such Subject Shares, except as contemplated by this Support Agreement. Notwithstanding anything to the contrary set forth herein, any
shares of capital stock or other securities of the Company that the Stockholder purchases or otherwise acquires beneficial ownership after
the date of this Support Agreement and during the Support Period shall be deemed Subject Shares and subject to the terms and conditions
of this Support Agreement. In the event of any stock split, stock dividend, merger, reorganization, recapitalization, reclassification,
combination, exchange of shares or the like of the capital stock of the Company affecting the Subject Shares, the terms of this Support
Agreement shall apply to the resulting securities.
(e) Absence
of Litigation. There is no Proceeding (whether judicial, arbitral, administrative or other) pending against or, to the knowledge of
the Stockholder, threatened against or affecting, such Stockholder or the Subject Shares that could reasonably be expected to impair or
affect the ability of such Stockholder to perform its obligations hereunder or to consummate the transactions contemplated hereby on a
timely basis.
(f) Reliance.
The Stockholder understands and acknowledges that Parent is entering into the Merger Agreement in reliance upon such Stockholder’s
execution, delivery and performance of this Support Agreement.
Section 2. Representations and Warranties
of Parent. Parent hereby represents and warrants to each Stockholder as follows:
(a) Authority.
Parent has all requisite corporate power and authority to execute and deliver this Support Agreement, to perform its obligations hereunder
and to consummate the transactions contemplated hereby. The execution, delivery and performance by Parent of this Support Agreement, the
performance by Parent of its obligations hereunder and consummation of the transactions contemplated hereby have been duly and validly
authorized by all necessary action on the part of Parent, and no other actions or proceedings on the part of Parent are necessary to authorize
the execution and delivery by Parent of this Support Agreement, the performance by Parent of Parent’s obligations hereunder and
the consummation of the transactions contemplated hereby.
(b) Execution;
Delivery; Enforceability. Parent has duly executed and delivered this Support Agreement, and this Support Agreement constitutes the
valid and binding obligation of Parent, enforceable against Parent in accordance with its terms, except that such enforceability (i) may
be limited by bankruptcy, insolvency, moratorium or other similar laws affecting or relating to the enforcement of creditors’ rights
generally and (ii) is subject to general principles of equity. No consent, approval, order or authorization of, or registration,
declaration or filing with, any Governmental Authority or any other person is required to be obtained or made by or with respect to Parent
in connection with the execution and delivery of this Support Agreement, the performance by Parent of its obligations hereunder or the
consummation of the transactions contemplated hereby, other than (i) reports, schedules or statements by Parent under Sections 13(d) and
16 of the 1934 Act as may be required in connection with this Support Agreement and the transactions contemplated hereby and (ii) such
consents, registrations or filings the failure of which to be obtained or made would not have a material adverse effect on Parent’s
ability to perform its obligations hereunder.
(c) No
Conflict. The execution and delivery of this Support Agreement by Parent do not, and the consummation of the transactions contemplated
hereby and compliance with the provisions hereof by Parent will not, conflict with, result in a breach or violation of or default (with
or without notice or lapse of time or both) under, give to others any rights of termination, amendment, acceleration or cancellation
of, or result in the creation of a Lien on any of the shares of Company Capital Stock beneficially owned by such Stockholder pursuant
to, any note, bond, mortgage, indenture, contract, agreement, lease, license, permit, franchise or other instrument or obligation to
which Parent is a party or by which Parent is bound, or any law, rule, regulation, judgment, order or decree by which Parent is bound,
except for such conflicts, breaches, violations or defaults that would not, individually or in the aggregate, materially prevent or delay
consummation of the Merger and the transactions contemplated by the Merger Agreement and this Support Agreement or otherwise prevent
or materially delay Parent from performing its obligations under this Support Agreement.
Section 3. Covenants of the Stockholders.
(a) Support.
At all times during the Support Period (as defined below), each Stockholder covenants and agrees as follows:
(i) Agreement to Vote. At every meeting
of the stockholders of the Company (and at every adjournment or postponement thereof) called to seek, and in every other circumstance
in which a vote, action, written consent, resolution or other approval of the stockholders of the Company is proposed seeking, the Company
Stockholder Approval, approval of the Merger, adoption of the Merger Agreement, or approval of any other transaction pursuant to or contemplated
by the Merger Agreement, and any matter that would reasonably be expected to facilitate the consummation of the Merger (including, without
limitation, any adjournment of any meeting of the stockholders in order to solicit additional proxies in favor of approval of the Merger
and adoption of the Merger Agreement if there are not sufficient votes to obtain the Company Stockholder Approval, and any amendment to
the Company Charter Documents to give effect to the Series B Charter Amendment), the Stockholder shall, and shall cause each holder
of record on any applicable record date to (including via proxy), (A) if a meeting is held, deliver a duly executed proxy card to
the Company directing that the Subject Shares be counted as present at such meeting for purposes of establishing a quorum and (B) cause
to be voted the Subject Shares:
(1) in
favor of (w) granting the Company Stockholder Approval, (x) approving the Merger, (y) adopting the Merger Agreement, and
(z) approving any other transaction pursuant to or contemplated by the Merger Agreement, and any other matter that would reasonably
be expected to facilitate the consummation of the Merger (including, without limitation, any adjournment of any meeting of the stockholders
in order to solicit additional proxies in favor of approval of the Merger and adoption of the Merger Agreement if there are not sufficient
votes to obtain the Company Stockholder Approval, and any amendment to the Company Charter Documents to give effect to the Series B
Charter Amendment); and
(2) against
(x) any Acquisition Proposal (other than the Merger Agreement and the Merger) without regard to the terms of such Acquisition Proposal,
(y) any other matter (including, without limitation, any amendment to the Company Charter Documents and any change in the Company
Board) that would reasonably be expected to impede, interfere with, delay, postpone or adversely affect the consummation of the Merger
or any of the transactions contemplated by the Merger Agreement, and (z) any other action, transaction or agreement that could reasonably
be expected to result in a breach of any representation, warranty, covenant or agreement of the Company in the Merger Agreement or of
any Stockholder in this Support Agreement.
For the avoidance of doubt, any obligation pursuant to the foregoing
clause (2) shall not be read to affect, reduce or eliminate the obligation of any Stockholder pursuant to clause (1).
(ii) Consents and Waivers. Each Stockholder
hereby gives any consents or waivers that are reasonably required for the consummation of the Merger under the terms of any Contracts
to which such Stockholder is a party or pursuant to any rights such Stockholder may have.
(b) No
Transfer. From the date hereof until the earlier of the expiration of the Support Period and obtaining the Company Stockholder Approval,
other than pursuant to this Support Agreement, each Stockholder shall not, directly or indirectly, (A) sell, transfer, exchange,
pledge or otherwise dispose of (collectively, “Transfer”) any Subject Shares to any person other than pursuant to the
Merger, provided that the Stockholder shall be permitted to distribute all or any portion of the Subject Shares pursuant to (x) bona
fide gifts to any member of the Stockholder’s immediate family or otherwise for estate planning purposes, (y) any Transfer
occurring by will, testamentary document or intestate succession upon the death of a Stockholder who is an individual, or (z) community
property laws or divorce decree; provided, further, that any such Transfer shall be permitted only if, as a precondition to such
Transfer, the transferee agrees in writing to be bound by all the terms of this Support Agreement, and any Transfer or attempted Transfer
of any Subject Shares in violation of this Section 3(b) shall, to the fullest extent permitted by Law, be null and void ab
initio, (B) permit to exist any Liens (other than those created by this Support Agreement) on any of the Subject Shares, (C) enter
into any voting arrangement, whether by proxy, power of attorney, voting agreement, voting trust or otherwise, with respect to any Subject
Shares, (D) enter into any swap or similar arrangement that transfers the economic consequences of ownership of the Subject Shares,
(E) take or permit any other action that would in any way restrict, limit or interfere with the performance of such Stockholder’s
obligations hereunder, and (F) make any offer or enter into any agreement providing for any of the foregoing; and
(c) IRREVOCABLE
PROXY. At all times during the Support Period, (i) each such Stockholder hereby grants to Parent (and any designee of Parent)
a proxy (and appoints Parent or any such designee of Parent as its attorney-in-fact) to vote, and to exercise all voting and consent
rights of such Stockholder with respect to, the Subject Shares owned beneficially or of record by such Stockholder (including, without
limitation, the power to execute and deliver written consents) in accordance with Section 3(a) at any annual, special, adjourned
or postponed meeting of stockholders of the Company at which any of the transactions, actions or proposals contemplated by Section 3(a) are
or will be considered and in every written consent in lieu of such meeting and (ii) such proxy and appointment shall (A) be
irrevocable in accordance with the provisions of Section 212(e) of DGCL, (B) be coupled with an interest, and (C) survive
the dissolution, bankruptcy or other incapacity of such Stockholder as well as the death, bankruptcy or other incapacity of such Stockholder;
provided, that any grant of such proxy shall only entitle Parent or its designee to vote on the matters specified by Section 3(a),
and each Stockholder shall retain the authority to vote on all other matters. Each Stockholder hereby revokes any proxy previously granted
by such Stockholder with respect to the Subject Shares of such Stockholder. Each Stockholder hereby represents that any proxies heretofore
given in respect of such Stockholder’s Subject Shares, if any, are revocable, and hereby revokes all such proxies, and that such
Stockholder agrees not to grant any subsequent proxies with respect to such Subject Shares at any time during the Support Period, except
to comply with its, his or her obligations under Section 3(a). Each Stockholder hereby affirms that the irrevocable proxy set forth
in this Section 3(c), if it becomes effective, is given in connection with the execution of the Merger Agreement, and that such
irrevocable proxy is given to secure the performance of the duties of such Stockholder under this Support Agreement. Each Stockholder
hereby ratifies and confirms all actions that the proxies appointed hereunder may lawfully do or cause to be done in accordance with
this Support Agreement.
The “Support Period” shall commence
on the date hereof and continue until the first to occur of (1) the Effective Time and (2) the date and time of the valid termination
of the Merger Agreement in accordance with its terms.
(d) Capacity.
Notwithstanding anything to the contrary in this Support Agreement, (i) each Stockholder is entering into this Support Agreement,
and agreeing to become bound hereby, solely in its capacity as a stockholder of the Company and not in any other capacity (including without
limitation any capacity as a director of the Company) and (ii) nothing in this Support Agreement shall obligate such Stockholder
to take, or forbear from taking, any action as a director (including without limitation through the individuals that it has elected to
the Company Board) or any other action, other than in the capacity as a Stockholder of the Company with respect to the voting of the Subject
Shares as specified in Section 3(a).
(e) Appraisal
Rights. Each Stockholder hereby irrevocably waives, and agrees not to exercise or assert, if applicable, any appraisal rights or rights
of dissent (including, without limitation, under Section 262 of DGCL) in connection with the Merger.
(f) No
Solicitation. Each Stockholder agrees that it will not, and will cause each of its Affiliates and its and their respective Representatives
to not, directly or indirectly, take any action that the Company is prohibited from taking pursuant to Section 5.02 of the Merger
Agreement.
(g) Waiver
of Certain Actions. Each Stockholder hereby agrees not to commence or participate in, and to take all actions necessary to opt out
of any class in any class action with respect to, any claim, derivative or otherwise, against Parent, the Company, Silk USA, Merger Sub
or any of their respective Subsidiaries or successors (a) challenging the validity of, or seeking to enjoin or delay the operation
of, any provision of this Support Agreement or the Merger Agreement (including any claim seeking to enjoin or delay the Closing) or (b) alleging
a breach of any duty of the Company Board or of the respective Board of Directors of Parent, Silk USA or Merger Sub in connection with
the Merger Agreement, this Support Agreement or the transactions contemplated thereby or hereby.
(h) Obligation
to Update Schedule A. The Stockholders agree that, in connection with any acquisitions or Transfers (to the extent permitted) of Subject
Shares by any Stockholder, the Stockholders will, as promptly as practicable following the completion of such acquisition or Transfer,
notify Parent in writing of such acquisition or Transfer and the parties will update Schedule A hereto to reflect the effect of
such acquisition or Transfer.
Section 4. Termination. This Support
Agreement shall terminate upon the earliest to occur of (a) the Effective Time, (b) the termination of the Merger Agreement,
(c) the amendment of the Merger Agreement, without the prior written consent of the Stockholders, in a manner that affects the economics
or material terms of the Merger Agreement in a manner that is adverse to the Company or its stockholders (including with respect to the
reduction of or the imposition of any restriction on the Stockholders’ right to receive the Merger Consideration (as defined in
the Merger Agreement), or any reduction in the amount or change in the form of the Merger Consideration), and (d) the date that is
six (6) months after May 17, 2024 (or, if the Outside Date is automatically extended for 90 days pursuant to Section 8.01(b)(i) of
the Merger Agreement, the date that is six (6) months after August 15, 2024).
Section 5. Further Assurances; Notice of
Certain Events. Subject to the terms and conditions of this Support Agreement, each Stockholder shall use its reasonable best efforts
to take, or cause to be taken, all actions, and to do, or cause to be done, all things necessary to fulfill such Stockholder’s obligations
under this Support Agreement. The Stockholders shall notify Parent in writing promptly of (a) any fact, event or circumstance that
would cause, or reasonably be expected to cause or constitute, a breach in any material respect of the representations and warranties
of the Stockholders under this Support Agreement or of the covenants and agreements of the Stockholders under this Support Agreement and
(b) the receipt by the Stockholders of any notice or other communication from any person alleging that the consent of such person
is or may be required in connection with this Support Agreement; provided, however, that the delivery of any notice pursuant to
this Section 5 shall not limit or otherwise affect the remedies available to any party.
Section 6. General Provisions.
(a) Amendments.
This Support Agreement may not be amended except by an instrument in writing signed by each of the parties hereto.
(b) Notices.
All notices and other communications hereunder shall be in writing and shall be deemed given if delivered personally or sent by overnight
courier (providing proof of delivery), faxed (with confirmation), or sent by email (provided, that such email states that it is a notice
defined pursuant to this Section 6(b)) to the Company and Parent in accordance with Section 10.03 of the Merger Agreement and
to a Stockholder at its address set forth on Schedule A hereto (or at such other address for a party as shall be specified by like
notice).
(c) Interpretation.
The Section headings herein are for convenience of reference only, do not constitute part of this Support Agreement and shall not
be deemed to limit or otherwise affect any of the provisions hereof. Where a reference in this Support Agreement is made to a Section,
such reference shall be to a Section of this Support Agreement unless otherwise indicated. Unless otherwise indicated, whenever
the words “include,” “includes” or “including” are used in this Support Agreement, they shall be
deemed to be followed by the words “without limitation.”
(d) Severability.
The provisions of this Support Agreement shall be deemed severable and the invalidity or unenforceability of any provision shall not
affect the validity or enforceability or the other provisions hereof. If any provision of this Support Agreement, or the application
thereof to any person or any circumstance, is invalid or unenforceable, (i) a suitable and equitable provision shall be substituted
therefor in order to carry out, so far as may be valid and enforceable, the intent and purpose of such invalid or unenforceable provision
and (ii) the remainder of this Support Agreement and the application of such provision to other persons or circumstances shall
not be affected by such invalidity or unenforceability, nor shall such invalidity or unenforceability affect the validity or enforceability
of such provision, or the application thereof, in any other jurisdiction.
(e) Specific
Performance. The parties hereto acknowledge that Parent may be irreparably harmed and that there may be no adequate remedy at law
for a violation of any of the covenants or agreements of any party hereto set forth herein. Therefore, it is agreed that, in addition
to any other remedies that may be available to Parent upon any such violation, Parent shall have the right to seek to enforce such covenants
and agreements by specific performance, injunctive relief or by any other means available to Parent at law or in equity. Each party agrees
that it will not oppose the granting of an injunction, specific performance and other equitable relief on the basis that any other party
has an adequate remedy at law or that any award of specific performance is not an appropriate remedy for any reason at law or in equity.
The parties further agree that no party shall be required to obtain, secure, furnish or post any bond, security or similar instrument
in connection with or as a condition to obtaining any remedy referred to in this Section 6(e) and each party waives any objection
to the imposition of such relief or any right it may have to require the obtaining, securing, furnishing or posting of any such bond,
security or similar instrument.
(f) Other
Remedies. Except as otherwise provided herein, any and all remedies herein expressly conferred upon a party will be deemed cumulative
with and not exclusive of any other remedy conferred hereby, or by law or equity upon such party, and the exercise by a party of any one
remedy will not preclude the exercise of any other remedy.
(g) Counterparts.
This Support Agreement may be executed in any number of counterparts, each such counterpart being deemed to be an original instrument,
and all such counterparts shall together constitute the same agreement.
(h) Entire
Agreement; No Third-Party Beneficiaries. This Support Agreement, together with Schedule A hereto, constitutes the entire agreement,
and supersedes all other prior agreements, understandings, representations and warranties both written and oral, among the parties, with
respect to the subject matter hereof. This Support Agreement is not intended to confer upon any person other than the parties hereto and
each such party’s respective heirs, successors and permitted assigns any rights or remedies hereunder.
(i) Governing
Law. This Support Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without regard
to the conflicts of law rules of such State.
(j) Waiver
of Jury Trial. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS SUPPORT AGREEMENT IS LIKELY
TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH
PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS SUPPORT
AGREEMENT, OR THE TRANSACTIONS CONTEMPLATED BY THIS SUPPORT AGREEMENT. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (i) NO REPRESENTATIVE,
AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION,
SEEK TO ENFORCE THE FOREGOING WAIVER, (ii) EACH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (iii) EACH
PARTY MAKES THIS WAIVER VOLUNTARILY, AND (iv) EACH PARTY HAS BEEN INDUCED TO ENTER INTO THIS SUPPORT AGREEMENT BY, AMONG OTHER THINGS,
THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 6(j).
(k) Assignment.
No rights or obligations under this Support Agreement may be assigned or delegated by operation of applicable Law or otherwise. Any purported
assignment or delegation in violation of this Support Agreement is void.
(l) Consent
to Jurisdiction. The parties hereto agree that any suit, action or proceeding seeking to enforce any provision of, or based on any
matter arising out of or in connection with, this Support Agreement or the transactions contemplated hereby (whether brought by any party
or any of its Affiliates or against any party or any of its Affiliates) shall be brought in the Delaware Court of Chancery, or, if the
Delaware Court of Chancery declines to accept jurisdiction over a particular matter, any federal court within the State of Delaware, or,
if both the Delaware Court of Chancery and the federal courts within the State of Delaware decline to accept jurisdiction over a particular
matter, any other state court within the State of Delaware, and, in each case, any appellate court therefrom, and each of the parties
hereto hereby irrevocably consents to the jurisdiction of such courts (and of the appropriate appellate courts therefrom) in any such
suit, action or proceeding and irrevocably waives, to the fullest extent permitted by law, any objection that it may now or hereafter
have to the laying of the venue of any such suit, action or proceeding in any such court or that any such suit, action or proceeding brought
in any such court has been brought in an inconvenient forum. Process in any such suit, action or proceeding may be served on any party
anywhere in the world, whether within or without the jurisdiction of any such court. Without limiting the foregoing, each party agrees
that service of process on such party as provided in Section 6(b) shall be deemed effective service of process on such party.
The parties hereto agree that a final trial court judgment in any such suit, action or proceeding shall be conclusive and may be enforced
in other jurisdictions by suit on the judgment or in any other manner provided by law; provided, however, that nothing in the foregoing
shall restrict any party’s rights to seek any post-judgment relief regarding, or any appeal from, such final trial court judgment.
(m) Expenses.
All costs and expenses incurred in connection with this Support Agreement shall be paid by the party incurring such cost or expense, whether
or not the Merger is consummated.
[Signature Page Follows]
IN WITNESS WHEREOF, each party has duly executed
this Support Agreement, all as of the date first written above.
|
Samsung Display Co., Ltd. |
|
|
|
By |
|
|
|
Name: |
|
|
Title: |
IN WITNESS WHEREOF, each party has duly executed
this Support Agreement, all as of the date first written above.
|
STOCKHOLDER: |
|
If an entity: |
|
|
|
Name: |
|
|
|
|
By: |
|
|
Name: |
|
|
Title: |
|
|
|
|
If an individual: |
|
|
|
Name: |
|
SCHEDULE A
Stockholder
[Stockholder] |
Type of Subject Shares
Number of Subject Shares [Common Stock / [ __________ ]
Series B Convertible Preferred Stock] |
|
Notice
[Stockholder] c/o [ ] [Address]
[Address] [Address] Attention: [] Fax: [] Email: []
with a copy (which shall not constitute
notice to the Stockholders) to:
[Address] [Address]
[Address] Attention: [] Fax: [] Email: []
EXHIBIT A
Form of Series B Charter Amendmen
Exhibit 10.2
LOAN
AND SECURITY AGREEMENT
THIS LOAN AND SECURITY
AGREEMENT (this “Agreement”), dated as of May 17, 2023 (the “Effective Date”), among EMERALD
INTERMEDIATE, INC., a Delaware corporation (“Lender”), SAMSUNG DISPLAY CO., LTD., a Korean corporation
(“Parent”), and EMAGIN CORPORATION, a Delaware corporation (“Borrower”), provides the terms
on which Lender shall lend to Borrower and Borrower shall repay Lender. The parties agree as follows:
1 ACCOUNTING
AND OTHER TERMS
Accounting terms not defined
in this Agreement shall be construed following GAAP. Calculations and determinations must be made following GAAP. Capitalized terms not
otherwise defined in this Agreement shall have the meanings set forth in Section 13. All other terms contained in this Agreement,
unless otherwise indicated, shall have the meaning provided by the Code to the extent such terms are defined therein.
2 LOAN
AND TERMS OF PAYMENT
2.1 Promise
to Pay. Borrower hereby unconditionally promises to pay Lender the outstanding principal amount of the Loan, accrued and unpaid interest
thereon, and all other amounts payable hereunder as and when due in accordance with this Agreement.
2.2 Loan.
(a) Availability.
Subject to the terms and conditions of this Agreement, upon five (5) Business Days’ prior written request from Borrower, Lender
shall lend to Borrower the following (the “Loan”): (i) on the Effective Date (or as soon thereafter as the conditions
to such borrowing under Section 4.1 of this Agreement are satisfied), an amount not to exceed Five Million Dollars ($5,000,000.00)
(the “First Advance”), (ii) from the first Business Day after the two-month anniversary of the date of the Effective
Date until the six-month anniversary of the date of the First Advance and thereafter, an amount not to exceed Five Million Dollars ($5,000,000.00)
(the “Second Advance”), and (iii) on any Business Day after the earlier of (x) five-month anniversary of
the date of the Second Advance and (y) the seventh-month anniversary of the Effective Date, an amount not to exceed Three Million
Dollars ($3,000,000.00) (or such greater amount reasonably agreed by Lender and Borrower after good faith discussions, taking into consideration
the actual cash needs of Borrower for the Proceeds Purpose and Collateral coverage, among other things, but which shall not in any event
exceed Five Million Dollars ($5,000,000.00)) (the “Third Advance”). The cash proceeds of the Loan shall be used by
Borrower solely for the Proceeds Purpose. For the avoidance of doubt, the advance amounts above are cumulative, such that the total amount
of the advances could, subject to the terms and conditions of this Agreement, equal up to $15,000,000.
(b) Repayment.
Borrower shall pay to Lender in cash the entire outstanding principal amount of the Loan plus all accrued and unpaid interest and all
other outstanding Obligations on the Maturity Date. After repayment, the Loan may not be reborrowed.
(c) Prepayment.
(i) Voluntary
Prepayment. Borrower may at any time and from time to time prepay the Loan, in whole or in part, without premium or penalty, in an
aggregate principal amount that is an integral multiple of $100,000 and not less than an aggregate principal amount equal to $500,000,
provided Borrower (a) delivers written notice to Lender of its election to prepay such amount of the Loan at least three (3) Business
Days prior to such prepayment, and (b) pays in cash, on the date of such prepayment (1) the aggregate principal amount of the
Loan set forth in such written notice, plus (2) the accrued and unpaid interest on the Loan with respect to such principal amount
set forth in such written notice. Each such notice of prepayment will specify the relevant Borrowing to be prepaid, the prepayment date
and the principal amount of each Borrowing (or portion thereof) to be prepaid. Any such notice may be revocable or conditioned upon the
consummation of other transactions, in which case such notice may be revoked or postponed by the Borrower (by notice to the Lender prior
to 2:00 p.m. on the specified effective date) if such condition is not satisfied.
2.3 Payment
of Interest on the Loan.
(a) Interest
Rate. Subject to Section 2.3(b) and Section 2.3(d), the outstanding principal amount of the Loan and all interest not
paid in cash when required to be paid in cash hereunder shall accrue interest at the Applicable Rate to be set on the first day of each
semi-annual interest period. Interest shall be paid semi-annually on May 17 and November 17, with the first interest payment
date being November 17, 2023. Borrower shall have the option to either pay all accrued and unpaid interest either in cash or in kind
by adding to the aggregate outstanding principal amount of the Loan on each semi-annual interest payment date an amount equal to the amount
of interest accrued and unpaid as of such date.
(b) Default
Rate. Immediately upon the occurrence and during the continuance of an Event of Default, Borrower shall pay interest on overdue amounts
hereunder at a rate per annum equal to two percentage points (2.0%) plus the rate that is otherwise applicable thereto (the “Default
Rate”). Fees and expenses which are required to be paid by Borrower pursuant to the Loan Documents but are not paid when due
shall bear interest until paid at a rate equal to the highest rate applicable to the Obligations. Payment or acceptance of the increased
interest rate provided in this Section 2.3(b) is not a permitted alternative to timely payment and shall not constitute a waiver
of any Event of Default or otherwise prejudice or limit any rights or remedies of Lender.
(c) Interest
Computation. Interest shall be computed on the basis of a three hundred sixty (360) day year for the actual number of days elapsed.
In computing interest, (i) all payments received after 12:00 p.m. Eastern time on any day shall be deemed received at the opening
of business on the next Business Day, and (ii) the Effective Date shall be included and the date of payment shall be excluded.
(d) Maximum
Interest. Notwithstanding any provision in this Agreement or any other Loan Document, it is the parties’ intent not to contract
for, charge or receive interest at a rate that is greater than the maximum rate permissible by law that a court of competent jurisdiction
shall deem applicable hereto (which under the laws of the State of New York shall be deemed to be the laws relating to permissible rates
of interest on commercial loans) (the “Maximum Rate”). If a court of competent jurisdiction shall finally determine
that Borrower has actually paid to Lender an amount of interest in excess of the amount that would have been payable if all of the Obligations
had at all times borne interest at the Maximum Rate, then such excess interest actually paid by Borrower shall be applied as follows:
first, to the payment of the Obligations consisting of the outstanding principal; second, after all principal is repaid, to the payment
of Lender’s accrued interest, costs, expenses, professional fees and any other Obligations; and third, after all Obligations are
repaid, the excess (if any) shall be refunded to Borrower.
2.4 Fees
and Expenses. Borrower shall pay to Lender all Lender Expenses incurred after the Termination Date, within thirty (30) days after
demand by Lender.
2.5 Payments;
Application of Payments.
(a) Subject
to Section 2.3(a), all payments to be made by Borrower under any Loan Document shall be made in immediately available funds in Dollars,
without setoff or counterclaim, before 12:00 p.m. Eastern time on the date when due. Payments of principal and/or interest received
after 12:00 p.m. Eastern time are considered received at the opening of business on the next Business Day. When a payment is due
on a day that is not a Business Day, the payment shall be due the next Business Day, and additional fees or interest, as applicable, shall
continue to accrue until paid.
(b) Subject
to the terms of the Intercreditor Agreement, Lender has the exclusive right to determine the order and manner in which all payments with
respect to the Obligations may be applied. Borrower shall have no right to specify the order or the accounts to which Lender shall allocate
or apply any payments required to be made by Borrower to Lender or otherwise received by Lender under this Agreement when any such allocation
or application is not specified elsewhere in this Agreement.
3 CREATION
OF SECURITY INTEREST
3.1 Grant
of Security Interest. Borrower hereby grants Lender, to secure the payment and performance in full of all of the Obligations, a continuing
security interest in, and pledges to Lender, the Collateral, wherever located, whether now owned or hereafter acquired or arising, and
all proceeds and products thereof.
3.2 Authorization
to File Financing Statements. Borrower hereby authorizes Lender to file financing statements under the UCC, without notice to Borrower,
with all jurisdictions deemed reasonably necessary or appropriate by Lender to perfect or protect Lender’s interest or rights hereunder.
3.3 Termination.
If this Agreement is terminated, Lender’s Lien in the Collateral shall continue until the Obligations (other than inchoate indemnity
obligations) are repaid in full in cash. Upon payment in full in cash of the Obligations (other than inchoate indemnity obligations) and
at such time as Lender’s obligation to make the Loan has terminated, Lender shall, at Borrower’s sole cost and expense, terminate
its security interest in the Collateral and all rights therein shall revert to Borrower.
3.4 Further
Assurances. Borrower agrees that it will execute any further instruments and take further action as Lender reasonably requests to
perfect or continue Lender’s Lien in the Collateral.
4 CONDITIONS
OF LOAN
4.1 Conditions
Precedent to First Advance Loan. Lender’s obligation to make the First Advance is subject to the condition precedent that:
4.1.1 Lender
shall have received, in form and substance reasonably satisfactory to Lender, the following:
(a) duly
executed signatures of the Borrower to the Loan Documents;
(b) a
duly executed copy of the Merger Agreement, which shall be in full force and effect;
(c) resolutions
for Borrower approving the transactions contemplated by this Agreement and the other Loan Documents, certified as of the Effective Date
by the secretary or similar officer of Borrower as being in full force and effect without modification or amendment;
(d) UCC-1
financing statements in form reasonably satisfactory to Lender;
(e) the
consent of the lender under the Existing Credit Agreement; and
(f) Lender
shall have established a bank account within the United States, which shall occur within thirty (30) days of the Effective Date.
4.2 Conditions
to Advances of the Loan. The making of each advance of the Loan is subject to the additional conditions precedent that the Lender
shall have received, in form and substance reasonably satisfactory to Lender:
(a) no
event shall have occurred and be continuing that constitutes an Event of Default;
(b) all
representations and warranties contained in this Agreement and the other Loan Documents shall be true and correct in all material respects
(except that such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified
by materiality or Company Material Adverse Effect in the text thereof) as of the date of the applicable advance of the Loan;
(c) a
certificate of an officer of Borrower certifying that (i) the proceeds of the Loan are reasonably necessary to fund the Proceeds
Purpose as determined by the Borrower in good faith and shall be used solely for the Proceeds Purpose and (ii) the conditions precedent
to Lender’s obligation to make the Loan have been satisfied; and
(d) the
Termination Date shall not have occurred.
5 REPRESENTATIONS
AND WARRANTIES
Borrower represents and warrants
as follows:
5.1 Due
Organization, Authorization; Power and Authority. Borrower is a corporation duly organized, validly existing and in good standing
under the Laws of the State of Delaware. Borrower has all requisite corporate power and authority to: (i) conduct its business in
the manner in which its business is currently being conducted; and (ii) own and use its assets in the manner in which its assets
are currently owned and used, except where the failure to have such power or authority has not, and would not be reasonably expected to
have a Company Material Adverse Effect. Borrower is duly qualified or licensed to do business as a foreign corporation and is in good
standing in each jurisdiction where the nature of its business requires such qualification or license, except where the failure to be
so qualified or licensed or to be in good standing, would not reasonably be expected to have, individually or in the aggregate, a Company
Material Adverse Effect. Borrower’s exact legal name is that indicated in the preamble hereto and on the signature page hereof.
Section 10 accurately sets forth Borrower’s place of business, or, if more than one, its chief executive office as well as
Borrower’s mailing address (if different than its chief executive office). Borrower has not, in the past five (5) years, changed
its jurisdiction of formation, organizational structure or type, or any organizational number assigned by its jurisdiction.
The execution, delivery and
performance by Borrower of the Loan Documents to which it is a party have been duly authorized, and do not (i) conflict with any
of Borrower’s organizational documents, (ii) contravene, conflict with, constitute a default under or violate any material
Requirement of Law, or (iii) conflict with, contravene, constitute a default or breach under, or result in or permit the termination
or acceleration of, any material agreement by which Borrower is bound except for such conflicts, contraventions, defaults, breaches, termination
or acceleration under clauses (ii) or (iii) above as could not be reasonably expected to be material to the Borrower and its
Subsidiaries, taken as a whole, or to the rights of Lender under this Agreement and the other Loan Documents. This Agreement and the other
Loan Documents to which it is a party constitutes the valid and binding obligation of Borrower, enforceable against Borrower in accordance
with its terms, subject to the Bankruptcy and Equity Exception.
5.2 Merger
Agreement. The Merger Agreement represents the valid and binding obligation of Borrower, enforceable against Borrower in accordance
with its terms, subject to the Bankruptcy and Equity Exception.
5.3 Proceeds
Purpose. The proceeds of the Loan are in the Borrower’s good-faith judgement necessary to fund the operations and working capital
of Borrower and any transaction fees or other out of pocket expenses (including without limitation advisor and counsel fees relating to
the Merger Agreement or any of the transactions contemplated thereby (the “Proceeds Purpose”) and shall be used solely
for the Proceeds Purpose.
6 AFFIRMATIVE
COVENANTS
Borrower shall do all of the
following:
6.1 Approvals.
(a) Obtain
all of the approvals reasonably necessary for the performance by Borrower of its obligations under the Loan Documents to which it is a
party and the grant of a security interest to Lender in all of its property. Borrower shall promptly provide copies of any such obtained
approvals to Lender.
6.2 Information.
Provide Lender with the following:
(a) Debt
Holder Notices. Prior to the termination of the Existing Credit Agreement, promptly upon receipt or delivery thereof, copies of all
material written notices and reports received or delivered in connection with the Existing Credit Agreement.
(b) Notice
of Default. After the Effective Date, within five (5) business days of any of Borrower’s executive officers obtaining knowledge
of any condition or event which constitutes an Event of Default or that any person has given written notice to Borrower or any Affiliate
of Borrower or taken any other action with respect to a claimed Event of Default, an officer’s certificate describing the same and
the period of existence thereof and specifying what action Borrower has taken, are taking and propose to take with respect thereto.
(c) Quarterly
Certification. Within the later of (x) two (2) business days of the filing of the 10-Q or 10-K and (y) forty-five (45)
days of the last day of each fiscal quarter of Borrower (nintey (90) days in respect of the fourth fiscal quarter), a certificate in the
form attached hereto as Exhibit 1 from a financial officer of Borrower certifying the book value of assets as set forth therein (i.e.,
account receivables, inventory and fixed assets, together with each sub-line items) as may be properly classified as such in accordance
with GAAP consistently applied as of the last day of such fiscal quarter, together with such supporting documentation as Lender may reasonably
request.
(d) Other
Notices and Information. After termination of the Existing Credit Agreement, promptly upon Lender’s request therefor, such further
information reasonably related to or affecting the Collateral or the value thereof as Lender may from time to time reasonably require.
6.3 Insurance.
(a) Solely
from and after the Termination Date, until payment in full of the Obligations and termination of this Agreement, Borrower shall obtain
and maintain in effect, at Borrower’s sole expense, policies of casualty insurance (i) as more specifically set forth on Exhibit D
annexed to the Existing Credit Agreement as of the Effective Date, each of which shall have ratings of at least “A-VIII” by
A.M. Best Company or (ii) if requested by the Borrower such other policies as otherwise reasonably approved by Lender.
(b) Subject
to Section 6.5(a), Borrower shall use commercially reasonable efforts to cause all property insurance policies maintained by Borrower
to have a lender’s loss payable endorsement showing Lender as lender loss payee, all liability insurance policies shall show, or
have endorsements showing, Lender as an additional insured, and Lender shall be named as lender loss payee and/or additional insured with
respect to any such insurance providing coverage in respect of any Collateral.
(c) After
the repayment in full of the obligations under and termination of the Existing Credit Agreement, ensure that proceeds payable under any
property policy are, at Lender’s option, payable to Lender on account of the Obligations.
6.4 Use
of Proceeds. Borrower shall use the proceeds of the Loan solely for the Proceeds Purpose.
6.5 Post-Closing
Perfection Requirements.
(a) Insurance.
Within thirty (30) days (or such longer period as approved by Lender (acting in its reasonable discretion)) after the Effective Date,
Borrower shall have delivered to Lender evidence reasonably satisfactory to Lender that the insurance endorsements required by Section 6.3
hereof are in full force and effect, together with appropriate evidence showing lender loss payable and/or additional insured clauses
or endorsements in favor of Lender.
(b) Control
Agreements. Within thirty (30) days after the termination of the Existing Credit Agreement (or such longer period as approved by Lender
(acting in its reasonable discretion)), with respect to all deposit accounts and securities accounts of Borrower in to which proceeds
of Collateral are or may be deposited, Borrower shall (or thirty (30) days after opening such deposit account or securities account for
each such deposit account and securities account opened after the termination date of the Existing Credit Agreement) deliver to Lender
a control agreement fully executed by Borrower and the bank or financial institution at or with which any such deposit account or securities
account is maintained by Borrower.
(c) Landlord
Consents. After the termination of the Existing Credit Agreement, within thirty (30) days (or such longer period as approved by Lender
(acting in its reasonable discretion)) of request therefor with respect to all leased locations for which a landlord agreement or similar
agreement is reasonably requested by Lender, Borrower shall use commercially reasonable efforts to execute and deliver a landlord consent
in customary form reasonably acceptable to Lender for each of such locations executed by the respective landlord thereof.
6.6 Other
Covenants. Solely from and after the Termination Date Borrower shall:
(a) At
all times be a corporation duly organized and in good standing under the laws of the State of Delaware, be duly qualified and existing
in good standing in every other state in which the nature of Borrower’s business requires it to be qualified, except where the failure
to be so qualified would not have a Material Adverse Effect.
(b) At
all times be, with respect to all Inventory, Equipment, intellectual property, cash collateral and other Collateral, the owner thereof
free from any lien, security interest or encumbrance of any kind, except for Permitted Liens.
(c) Maintain
customary books and records relating to Borrower’s receivables and Collateral at the office as set forth in accordance with Section 10
below.
(d) Duly
pay and discharge all federal and all material state taxes, assessments, contributions and governmental charges upon or against it or
its properties or assets prior to the date on which penalties attach thereto.
(e) Cause
to be maintained at the end of each of its fiscal quarters, Tangible Net Worth in an amount not less than $13,000,000 and Working Capital
of not less than $3,500,000.
(f) Advise
Lender of the existence of any material commercial tort claims in favor of and asserted by Borrower, which advice shall be given to Lender
in writing no later than ten (10) business days after Borrower asserts such a claim in its favor.
(g) (i) Use
commercially reasonable efforts (as determined by the board of directors of Borrower) to protect, defend and maintain the validity and
enforceability of Borrower’s intellectual property; (ii) promptly advise Lender in writing of material infringements or any
other event that could reasonably be expected to materially and adversely affect the value of Borrower’s or any of its Subsidiaries’
Intellectual Property; and (iii) not allow any Intellectual Property material to Borrower’s or any of its Subsidiaries’
business to be abandoned, forfeited or dedicated to the public without Lender’s written consent.
7 NEGATIVE
COVENANTS
Borrower shall not do any
of the following without Lender’s prior written consent:
7.1 Changes
in Name, etc. Borrower shall not, without at least thirty (30) days prior written notice to Lender: (1) change its jurisdiction
of organization, (2) change its organizational structure or type, (3) change its legal name, or (4) change any organizational
number (if any) assigned by its jurisdiction of organization.
7.2 Use
of Proceeds. Use the proceeds of the Loan for any other purpose other than for the Proceeds Purposes.
7.3 Other
Covenants. Solely from and after the Termination Date, Borrower shall not:
(a) Assign,
pledge, transfer or in any way or encumber or subject to any security interest any assets, including intellectual property any other intangible
property, to any person other than Lender except for Permitted Liens and sales of inventory in the ordinary course of business and
dispositions of old or obsolete assets or assets no longer used or useable by Borrower.
(b) (i) Make
any loans or advances to officers, directors, shareholders or Affiliates; (ii) engage in any other transactions with Affiliates except
on terms similar to those that would be in effect in transactions between unrelated parties (iii) incur or repay indebtedness for
borrowed money (except indebtedness under the Existing Credit Agreement and indebtedness to CIT Technology Financing SRVC Inc. (“CIT”)
to finance Borrower’s insurance premiums) or guaranty the obligations of Affiliates or other Persons; (iv) declare any dividends,
redeem or repurchase any stock, or make any other distributions in respect of its stock; or (v) enter into any agreements to buy
or sell goods on consignment terms.
(c) (i) Conduct
any business or engage in any transaction or dealing with any Blocked Person (as hereafter defined), including the making or receiving
of any contribution of funds, goods or services to or for the benefit of any Blocked Person; (ii) deal in, or otherwise engage
in any transaction relating to any property or interests in property blocked pursuant to Executive Order No. 13224; or (iii) engage
in or conspire to engage in any transaction that evades or avoids, or has the purpose of evading or avoiding, or attempts to violate,
any of the prohibitions set forth in Executive Order No. 13224, the USA Patriot Act or any other Anti-Terrorism Law. Borrower shall
deliver to Lender any certification or other evidence requested from time to time by Lender in its sole discretion, confirming Borrower’s
compliance with this Section. Borrower is not in violation of any Anti-Terrorism Law and Borrower is not a Person (a “Blocked
Person”) that (a) is listed in the annex to, or is otherwise subject to the provisions of, Executive Order No. 13224;
(b) is owned or controlled by, or acting for or on behalf of, any Person that is listed in the annex to, or is otherwise subject
to the provisions of, Executive Order No. 13224; (c) any financial institution is prohibited from dealing or otherwise
engaging in any transaction by any Anti-Terrorism Law; (d) commits, threatens or conspires to commit or supports “terrorism”
as defined in Executive Order No. 13224; (e) is named as a “specially designated national” on the most current
list published by the U.S. Treasury Department Office of Foreign Asset Control at its official website or any replacement website or other
replacement official publication of such list, or is affiliated or associated with a person or entity listed above; (f) conducts
any business or engages in making or receiving any contribution of funds, goods or services to or for the benefit of any Blocked Person,
or deals in, or otherwise engages in any transaction relating to, any property or interests in property blocked pursuant to Executive
Order No. 13224. For purposes of this Section 7.3(c), (i) “Anti-Terrorism Laws” shall mean any laws, regulations,
rules, orders and directives relating to terrorism or money laundering, including Executive Order No. 13224, the USA Patriot Act,
the Laws comprising or implementing the Bank Secrecy Act, and the Law administered by the United States Treasury Department’s Office
of Foreign Asset Control (as any of the foregoing laws, regulations, rules, orders and directives may from time to time be amended, renewed,
extended, or replaced); (ii) “Executive Order No. 13224” shall mean Executive Order No. 13224 on
Terrorist Financing, effective September 24, 2001, as the same has been, or shall hereafter be, renewed, extended, amended or replaced;
and (iii) “USA Patriot Act” shall mean the Uniting and Strengthening America by Providing Appropriate Tools Required
to Intercept and Obstruct Terrorism Act of 2001, Public Law 107-56, as the same has been, or shall hereafter be, renewed, extended, amended
or replaced.
8 EVENTS
OF DEFAULT
Any one of the following shall
constitute an event of default (an “Event of Default”) under this Agreement:
8.1 Payment
Default. Borrower fails to (a) make any payment of principal on the Loan when due, or (b) pay interest on the Loan or any
other amount due under any Loan Document (other than an amount referred to in clause (a) of this Section 8.1), when and as the
same becomes due and payable, and such default continues unremedied for a period of five (5) Business Days; or
8.2 Covenant
Default. Borrower fails to perform or observe any covenant or agreement contained in this Agreement or any other Loan Documents (other
than as set forth in Section 8.1 above), and such default shall continue unremedied for a period of 30 days after the earlier of
the date on which (x) any executive officer of the Borrower becomes actually aware of such failure or (y) written notice thereof
shall have been given to the Borrower from Lender.
8.3 Insolvency.
(a) Borrower or any of its Subsidiaries is unable to pay its debts (including trade debts) as they become due or otherwise becomes
insolvent; (b) Borrower or any of its Subsidiaries begins an Insolvency Proceeding; or (c) an Insolvency Proceeding is commenced
against Borrower or any of its Subsidiaries and is not dismissed or stayed within forty-five (45) days;
8.4 Other
Agreements. There is, at any time after the occurrence of the Termination Date, prior to the termination of the Existing Credit Agreement,
to the extent not cured, waived or forebeared within thirty (30) days after any default resulting (a) in a right by any third party
or parties under the Existing Credit Agreement, whether or not exercised, to accelerate the maturity of any obligations under the Existing
Credit Agreement or (b) from the failure to repay any monetary obligations under the Existing Credit Agreement upon the maturity
thereof;
8.5 Misrepresentations.
Borrower makes any representation or warranty, in this Agreement or any other Loan Document, and such representation, warranty, or other
statement is incorrect in any material respect when made; provided that, to the extent such representation or warranty is capable of being
cured, such default shall continue unremedied for a period of thirty (30) days’ notice after written notice thereof from the Lender
to the Borrower;
8.6 Change
in Control. There occurs a Change in Control.
8.7 Other
Defaults. Solely from and after the Termination Date, any of the following events shall have occurred and have continued unremedied
for a period of thirty (30) days (or such longer period as approved by Lender in its discretion):
(a) Borrower
shall fail to pay when due any indebtedness for borrowed money in an amount exceeding $500,000 beyond any applicable grace period;
(b) One
or more fines, penalties, attachments, levies, or final judgments, orders or decrees for the payment of money in an amount, individually
or in the aggregate, of more than $500,000 (not covered by independent third-party insurance) shall be rendered against Borrower by any
Governmental Authority, assessment or issuance thereof, discharged, satisfied, or paid, or after execution thereof, stayed or bonded pending
appeal, or such judgments are not discharged prior to the expiration of any such stay;
(c) A
material portion of any tangible Collateral for the Obligations is destroyed or lost or rendered valueless (unless subject to insurance
coverage);
(d) (x) Borrower
shall default in the payment under the terms of any present or future lease (each a “Lease”)
of any material premises now or hereafter leased by Borrower (“Material
Leased Premises”) except for such payment defaults or breaches as are being disputed in good faith by appropriate proceedings
and for which adequate reserves are maintained by Borrower in accordance with GAAP (a “Permitted Dispute”) or (y) Lender
shall receive notice from any lessor of any Material Leased Premises that a payment default has occurred under any Lease for Material
Leased Premises other than defaults that are subject to a Permitted Dispute; or
(e) Any
employee benefit plan of Borrower subject to the Employee Retirement Income Security Act is completely or partially involuntarily terminated
or the Pension Benefit Guaranty Corporation commences proceedings for the purpose of effecting any such termination or an event or circumstance
occurs which could result in any such termination and such would, in each case, have a material effect on the Borrower and its Subsidiaries
taken as whole.
9 LENDER’S
RIGHTS AND REMEDIES
9.1 Rights
and Remedies. Upon the occurrence and during the continuance of an Event of Default, Lender may, without notice or demand, do any
or all of the following:
(a) declare
all Obligations immediately due and payable (but if an Event of Default described in Section 8.3(b) or (c) occurs, all
Obligations are immediately due and payable without any action by Lender);
(b) stop
advancing money or extending credit for Borrower’s benefit under this Agreement;
(c) verify
the amount of, demand payment of and performance under, and collect any accounts receivable and general intangibles (other than any intellectual
property), settle or adjust disputes and claims directly with account debtors for amounts on terms and in any order that Lender considers
advisable, and notify any Person owing Borrower money of Lender’s security interest in such funds;
(d) make
any payments and do any acts it considers necessary or reasonable to protect the Collateral and/or its security interest in the Collateral.
Borrower shall assemble the Collateral if Lender requests and make it available as Lender designates. Lender may enter premises where
the Collateral is located, take and maintain possession of any part of the Collateral, and pay, purchase, contest, or compromise any Lien
which appears to be prior or superior to its security interest and pay all expenses incurred. Borrower grants Lender a license to enter
and occupy any of its premises, without charge, to exercise any of Lender’s rights or remedies;
(e) ship,
reclaim, recover, store, finish, maintain, repair, prepare for sale, advertise for sale, and sell the Collateral. Lender is hereby granted
a non-exclusive, royalty-free license or other right to use, without charge, Borrower’s labels, patents, copyrights, mask works,
rights of use of any name, trade secrets, trade names, trademarks, and advertising matter, or any similar property as it pertains to the
Collateral, in completing production of, advertising for sale, and selling any Collateral and, in connection with Lender’s exercise
of its rights under this Section, Borrower’s rights under all licenses and all franchise agreements inure to Lender’s benefit;
(f) exercise
all rights and remedies available to Lender under the Loan Documents or at law or equity, including all remedies provided under the Code
(including disposal of the Collateral pursuant to the terms thereof).
9.2 Protective
Payments. If Borrower fails to obtain the insurance called for by Section 6.3 or fails to pay any premium thereon or fails to
pay any other amount which Borrower is obligated to pay under this Agreement or any other Loan Document or which may be required to preserve
the Collateral, Lender may obtain such insurance or make such payment, and all amounts so paid by Lender are Lender Expenses and immediately
due and payable, bearing interest at the then highest rate applicable to the Obligations, and secured by the Collateral. Lender will make
reasonable efforts to provide Borrower with prior written notice of Lender obtaining such insurance. No payments by Lender are deemed
an agreement to make similar payments in the future or Lender’s waiver of any Event of Default.
9.3 Application
of Payments and Proceeds Upon Default. Subject to the terms of the Intercreditor Agreement, if an Event of Default has occurred and
is continuing, Lender shall have the right to apply in any order any funds in its possession, whether from Borrower account balances,
payments, proceeds realized as the result of any collection of accounts or other disposition of the Collateral, or otherwise, to the Obligations.
Lender shall pay any surplus to Borrower or to other Persons legally entitled thereto; Borrower shall remain liable to Lender for any
deficiency. If Lender, directly or indirectly, enters into a deferred payment or other credit transaction with any purchaser at any sale
of Collateral, Lender shall have the option, exercisable at any time, of either reducing the Obligations by the principal amount of the
purchase price or deferring the reduction of the Obligations until the actual receipt by Lender of cash therefor.
9.4 Lender’s
Liability for Collateral. So long as Lender complies with reasonable banking and business practices regarding the safekeeping of the
Collateral in the possession or under the control of Lender, Lender shall not be liable or responsible for: (a) the safekeeping of
the Collateral; (b) any loss or damage to the Collateral; (c) any diminution in the value of the Collateral; or (d) any
act or default of any carrier, warehouseman, bailee, or other Person. Borrower bears all risk of loss, damage or destruction of the Collateral.
9.5 No
Waiver; Remedies Cumulative. Lender’s failure, at any time or times, to require strict performance by Borrower of any provision
of this Agreement or any other Loan Document shall not waive, affect, or diminish any right of Lender thereafter to demand strict performance
and compliance herewith or therewith. No waiver hereunder shall be effective unless signed by the party granting the waiver and then is
only effective for the specific instance and purpose for which it is given. Lender’s rights and remedies under this Agreement and
the other Loan Documents are cumulative. Lender has all rights and remedies provided under the Code, by law, or in equity. Lender’s
exercise of one right or remedy is not an election and shall not preclude Lender from exercising any other remedy under this Agreement
or other remedy available at law or in equity, and Lender’s waiver of any Event of Default is not a continuing waiver. Lender’s
delay in exercising any remedy is not a waiver, election, or acquiescence.
9.6 Demand
Waiver. Borrower waives demand, notice of default or dishonor, notice of payment and nonpayment, notice of any default, nonpayment
at maturity, release, compromise, settlement, extension, or renewal of accounts, documents, instruments, chattel paper, and guarantees
held by Lender on which Borrower is liable.
10 NOTICES
All notices, consents, requests,
approvals, demands, or other communication by any party to this Agreement or any other Loan Document must be in writing and shall be deemed
to have been validly served, given, or delivered: (a) upon the earlier of actual receipt and three (3) Business Days after deposit
in the U.S. mail, first class, registered or certified mail return receipt requested, with proper postage prepaid; (b) upon transmission,
when sent by electronic mail or facsimile transmission; (c) one (1) Business Day after deposit with a reputable overnight courier
with all charges prepaid; or (d) when delivered, if hand-delivered by messenger, all of which shall be addressed to the party to
be notified and sent to the address, facsimile number, or email address indicated below. Lender or Borrower may change its mailing or
electronic mail address or facsimile number by giving the other party written notice thereof in accordance with the terms of this Section 10.
If to Borrower: |
eMagin Corporation |
|
700 South Drive, Suite 201 |
|
Hopewell Junction, NY 12533 |
|
Attn: |
|
Email: |
|
|
|
With a copy to: |
|
White & Case LLP |
|
1221 Avenue of the Americas |
|
New York, New York 10020 |
|
Attn: John Reiss; Ross Sturman |
|
Email: jreiss@whitecase.com; ross.sturman@whitecase.com |
|
|
If to Lender: |
Emerald Intermediate, Inc. |
|
c/o Samsung Display Co., Ltd. |
|
1 Samsung-Ro, Giheung-Gu |
|
Yong-In City, Gyeonggi-Do, Korea 17113 |
|
Attn: |
|
Email: |
|
|
|
With a copy to: |
|
O’Melveny & Myers LLP |
|
23/F Meritz Tower |
|
382 Gangnam-daero |
|
Gangnam-gu, Seoul, Korea 06232 |
|
Attention: Daniel Kim |
|
Email: dkim@omm.com |
|
|
|
and |
|
|
|
O’Melveny & Myers LLP |
|
2765 Sand Hill Road |
|
Menlo Park, CA 94025 |
|
Attention: Brad Finkelstein; Noah Kornblith |
|
Email: bfinkelstein@omm.com; nkornblith@omm.com |
11 CHOICE
OF LAW, VENUE and JURY TRIAL WAIVER
Except as otherwise expressly provided in any of
the Loan Documents, New York law governs the Loan Documents without regard to principles of conflicts of law. Borrower and Lender each
submit to the exclusive jurisdiction of exclusively in the Delaware Court of Chancery, or, if the Delaware Court of Chancery declines
to accept jurisdiction over a particular matter, any federal court within the State of Delaware, or, if both the Delaware Court of Chancery
and the federal courts within the State of Delaware decline to accept jurisdiction over a particular matter, any other state court within
the State of Delaware, and, in each case, any appellate court therefrom; provided, however, that nothing in this Agreement shall be deemed
to operate to preclude Lender from bringing suit or taking other legal action in any other jurisdiction to realize on the Collateral or
any other security for the Obligations, or to enforce a judgment or other court order in favor of Lender. Borrower expressly submits and
consents in advance to such jurisdiction in any action or suit commenced in any such court, and Borrower hereby waives any objection that
it may have based upon lack of personal jurisdiction, improper venue, or forum non conveniens and hereby consents to the granting of such
legal or equitable relief as is deemed appropriate by such court. Borrower hereby waives personal service of the summons, complaints,
and other process issued in such action or suit and agrees that service of such summons, complaints, and other process may be made by
registered or certified mail addressed to Borrower at the address set forth in, or subsequently provided by Borrower in accordance with,
Section 10 of this Agreement and that service so made shall be deemed completed upon the earlier to occur of Borrower’s actual
receipt thereof or three (3) days after deposit in the U.S. mails, proper postage prepaid.
TO THE FULLEST EXTENT PERMITTED
BY APPLICABLE LAW, BORROWER AND LENDER EACH WAIVE THEIR RIGHT TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION ARISING OUT OF OR BASED
UPON THIS AGREEMENT, THE LOAN DOCUMENTS OR ANY CONTEMPLATED TRANSACTION, INCLUDING CONTRACT, TORT, BREACH OF DUTY AND ALL OTHER CLAIMS.
THIS WAIVER IS A MATERIAL INDUCEMENT FOR BOTH PARTIES TO ENTER INTO THIS AGREEMENT. EACH PARTY HAS REVIEWED THIS WAIVER WITH ITS COUNSEL.
This Section 11 shall
survive the termination of this Agreement.
12 GENERAL
PROVISIONS
12.1 Termination
Prior to Maturity Date; Survival. All covenants, representations and warranties made in this Agreement continue in full force until
this Agreement has terminated pursuant to its terms and all Obligations have been satisfied. Those obligations that are expressly specified
in this Agreement as surviving this Agreement’s termination shall continue to survive notwithstanding this Agreement’s termination.
12.2 Successors
and Assigns. This Agreement binds and is for the benefit of the successors and permitted assigns of each party. Borrower may not assign
this Agreement or any rights or obligations under it without Lender’s prior written consent (which may be granted or withheld in
Lender’s sole discretion). Lender may not without the consent of Borrower (which may be granted or withheld in Borrower’s
sole discretion), sell, transfer, assign, negotiate, or grant participation in all or any part of, or any interest in, Lender’s
obligations, rights, and benefits under this Agreement and the other Loan Documents; provided that no such consent shall be required to
sell, transfer, assign, negotiate or grant a participation to an affiliate of Lender.
12.3 Confidentiality.
In handling any confidential information, Lender shall exercise the same degree of care that it exercises for its own proprietary information,
but disclosure of information may be made: (a) to Lender’s Subsidiaries or Affiliates (such Subsidiaries and Affiliates, together
with Lender, collectively, “Lender Entities”); (b) as required by law, regulation, subpoena, legal process, or
other order; (d) to Lender’s regulators or as otherwise required or requested in connection with Lender’s examination
or audit; (e) as Lender considers appropriate in exercising remedies under the Loan Documents; and (f) to third-party service
providers of Lender so long as such service providers have executed a confidentiality agreement with Lender with terms no less restrictive
than those contained herein or are otherwise subject to professional obligations of confidentiality. Confidential information does not
include information that is either: (i) in the public domain or in Lender’s possession when disclosed to Lender (unless subject
to another confidentiality agreement with the Borrower), or becomes part of the public domain (other than as a result of its disclosure
by Lender in violation of this Agreement) after disclosure to Lender; or (ii) disclosed to Lender by a third party, if Lender does
not know that the third party is prohibited from disclosing the information. Lender acknowledges that it is aware that the United States
securities laws prohibit any person who has material non-public information about a company from purchasing or selling securities of such
company, or from communicating such information to any other person under circumstances in which it is reasonably foreseeable that such
person is likely to purchase or sell such securities
12.4 Indemnification.
Borrower agrees to indemnify, defend and hold Lender and its directors, officers, employees, agents, attorneys, or any other Person affiliated
with or representing Lender (each, an “Indemnified Person”) harmless against all obligations, demands, claims, and
liabilities (collectively, “Claims”) claimed or asserted by any other party in connection with the transactions contemplated
by the Loan Documents, except for Claims and/or losses directly caused by such Indemnified Person’s gross negligence or willful
misconduct. This Section 12.4 shall survive until all statutes of limitation with respect to the Claims, losses, and expenses for
which indemnity is given shall have run.
12.5 Severability
of Provisions. Each provision of this Agreement is severable from every other provision in determining the enforceability of any provision.
12.6 Amendments
in Writing; Waiver; Integration. No purported amendment or modification of any Loan Document, or waiver, discharge or termination
of any obligation under any Loan Document, shall be enforceable or admissible unless, and only to the extent, expressly set forth in a
writing signed by the party against which enforcement or admission is sought. Without limiting the generality of the foregoing, no oral
promise or statement, nor any action, inaction, delay, failure to require performance or course of conduct shall operate as, or evidence,
an amendment, supplement or waiver or have any other effect on any Loan Document. Any waiver granted shall be limited to the specific
circumstance expressly described in it, and shall not apply to any subsequent or other circumstance, whether similar or dissimilar, or
give rise to, or evidence, any obligation or commitment to grant any further waiver. The Loan Documents represent the entire agreement
about this subject matter and supersede prior negotiations or agreements. All prior agreements, understandings, representations, warranties,
and negotiations between the parties about the subject matter of the Loan Documents merge into the Loan Documents.
12.7 Counterparts.
This Agreement may be executed in any number of counterparts and by different parties on separate counterparts, each of which, when executed
and delivered, is an original, and all taken together, constitute one Agreement.
12.8 Electronic
Execution of Documents. The words “execution,” “signed,” “signature” and words of like import
in any Loan Document shall be deemed to include electronic signatures or the keeping of records in electronic form, each of which shall
be of the same legal effect, validity and enforceability as a manually executed signature or the use of a paper-based recordkeeping systems,
as the case may be, to the extent and as provided for in any applicable law, including, without limitation, any state law based on the
Uniform Electronic Transactions Act.
12.9 Captions.
The headings used in this Agreement are for convenience only and shall not affect the interpretation of this Agreement.
12.10 Construction
of Agreement. The parties mutually acknowledge that they and their attorneys have participated in the preparation and negotiation
of this Agreement. In cases of uncertainty this Agreement shall be construed without regard to which of the parties caused the uncertainty
to exist.
12.11 Relationship.
The relationship of the parties to this Agreement is determined solely by the provisions of this Agreement. The parties do not intend
to create any agency, partnership, joint venture, trust, fiduciary or other relationship with duties or incidents different from those
of parties to an arm’s-length contract.
12.12 Third
Parties. Nothing in this Agreement, whether express or implied, is intended to: (a) confer any benefits, rights or remedies under
or by reason of this Agreement on any persons other than the express parties to it and their respective permitted successors and assigns;
(b) relieve or discharge the obligation or liability of any person not an express party to this Agreement; or (c) give any person
not an express party to this Agreement any right of subrogation or action against any party to this Agreement.
12.13 Intercreditor
Agreement. Nothing in this Agreement to the contrary, (a) Lender agrees that it will be bound by and will take no actions contrary
to the provisions of the Intercreditor Agreement and (b) in the event of any conflict or inconsistent between the provisions of the
Intercreditor Agreement and this Agreement, the provisions of the Intercreditor Agreement shall control in all respects.
12.14 Lender/Parent
Covenants.
(a) Lender
shall establish a bank account referred to in Section 4.1.1(f) above within the United States as soon as reasonably practicable
(but in any event within thirty (30) days of the Effective Date).
(b) Upon
the request of the Borrower, if the Existing Credit Agreement is refinanced or replaced pursuant to the definition of “Existing
Credit Agreement” (any such refinancing or replacement, a “New Facility”), Lender shall execute and deliver an
intercreditor agreement or subordination agreement, as applicable and substantially in the same form as the Intercreditor Agreement (or
as otherwise reasonably acceptable to Lender), with Borrower and the applicable agent, debt representative and/or lender(s) with
respect to such New Facility.
(c) Parent
agrees to send to Lender in immediately available funds: (i) no less than the amount of the First Advance within five (5) Business
Days after Lender has established the bank account referred to in Section 4.1.1(f), (ii) no less than the amount of the Second
Advance at least one (1) Business Day prior to the two-month anniversary of the Effective Date, and (iii) no less than the amount
of the Third Advance at least one (1) Business Day prior to the earlier of (x) five-month anniversary of the date of the Second
Advance and (y) the seventh-month anniversary of the Effective Date.
13 DEFINITIONS
13.1 Definitions.
As used in the Loan Documents, the word “shall” is mandatory, the word “may” is permissive, the word “or”
is not exclusive, the words “includes” and “including” are not limiting, the singular includes the plural, and
numbers denoting amounts that are set off in brackets are negative. As used in this Agreement, the following capitalized terms have the
following meanings:
“Affiliate”
is, with respect to any Person, each other Person that owns or controls directly or indirectly the Person, any Person that controls or
is controlled by or is under common control with the Person, and each of that Person’s senior executive officers, directors, partners
and, for any Person that is a limited liability company, that Person’s managers and members.
“Agreement”
is defined in the preamble hereof.
“Applicable Rate”
means the rate per annum equal to the Prime Rate.
“Bankruptcy and Equity
Exception” is defined in the Merger Agreement.
“Bankruptcy Code”
is Title 11 of the United States Code entitled “Bankruptcy”.
“Blocked Person”
is defined in Section 7.3(c).
“Borrower”
is defined in the preamble hereof.
“Business Day”
is any day that is not a Saturday, Sunday or a day on which Lender is closed.
“Change in Control”
means at any time, any “person” or “group” (as such terms are used in Sections 13(d) and 14(d) of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”)) (other than any shareholder of the Borrower on the
date hereof), shall become, the “beneficial owner” (as defined in Rules 13(d)-3 and 13(d)-5 under the Exchange Act),
directly or indirectly, of twenty-five percent (25%) or more of the ordinary voting power for the election of directors of Borrower (determined
on a fully diluted basis) other than by the sale of Borrower’s equity securities in a public offering (or a “PIPE” or
similar transaction to unaffiliated third-parties); provided, however, that the consummation of the transactions under the Merger Agreement
shall not constitute a Change in Control.
“CIT” is
defined in Section 7.3(b).
“Claims”
is defined in Section 12.4.
“Closing”
is defined in the Merger Agreement.
“Code”
is the Uniform Commercial Code, as the same may, from time to time, be enacted and in effect in the State of New York; provided, that,
to the extent that the Code is used to define any term herein or in any Loan Document and such term is defined differently in different
Articles or Divisions of the Code, the definition of such term contained in Article or Division 9 shall govern; provided further,
that in the event that, by reason of mandatory provisions of law, any or all of the attachment, perfection, or priority of, or remedies
with respect to, Lender’s Lien on any Collateral is governed by the Uniform Commercial Code in effect in a jurisdiction other than
the State of New York, the term “Code” shall mean the Uniform Commercial Code as enacted and in effect in such other
jurisdiction solely for purposes of the provisions thereof relating to such attachment, perfection, priority, or remedies and for purposes
of definitions relating to such provisions.
“Collateral”
is “Collateral” as defined in the Existing Credit Agreement as of the date hereof; provided, however, that Collateral shall
not include intellectual property.
“Company Material
Adverse Effect” has the meaning assigned to such term in the Merger Agreement solely with respect to clause (b) therein.
“Current Assets”
shall mean, at a particular date, all amounts which would, in conformity with GAAP, be included under current assets on a balance sheet
of Borrower, as at such date, including but not limited to (i) cash and cash equivalents, (ii) accounts, (iii) inventory;
and (iv) prepaid current assets of Borrower provided however, that such amounts shall not include any amounts for any indebtedness
owing by any Affiliate to Borrower.
“Current Liabilities”
shall mean, at a particular date, all amounts which would, in conformity with GAAP, be included under current liabilities on a balance
sheet of Borrower, as at such date, but in any event including, without duplications, the amounts of (a) all indebtedness payable
on demand, or at the option of the person or entity to whom such indebtedness is owed, not more than twelve (12) months after such date,
(b) any payments in respect of any indebtedness (whether installment, serial maturity, sinking fund payment or otherwise) required
to be made not more than twelve (12) months after such date, (c) all reserves in respect of liabilities or indebtedness payable on
demand or, at the option of the person or entity to whom such indebtedness is owed, not more than twelve (12) months after such date,
the validity which is not contested to such date, and (d) all accruals for federal or other taxes measured by income payable within
twelve (12) months of such date.
“Default Rate”
is defined in Section 2.3(b).
“Dollars,”
“dollars” or use of the sign “$” means only lawful money of the United States and not any other
currency, regardless of whether that currency uses the “$” sign to denote its currency or may be readily converted into lawful
money of the United States.
“Effective Date”
is defined in the preamble hereof.
“Event of Default”
is defined in Section 8.
“Exchange Act”
is defined in the definition of “Change in Control”.
“Existing Credit
Agreement” is that certain Financing Agreement dated as of December 29, 2016, between Borrower, as borrower, and Rosenthal &
Rosenthal, Inc., as lender, as of the date hereof, and any refinancing, refunding, extension, renewal, or replacement as of the date
of such refinancing, refunding, extension, renewal, or replacement, so long as such refinancing, refunding, extension, renewal, or replacement
is entered into on an arm’s length basis with any bank, financial institution or other party in the business of making commercial
loans who is not an Affiliate of Borrower.
“First Advance”
is defined in Section 2.2(a).
“GAAP”
is generally accepted accounting principles set forth in the opinions and pronouncements of the Accounting Principles Board of the American
Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board or in such other
statements by such other Person as may be approved by a significant segment of the accounting profession, which are applicable to the
circumstances as of the date of determination.
“Governmental Authority”
is any nation or government, any state or other political subdivision thereof, any agency, authority, instrumentality, regulatory body,
court, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative functions of or
pertaining to government, any securities exchange and any self-regulatory organization.
“Indemnified Person”
is defined in Section 12.4.
“Insolvency Proceeding”
is any proceeding by or against any Person under the Bankruptcy Code, or any other bankruptcy or insolvency law, including assignments
for the benefit of creditors, compositions, extensions generally with its creditors, or proceedings seeking reorganization, arrangement,
or other similar relief.
“Intercreditor Agreement”
means that certain Letter Agreement Re: eMagin Corporation, dated as of the Effective Date, by and among Rosenthal & Rosenthal, Inc.,
Lender and Borrower, as amended, restated, supplemented or otherwise modified from time to time, which shall be substantially in the form
attached hereto as Exhibit 2.
“Lease”
is defined in Section 8.7(d).
“Lender”
is defined in the preamble hereof.
“Lender Entities”
is defined in Section 12.3.
“Lender Expenses”
are all reasonable and documented out-of-pocket fees and expenses (including attorneys’ fees and expenses) for enforcing the Loan
Documents (including, without limitation, those incurred in connection with appeals or Insolvency Proceedings).
“Lien”
is a claim, mortgage, deed of trust, levy, charge, pledge, security interest or other encumbrance of any kind, whether voluntarily incurred
or arising by operation of law or otherwise against any property.
“Loan”
is defined in Section 2.2(a).
“Loan Documents”
are, collectively, this Agreement, the Intercreditor Agreement, and any schedules, exhibits, certificates, notices, and any other documents
related to any of the foregoing, any subordination agreement, any note, or notes or guaranties executed by Borrower or any other Person,
any collateral documents granting or perfecting a Lien in favor of Lender to secure the Obligations and any other present or future agreement
by Borrower with or for the benefit of Lender in connection with this Agreement, all as amended, restated, or otherwise modified.
“Material Adverse
Effect” shall mean a fact, occurrence, act or omission pending or applying to the Borrower, any subsidiary of Borrower or any
of their assets, or which in the opinion of Lender, if adversely determined, could have a material adverse effect on (i) the business,
operations, results of operations, assets, liabilities or condition (financial or otherwise) of Borrower, (ii) Borrower’s ability
to perform its obligations under this Agreement or any loan document to which it is a party, (iii) the ability of Lender to enforce
the Obligations, or (iv) the value of the Collateral taken as a whole.
“Material Leased
Premises” is defined in Section 8.7(d).
“Maturity Date”
is the date that is the earlier of (i) five (5) years after the Termination Date and (ii) five (5) years after the
Outside Date (as defined in the Merger Agreement)].
“Maximum Rate”
is defined in Section 2.3(d).
“Merger Agreement”
is that certain Agreement and Plan of Merger dated as of May 17, 2023, by and among Samsung Display Co., Ltd., Lender, Emerald
Merger Sub, Inc., and Borrower, as amended or modified from time to time.
“New Facility”
is defined in Section 12.14(b).
“Obligations”
are Borrower’s obligations to pay when due any debts, principal, interest, fees, Lender Expenses, and other amounts Borrower owes
Lender now or later, whether under this Agreement, the other Loan Documents, or otherwise, and including interest accruing after Insolvency
Proceedings begin, and to perform Borrower’s duties under the Loan Documents.
“Parent”
is defined in the preamble hereof.
“Permitted Dispute”
is defined in Section 8.7(d).
“Permitted Liens”
are:
(a) the security interests
and liens of Lender;
(b) liens securing the
payment of taxes, assessments or other governmental charges or levies either not yet overdue or the validity of which are being contested
in good faith by appropriate proceedings diligently pursued and available to such Borrower, or Guarantor or Subsidiary, as the case may
be and with respect to which adequate reserves have been set aside on its books;
(c) non-consensual statutory
liens (other than liens securing the payment of taxes) arising in the ordinary course of such Borrower's or Guarantor’s business
to the extent: (i) such liens secure indebtedness which is not overdue or (ii) such liens secure indebtedness relating to claims
or liabilities which are fully insured and being defended at the sole cost and expense and at the sole risk of the insurer or being contested
in good faith by appropriate proceedings diligently pursued and available to such Borrower or Guarantor, in each case prior to the commencement
of foreclosure or other similar proceedings and with respect to which adequate reserves have been set aside on its books;
(d) zoning restrictions,
easements, licenses, covenants and other restrictions affecting the use of real property which do not interfere in any material respect
with the use of such real property or ordinary conduct of the business of such Borrower as presently conducted thereon or materially impair
the value of the real property which may be subject thereto;
(e) purchase money security
interests in machinery and equipment (including capital leases where the landlord has signed a subordination agreement/waiver acceptable
to Lender);
(f) pledges and deposits
of cash by any Borrower after the date hereof in the ordinary course of business in connection with workers' compensation, unemployment
insurance and other types of social security benefits consistent with the current practices of such Borrower as of the date hereof;
(g) pledges and deposits
of cash by Borrower after the date hereof to secure the performance of tenders, bids, leases, trade contracts (other than for the repayment
of indebtedness), statutory obligations and other similar obligations in each case in the ordinary course of business consistent with
the current practices of Borrower as of the date hereof; provided, that, in connection with any performance bonds issued by a surety
or other person, the issuer of such bond shall have waived in writing any rights in or to, or other interest in, any of the Collateral
in an agreement, in form and substance satisfactory to Lender;
(h) liens arising from
(i) operating leases and the precautionary UCC financing statement filings (satisfactory to Lender) in respect thereof and (ii) equipment
or other materials which are not owned by Borrower located on the premises of the Borrower (but not in connection with, or as part of,
the financing thereof) from time to time in the ordinary course of business and consistent with current practices of the Borrower and
the precautionary UCC financing statement filings (satisfactory to Lender) in respect thereof;
(i) judgments and other
similar liens arising in connection with court proceedings that do not constitute an Event of Default, provided, that, (i) such liens
are being contested in good faith and by appropriate proceedings diligently pursued, (ii) adequate reserves or other appropriate
provision, if any, as are required by GAAP have been made therefor, and (iii) a stay of enforcement of any such liens is in effect;
(j) liens on proceeds
of insurance in favor of CIT securing payment of the Borrower’s premiums for insurance; and
(k) the Liens securing
the obligations under the Existing Credit Agreement.
“Person”
is any individual, sole proprietorship, partnership, limited liability company, joint venture, company, trust, unincorporated organization,
association, corporation, institution, public benefit corporation, firm, joint stock company, estate, entity or government agency.
“Prime Rate”
is the prime rate as published in the Wall Street Journal (or if not, available, such other source reasonably selected by Lender); provided,
however, that in no event shall the Prime Rate be less than 0.0%.
“Proceeds Purpose”
is defined in Section 5.3.
“Requirement of Law”
is as to any Person, the organizational or governing documents of such Person, and any law (statutory or common), treaty, rule or
regulation or determination of an arbitrator or a court or other Governmental Authority, in each case applicable to or binding upon such
Person or any of its property or to which such Person or any of its property is subject.
“Second Advance”
is defined in Section 2.2(a).
“Subsidiary”
is, as to any Person, a corporation, partnership, limited liability company or other entity of which shares of stock or other ownership
interests having ordinary voting power (other than stock or such other ownership interests having such power only by reason of the happening
of a contingency) to elect a majority of the board of directors or other managers of such corporation, partnership or other entity are
at the time owned, or the management of which is otherwise controlled, directly or indirectly through one or more intermediaries, or both,
by such Person. Unless the context otherwise requires, each reference to a Subsidiary herein shall be a reference to a Subsidiary of Borrower.
“Tangible Net Worth”
is, at a particular date (a) the aggregate amount of all assets of Borrower as may be properly classified as such in accordance with
GAAP consistently applied excluding such other assets as are properly classified as intangible assets under GAAP, less (b) the aggregate
amount of all liabilities of Borrower (excluding (i) subordinated liabilities to Lender, (ii) the Obligations, and (iii) the
obligations under the Existing Credit Agreement) determined in accordance with GAAP.
“Termination Date”
is the date on which the Merger Agreement is terminated pursuant to Article VIII thereof.
“Third Advance”
is defined in Section 2.2(a).
“Working Capital”
shall mean the excess, if any, of Current Assets less Current Liabilities.
[Balance of Page Intentionally Left
Blank]
IN WITNESS WHEREOF,
the parties hereto have caused this Agreement to be executed as of the Effective Date.
BORROWER: |
|
|
|
EMAGIN CORPORATION |
|
|
|
By: |
/s/ Andrew G. Sculley |
|
|
|
Name: |
Andrew G. Sculley |
|
|
|
Title: |
Chief Executive Officer |
|
|
|
|
|
LENDER: |
|
|
|
EMERALD INTERMEDIATE, INC. |
|
|
|
By: |
/s/ Seo Young Son |
|
|
|
Name: |
Seo Young Son |
|
|
|
Title: |
President and Chief Executive Officer |
|
PARENT: |
|
|
|
SAMSUNG DISPLAY CO., LTD. |
|
|
|
By: |
/s/ Kwonyoung Choi |
|
|
|
Name: |
Kwonyoung Choi |
|
|
|
Title: |
Executive Vice President and Chief Strategy Officer |
|
EXHIBIT 1
TANGIBLE ASSET VALUE CERTIFICATE
EXHIBIT 2
Intercreditor Agreement
See attached
Exhibit 99.1
eMagin Enters Into Definitive Merger Agreement With Samsung Display
eMagin Shareholders to Receive $2.08 Per Share
in a Transaction Valued at Approximately $218 Million
HOPEWELL
JUNCTION, N.Y. – May 17, 2023 – eMagin Corporation (NYSE American: EMAN) (“eMagin” or the “Company”),
a U.S.-based leader in the development, design, and manufacture of Active-Matrix OLED microdisplays for high-resolution, AR/VR and other
near-eye imaging products, today announced that the Company has entered into a definitive merger agreement with Samsung Display Co., Ltd.
(“Samsung Display”), a subsidiary of Samsung Electronics Co., Ltd. (KRX: 005930) and manufacturer and distributor of
display products. Under the terms of the agreement, all outstanding shares of eMagin common stock on a fully diluted basis will be acquired
for $2.08 per share in cash, in a transaction valued at approximately $218 million.
The purchase price represents a premium of approximately
10% to eMagin’s closing stock price of $1.89 on May 16, 2023, and a premium of approximately 24% to eMagin’s six-month
volume-weighted average price of $1.68.
“This
agreement is a validation of our technical achievements to date including our proprietary direct patterning (dPd) technology, provides
a significant premium for our shareholders, and represents a win for our customers and employees,” said Andrew G. Sculley,
eMagin’s Chief Executive Officer. “By teaming with Samsung Display, we will be able to achieve the full potential of our
next-generation microdisplay technology with a partner that can provide the resources and expertise we will need to scale production.
Moreover, our customers will benefit from resulting improvements to our production capabilities in terms of yield, efficiency, and quality
control.”
President & Chief Executive Officer
of Samsung Display, Joo Sun Choi, emphasized the strategic significance of the acquisition, stating, “We expect XR (Extended
Reality) devices to have significant potential of growth in the future, and eMagin’s technology in this space will enable
Samsung to offer innovative products to more customers and strengthen its XR-related business.”
Following the closing of the transaction, eMagin
will continue to maintain its operations and facilities in Hopewell Junction, NY.
Approvals and Timing
eMagin’s Board of Directors has unanimously
approved the transaction and is recommending that eMagin’s stockholders approve the transaction and adopt the merger agreement
at a special meeting of stockholders to be called in connection with the transaction. Certain of eMagin’s stockholders who collectively
hold approximately 98% of the total voting power of eMagin’s Series B Convertible Preferred Stock, which is convertible into
approximately 21% of the total voting power of eMagin’s common stock on a fully diluted basis, have entered into a support agreement
pursuant to which they have committed to vote such shares in favor of the transaction.
The transaction is expected to close in the second
half of 2023, subject to the approval by eMagin’s stockholders, applicable regulatory approvals and other customary closing conditions.
Until closing, eMagin and Samsung Display remain separate and independent companies.
Advisors
Nomura Securities International, Inc. is
serving as exclusive financial advisor to eMagin. White & Case LLP and Goodwin Procter LLP are acting as the Company’s
legal counsel. Evercore Inc. is serving as exclusive financial advisor to Samsung Display and O'Melveny & Myers LLP is acting
as legal counsel.
About Samsung Display
Samsung Display is a global leader of cutting-edge
display solutions. The company diversifies display applications not only for smartphones, TVs, laptops, and monitors, but also smartwatches,
game consoles and automotive applications and has close partnerships with a variety of global manufacturers. Samsung Display is leading
the foldable display market based on its innovative technology, enabling the world’s first mass-production of OLED and Quantum
Dot-OLED, and endeavors to develop next-generation technology such as slidable, rollable, and stretchable displays to provide new experiences
and possibilities to consumers. Samsung Display prioritizes environmental and social values throughout the entire process of product
manufacturing. The company will further evolve into a sustainable company dedicated to the development and happiness of humanity. For
more information, please visit https://www.samsungdisplay.com /eng/index.jsp or https://global.samsungdisplay.com.
About eMagin Corporation
eMagin
is the leader in OLED microdisplay technology, enabling the visualization of digital information and imagery for world-class customers
in the military, consumer, medical and industrial markets. The Company invents, engineers, and manufactures display technologies of the
future and is the only manufacturer of OLED displays in the United States. eMagin's Direct Patterning Technology (dPd™) will transform
the way the world consumes information. Since 2001, eMagin's microdisplays have been used in AR/VR, aircraft helmets, heads-up display
systems, thermal scopes, night vision goggles, future weapon systems and a variety of other applications. For more information, please
visit www.emagin.com.
Cautionary Statement Regarding Forward-Looking
Statements
This
document contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A
of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements
are based on the Company’s current expectations, estimates and projections about the expected date of closing of the proposed transaction
and the potential benefits thereof, its business and industry, management’s beliefs and certain assumptions made by the Company
and Samsung Display, all of which are subject to change. In this context, forward-looking statements often address expected future business
and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,”
“plan,” “believe,” “could,” “seek,” “see,” “will,” “may,”
“would,” “might,” “potentially,” “estimate,” “continue,” “expect,”
“target,” similar expressions or the negatives of these words or other comparable terminology that convey uncertainty of
future events or outcomes. All forward-looking statements by their nature address matters that involve risks and uncertainties, many
of which are beyond our control, and are not guarantees of future results, such as statements about the consummation of the proposed
transaction and the anticipated benefits thereof. These and other forward-looking statements, including the failure to consummate the
proposed transaction or to make or take any filing or other action required to consummate the proposed transaction in a timely matter
or at all, are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results
to differ materially from those expressed in any forward-looking statements. Accordingly, there are or will be important factors that
could cause actual results to differ materially from those indicated in such statements and, therefore, you should not place undue reliance
on any such statements and caution must be exercised in relying on forward-looking statements. Important risk factors that may cause
such a difference include, but are not limited to: (i) the ability of the parties to consummate the proposed transaction in a timely
manner or at all; (ii) the satisfaction (or waiver) of closing conditions to the consummation of the proposed transaction, including
with respect to the approval of the Company’s stockholders; (iii) potential delays in the consummation of the proposed transaction;
(iv) the ability of the Company to timely and successfully achieve the anticipated benefits of the proposed transaction; (v) the
occurrence of any event, change or other circumstance or condition that could give rise to the termination of the merger agreement; (vi) the
impact of the COVID-19 pandemic and the current conflict between the Russian Federation and Ukraine on the Company’s business and
general economic conditions; (vii) the Company’s ability to implement its business strategy; (viii) significant transaction
costs associated with the proposed transaction; (ix) potential litigation relating to the proposed transaction; (x) the risk
that disruptions from the proposed transaction will harm the Company’s business, including current plans and operations; (xi) the
ability of the Company to retain and hire key personnel; (xii) potential adverse reactions or changes to business relationships
resulting from the announcement or completion of the proposed transaction; (xiii) legislative, regulatory and economic developments
affecting the Company’s business; (xiv) general economic and market developments and conditions; (xv) the evolving legal,
regulatory and tax regimes under which the Company operates; (xvi) potential business uncertainty, including changes to existing
business relationships, during the pendency of the proposed transaction that could affect the Company’s financial performance;
(xvii) restrictions during the pendency of the proposed transaction that may impact the Company’s ability to pursue certain
business opportunities or strategic transactions; and (xviii) unpredictability and severity of catastrophic events, including, but
not limited to, acts of terrorism or outbreak of war or hostilities, as well as the Company’s response to any of the aforementioned
factors. These risks, as well as other risks associated with the proposed transaction, will be more fully discussed in the proxy statement
to be filed with the SEC in connection with the proposed transaction (the “Proxy Statement”). Additional risks and
uncertainties that could cause actual outcomes and results to differ materially from those contemplated by the forward-looking statements
are included under the caption “Risk Factors” in the Company’s most recent annual and quarterly reports filed with
the SEC and any subsequent reports on Form 10-K, Form 10-Q or Form 8-K filed from time to time and available at www.sec.gov.
While the list of factors presented here is, and the list of factors presented in the Proxy Statement will be, considered representative,
no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant
additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with
those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial
loss, legal liability and similar risks, any of which could have a material adverse effect on the Company’s financial condition,
results of operations, or liquidity. The forward-looking statements included herein are made only as of the date hereof. The Company
does not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new
information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable
laws.
Additional Information and Where to Find It
In
connection with the proposed transaction between the Company and Samsung Display, the Company will file with the SEC a Proxy Statement,
the definitive version of which will be sent or provided to Company stockholders. The Company may also file other documents with the
SEC regarding the proposed transaction. This document is not a substitute for the Proxy Statement or any other document which the Company
may file with the SEC. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE PROXY STATEMENT AND ANY OTHER RELEVANT DOCUMENTS THAT ARE
FILED OR WILL BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS AND DOCUMENTS INCORPORATED BY REFERENCE
THEREIN, CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION AND
RELATED MATTERS. Investors and security holders may obtain free copies of the Proxy Statement (when it is available) and other documents
that are filed or will be filed with the SEC by the Company through the website maintained by the SEC at www.sec.gov, the Company’s
investor relations website at emagin.com/investors or by contacting the Company’s investor relations department at the following:
Investor Relations
investorrelations@emagin.com
Participants in the Solicitation
The Company and certain of its directors and
executive officers may be deemed to be participants in the solicitation of proxies from the Company’s stockholders in respect of
the proposed transaction and any other matters to be voted on at the special meeting. Information regarding the Company’s directors
and executive officers, including a description of their direct interests, by security holdings or otherwise, will be contained in the
Proxy Statement in connection with the proposed transaction. Company stockholders may obtain additional information regarding the direct
and indirect interests of the participants in the solicitation of proxies in connection with the proposed transaction, including the
interests of Company directors and executive officers in the proposed transaction, which may be different than those of Company stockholders
generally, by reading the Proxy Statement and any other relevant documents that are filed or will be filed with the SEC relating to the
proposed transaction. You may obtain free copies of these documents using the sources indicated above.
Contact
eMagin Corporation
Mark A. Koch
Chief Financial Officer
845-838-7900
investorrelations@emagin.com
Sharon Merrill
Associates, Inc.
Nicholas Manganaro
617-542-5300
eman@investorrelations.com